Nutrition Advisor LLC Directions
E-mail
Scientific references
Navigation
 

 
 


My Story
 

01-06-99 As a clinical scientist and a certified nutritionist, I probably would have never tried Calorad® if it had not been recommended to me by my best friend, Scott.

01-10-99 Purchased and started using Calorad® for the first time.

01-17-99 Day 7 - Weight loss ...4 lbs.

01-24-99 Day 14 - I lose 4 more lbs and decide to become a distributor!

02-10-99 Day 30 - I finish my first bottle and lose .. another 4 lbs for a total of 12 pounds!

02-10-99 Day 30 I have lost almost 12 pounds and over two and a half inches off my waist within my first four weeks on Calorad®.

02-10-99 Day 30 My wife, Lynn, loses three pounds and a total of five inches in the same time period.

02-24-99 Six weeks on the product. I experience increased energy, improved sleep, and several lipofuscin deposits (age spots) on my hands recede and totally disappear.

03-03-99 My wife, who previously suffered from frequent and rather severe bouts of insomnia, now 'sleeps like a baby.'

04-07-99 My teenage son and daughter also start to use the product and experience similar weight loss and muscle toning.

05-11-99 My sister loses 10 pounds and two dress sizes in three weeks, and she loves the product.

11-07-99 I decide to spread the word online, and establish my nutrition advisor website.

I can truly say that Calorad® is one of the best diet products I've ever seen!

In the 4 1/2 years since, we have sold over $1 million dollars of Calorad® online, and have seen many great Calorad® success stories.

Sincerely, Steve Petrosino.

Order Calorad® Now at our sale price!






 
 


Introduction

1. Berleston DM et al. Epidemiology of the killer chronic diseases. in: Nutrition and the Killer Diseases, ed. M. Winick, (New York: John Wiley and Sons, 1981), p 17-55.

2. Slattery ML et al, Trends in coronary heart disease mortality and food consumption in the US between 1909 and 1980. Am J Clin Nutr 1988; 47:1060-1067.

3. Brown JE, Identifying diet-disease relationships, in The Science of Human Nutrition, Harcourt Brace Jovanovich, 1990, p 7-10.

4. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: A review of the literature. Circulation 1993; 88(4, pt 1):1973-98.

5. LaRosa JC. Cholesterol Lowering, Low Cholesterol, and Mortality. Am J Cardiol 1993;72:776-786. 6. Blackburn H et al. Heart disease. in: Health and Preventive Medicine, 12th ed., ed. J. Last (Norwalk, Conn:Apple-Century-Croft, 1985), p 1159-1193.

7. Roemer MI. The value of medical care for health promotion. Am J Public Health 1984;74:243-248. 8. Vital Statistics of the United States, 1985; vol. II. Mortality Part A. National Center for Health Statistics, PHS# 88-1101, Washington DC: U.S. Government Printing Office, 1988.

9. Charting the Nation's Health Trends since 1960, DHHS publication no. (PHS) 85-125 (Washington D.C.:National Center For Health Statistics, 1985).

10. Eliot RS. Is it Worth Dying For? How to Make Stress Work For You Not Against You. Bantam, 1989.

11. Vital Statistics of the United States, 1985(1988); vol I, National Center for Health Statistics, PHS 88-1101, Washington D.C.: U.S. Government Printing Office.

12. Juvenile Justice Digest, Vol 1; Aug 4, 1993.

13. Hespel P. Changes in plasma lipids and apoproteins associated with physical training in middle-aged sedentary men. Am Heart J 1988; 115:786-792.

14. Houston, MC. New Insights and New Approaches for the Treatment of Essential Hypertension. Am Heart J 1989;117:911-951.

15. Kaplan, NM. Clinical Hypertension. 4th ed. Baltimore: The Williams and Wilkins Co, 1986:1-56. 16. The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-38.

17. Castelli WP. Epidemiology of Coronary Artery Disease: The Framingham Study. Am J Med 1984;76:4-12. 18. Hypertension Detection and Follow-up Program Cooperative Group. Five- year findings of the Hypertension Detection and Follow-up Program. JAMA 1979;242:2562-71.

19. Rowland M, Roberts J. Blood Pressure Levels in Persons 6-74 years: United States 1976-1980, Advance data. National Center for Health Statistics, Vital and Health Statistics. No. 84. Washington D.C.: United States Department of Health and Human Services, United States Public Health Service, October 8, 1982.

20. Neaton JD, Kuller LH, Wentworth D, Borhani NO. Total and cardiovascular mortality in relation to cigarette smoking, serum cholesterol concentration, and diastolic blood pressure among black and white males followed up for five years. Am Heart J 1984;108:759-69.

21. Castelli W, Leaf A. Identification and assessment of cardiac risk--an overview. Cardiology Clin 1985;3:171-8.

22. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. JAMA 1970;213:1143-52.

23. Smith WM. Treatment of mild hypertension: Results of a ten-year intervention trial. Circ Res 1977;40(Suppl I)I98-I105.

24. Perry HM Jr. Treatment of mild hypertension: Preliminary results of a two- year feasibility trial. Circ Res 1977;40(Suppl I)I180-I187.

25. Helgeland A. Treatment of mild hypertension: a five year controlled drug trial. The Oslo study. Am J Med 1980;69:725-32.

26. Report by the Management Committee. The Australian Therapeutic Trial in Mild Hypertension. Lancet 1980;1:1261-1267. 27. Greenberg G, Brennan PJ, Miall WE. Effects of diuretic and beta-blocker therapy in the Medical Research Council Trial. Am J Med 1984;76:45-51.

28. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial. Risk factor changes and mortality results. JAMA 1982;248:1465-1477.

29. Amery A, Birkenhager W, Brixko P, et al. Mortality and morbidity results from the European Working Party in High Blood Pressure in the Elderly trial.Lancet 1985;1:1349-54.

30. Mittinen TA, Huttunen JK, Naukkarlnen V et al. Multifactorial primary prevention of cardiovascular diseases in middle-aged men. Risk factor changes, incidence, and mortality. JAMA 1985;254:2097-2102.

31. Wilhelmsin L, Tibblin G, Werko, L. A primary preventive study in Gothenberg, Sweden. Prev Med 1972;1:153-60.

32. Kannel WB, Sorlie P. Hypertension in Framingham. In: Paul O, ed. Epidemiology and control of hypertension. New York: Stratton Intercontinental Medical Books, 1975:553.

33. Goldberg RJ, Gore JM et al. Recent changes in the attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA 1986;255:2774-9

34. Kannel WB, Eaker ED. Psychosocial and other features of coronary heart disease: Insights from the Framingham study. Am Heart J 1986;112:1066-73

35. Stamler J. Research related to risk factors. Circulation 1979;60(7):1575-87.

36. Kahn HA. Change in serum cholesterol associated with changes in the United States civilian diet, 1909-1965. Am J Clin Nutr 1970;23(7):879-882.

37. Wright JT Jr. Profile of systemic hypertension in black patients. Am J Cardiol 1988;61:41H-45H.

38. Weir MR, Saunders E. Pharmacologic management of systemic hypertension in blacks. Am J Cardiol 1988;61:46H-52H.

39. Kannel WB. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis 1974;17:5-24

40. Messerli FH. Management of essential hypertension in the black patient: Profiling as the initial approach to treatment. JAMA 1989;81(1):17-23

41. Rostand SG, Kirk KA et al. Racial differences in the incidence of treatment for end stage renal disease. N Engl J Med 1982;306:1276-1289.

42. Knapp JA, Haffner SM et al. Dietary intakes of essential nutrients among Mexican-Americans and Anglo-Americans: The San Antonio Heart Study. Am J Clin Nutr 1985;42:307-316.

43. Gillum RF, Liu KC. Coronary heart disease mortality in United States Blacks, 1940-1978: Trends and unanswered questions. Am Heart J 1984;108:728-732

44. Phillips JH, Bruce GE. A review of cardiovascular diseases in the white and negro races. Medicine 1960;39:241-289.

45. Watkins LO. Epidemiology of coronary artery disease in black populations: Methodologic proposals. Am Heart J 1984;108:635-640.

46. Levy RI, Feinleib M. Risk factors for coronary artery disease and their management. In: Braunwald E, ed. Heart Disease. A textbook of cardiovascular medicine. Philadelphia. WB Saunders, 1980:1246.

47. Kottke TE, Young DT, McCall MM. Effect of social class on recovery from myocardial infarction. Minn Med 1980;63:590-597.

48. Hagstorm RM, Federsteil CF, Ho WY. Incidence of myocardial infarction and sudden death from coronary artery disease in Nashville, Tennessee.Circulation 1971;44:884-890.

49. Cassel J, Heyden S, Bartel AG, et al. Incidence of coronary heart disease by ethnic group, social class and sex. Arch Intern Med 1971;128:901-906.

50. Tyroler HA, Knowles MG,et al. Ischemic heart disease risk factors and 20- year mortality in middle-age Evans County Black Males. Am Heart J 1984;108:738-746.

51. Cardiovascular and cerebrovascular disease. vol IV. Report of the Secretary's Task Force on Black and Minority Health, HHS, 1986.

52. Hiser E. "Obesity: Stress and the big gutted man." Nutrition Letter. Eating Well 1994;IV(4):93

53. Multiple Risk Factor Intervention Trial Research Group, JAMA 1982;248(12):1465-1477

54. McLanahan S., and Booth K. "Mother-only families: Problems, prospects and politics." Journal of Marriage and the Family 1989;51:557-580.

55. Davidson N. "Life without father." Policy Review, Winter 1990:40.

56. Hess T, "Recruiting fathers to heal a nation." Citizen 1993; 7(10):1-4.

57. Readership poll, Newsweek, August 30, 1993.

57. Friedman M and Rosenman RH. Type A Behavior and Your Heart. New York: Knopf, 1974

58. Selye H. Stress Without Distress. Philadelphia: Lippincott, 1974.

59. Biggs M. "The long lunch theory." Nutrition Letter. Eating Well 1994;IV(4):94

60. Clarkson TB, Weingand KW, et al. Mechanisms of atherogenesis. Circulation 1987;76(Suppl 1):20-28.

61. Armstrong BK, Mann JI et al. Commodity consumption and ischemic heart disease mortality, with special references to dietary practices. J Chron Dis 1975;28:455-469.

62. Harper AE. Coronary heart disease-an epidemic related to diet? Am J Clin Nutr 1983;37:669-681.

63. Stallones RA. The rise and fall of ischemic heart disease. Sci Am 1980;243:53-9.

64. Kiplinger Washington Editors. The Kiplinger Washington Letter 1994;71(6):2

65. Ravnskov U. Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. British Med J 1992;305:15-19

66. Cifkova, R. Science News 139,16:246

67. Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991;53:326S-334S

68. Vitamin C and high density lipoprotein. Medical World News (32,8:11)

69. Manson JE, Stampfer MJ, et al. Antioxidant vitamins and secondary prevention of cardiovascular disease in high risk women. Circulation 1993; 88,4(Pt 2):I70

70. Mattiasson I, Lindgarde F, Nilsson JA, Theorell T. Threat of unemployment and cardiovascular risk factors: longitudinal study of quality of sleep and serum cholesterol concentrations in men with threatened redundancy. British Med J 1990; 301:461-6.

71. Edelstein SL, Barrett-Connor E, Wingard D, Cohn B. Increased meal frequency associated with decreased cholesterol concentrations: Rancho Bernardo, CA 1984-1987. Am J Clin Nutr 1992;55:664-9.

72. Maynard C., Weaver W. et al. Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the myocardial infarction triage and intervention project. Am J Cardiol 1993;72:877-882.

73. Gillum RF. Acute myocardial infarction in the United States, 1970-1983. Am Heart J. 1987;113:804-811. 74. Neaton JD, Blackburn H et al. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Int Med 1992;152:1490-1500

75. Jacobs D, Blackburn H. et al. Report on the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-1060.

76. Hulley SB, Walsh JMD, Newton TB. Health policy on blood cholesterol: Time to change directions. Circulation 1992;86:1026-1029.

77. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials.

78. Br Med J 1990;301:309-314. 78. Warram JH,Lori MB, et al. Excess mortality associated with diuretic therapy in diabetes mellitus. Arch Intern Med 1991;151:1350-1356

79. Aberg A, Bergstrand R, Johansson S. et al. Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J 1983;49:416-422.

80. Davenport J. Whittaker K. Secondary prevention in elderly survivors of heart attacks. AFP 1988;38(1):216-224

81. Schlant RC, Forman S et al. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project. Circulation 1982;66:401-14.

82. The prognostic importance of plasma glucose levels and of the use of oral hypoglycemic drugs after myocardial infarction in men. Diabetes 1977;26:453- 65.

83. Haft JI. Role of blood platelets in coronary artery disease. Am J Cardiol 1979;43(6):1197-206.

84. Eliot RS. Coronary artery disease:Biobehavioral factors. Circulation 1987;76(Suppl I):I110-11.

85. Blumenthal JA, Levenson RM. Behavioral approaches to secondary prevention of coronary heart disease. Circulation 1987;76(1Pt2):I130-7.

86. Shaw LW. Effects of a prescribed supervised exercise program on mortality and cardiovascular morbidity in patients after a myocardial infarction. The National Exercise and Heart Disease Project. Am J Cardiol 1981;48(1):39-46.

87. Leon AS, Connett J et al. Leisure-time physical activity levels and risk of coronary heart disease and death. The Multiple Risk Factor Intervention trial.JAMA 1987;258:2388-95.

88. Saltin B. Lindgarde F. et al. Physical training and glucose tolerance in middle-aged men with chemical diabetes. Diabetes 1979;28(Suppl 1):30-2.

89. Freknay GA, Leslie DK. Effects of an exercise program on selected flexibility measurements of senior citizens. Gerontologist 1975;15:182-3.

90. Seals DR, Allen WK et al. Elevated high density lipoprotein cholesterol levels in older endurance athletes. Am J Cardiol 1984;54(3):390-3.

91. Blackburn H, Taylor HL et al. Premature ventricular complexes induced by stress testing. Their frequency and response to physical conditioning. Am J Cardiol 1973;31(4):441-9.

92. Trial of clofibrate in the treatmment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region. Br Med J 1971;790(4):767-75.

93. Clofibrate and niacin in coronary heart disease. JAMA 1975;231:360-81.

94. Ischaemic heart disease:a secondary prevention tria using clofibrate. Report by a research committee of the Scottish Society of Physicians. Br Med J 1971;790(4):775-84.

95. Wilhelmsson C, Vedin JA et al. Smoking and myocardial infarction. Lancet 1975;1(7904):415-20.

96. Koenig K. Recommendations of the scientific councils of the International Society and Federation of Cardiology on risk reduction after myocardial infarction. Adv Cardiol 1986;33:28-39.

97. Sparrow D, Dawber TR. The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. J Chron Dis 1978;31(6-7):425-32.

98. Intact group investigators. Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990;335:1109-13.

99. Houston MC. New insights and approaches to reduce end-organ damage in the treatment of hypertension: Subsets of hypertension approach. Am Heart J 1992;123:1337-67.

100. Stamler J, Stamler R. Intervention for the prevention and control of hypertension and atherosclerotic diseases: United States and international experience. Am J Med 1984;76:13-36.

101. Moser M. Clinical trials, diuretics, and the management of hypertension. Arch Intern Med 1984;144:789-93.

102. Abbott RD, Yin Y et al. Risk of stroke in male cigarette smokers. New Engl J Med 1986;315:717-20.

103. Colditz GA, Bonita R, et al. Cigarette smoking and risk of stroke in middle-aged women. New Engl J Med 1988;318:937-41.

104. Miller GD, Kuller LH. Trends in mortality from stroke in Baltimore, Maryland: 1940-1941 through 1968-1969. Am J Epidemiol 1973;98:233-42.

105. Acheson RM, Williams DRR. Does consumption of fruits and vegetables protect against stroke? Lancet 1983; 1:1191-3. 106. Khaw KT,Barrett-Conner E. Dietary potassium and stroke-associated mortality:a 12-year prospective population study. New Engl J Med 1987;316:235-40.

107.Barber DJP, Osmond C. Death rates from stroke in England and wales predicted from past maternal mortality. Br Med J 1987;295:83-6.

108. Covey, S.R. The Seven Habits of Highly Effective People. Fireside: Simon and Schuster. New York, 1990

109. Robertson P. The Turning Tide: The Fall of Liberalism and the Rise of Common Sense. Dallas: Word, 1993.

110. Gillman MW, Kannel WB, Belanger A, D'Agostino RB. Influence of heart rate on mortality among persons with hypertension: The Framingham Study. Am Heart J 1993;125:1148-1154.

111. Hespel P. et al. Changes in plasma lipids and apoproteins associated with physical training in middle aged sedentary men. Am Heart J 1988;115:786-92.

112. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 1993;329:103-9.

113. Keil JE, Sutherland S, Knapp R, Lackland D, Gazes P, Tyroler H. Mortality rates and risk factors for coronary disease in black as compared to white men and women. N Engl J Med 1993;329:73-8.

114. Guralnik J, Land K, Blazer D, Fillenbaum G, Branch L. Educational status and life expectancy among older blacks and whites. N Engl J Med 1993; 329:110-6.

115. McGinnis J, Foege W. Actual causes of death in the United States. JAMA 1993;270:2207-2212. 116. Brenner MH. Economic change, alcohol consumption and heart disease mortality in nine industrialized countries. Soc Sci Med 1987;25:119-32.

117. Starrin B, Larsson G, Brenner SO. Regional variations in cardiovascular mortality in Sweden--structural vulnerability in the local community. Soc Sci Med 1988;27:911-7.

118. Moser KA, Goldblatt PO, Fox AJ, Jones DR. Unemployment and mortality:comparisons of the 1971 and 1981 longitudinal study census sample. Br Med J 1987;294:86-90.

119. Beale N, Nethercott S. Job loss and health--the influence of age and previous morbidity. J R Coll Gen Pract 1986;36:261-4.

120. Kammerling R, O'Connor S. Unemployment rate as predictor of rate of psychiatric admission. Br Med J 1993;307:1536-9.

121. Faris REL, Dunham HW. Mental disorders in urban areas. Chicago:Hafner, 1939.

122. Bolton W, Oatley K. A longitudinal study of social support and depression in unemployed men. Psychol Med 1987;17:453-60.

123. Melville D, Hope D, Bennison D, Barraclough B. Depression among men made involuntarily redundant. Psychol Med 1985;15:789-93.

124. Eales MJ. Depression and anxiety in unemployed men. Psychol Med 1988;18:935-45.

125. Campbell DA,Radford JMC, Burton P. Unemployment rates; an alternative to the Jarman index? Brit Med J 1991;303:750-5.

126. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res 1967;11:213-218.

127. Kessler RC, Turner JB, Hoare JS. Unemployment and emotional functioning in a community sample. Am Sociol Rev 1989;24:648-57.

128. Newton J. Preventing mental illness. Routledge:London, 1988.

129. Kaplan GA, Keil JE. "Socioeconomic Factors and Cardiovascular Disease: A review of the Literature", American Heart News, Nov. 10, 1993.

130. Haan M, Kaplan GA, Camacho T. Poverty and health: prospective evidence from the Alameda County Study. Am J Epidemiol 1987;125:989-998.

131. Wilson TW, Kaplan GA, Kauhanen J, Cohen RD, Wu M, Salonen R, Salonen JT. The association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study.Am J Epidemiol 1993;137:292-300.

132. Marmot MG,Kogevinas M,Elston MA. Social/economic status and disease. Ann Rev Public Health 1987; 8:111-135.

133. Goldberg KC, Hartz AJ, Jacobsen SJ, Krakauer H, Rimm AA. Racial and community factors influencing coronary artery bypass graft surgery rates for all 1986 Medicare patients. JAMA 1992; 267:1473-1477.

134. Ford E, Cooper R, Castaner A, Simmons B, Mar M. Coronary arteriography and coronary bypass surgery among white and other racial groups relative to hospital-based incidence rates for coronary artery disease: findings from the NHDS. Am J Public Health 1989; 79:437-440.

135. Oberman A,Cutter G. Issues in the natural history and treatment of coronary heart disease in black populations: surgical treatment. Am Heart J. 1984;108(Pt 2):688-694.

136. Maynard C, Fisher LD, Passamani ER, Pullum T. Blacks in the Coronary Artery Surgery Study (CASS): race and clinical decision making. Am J Public Health 1986;76:1446-1448.

137. Holme I, Helgeland A, Hjermann I, Leren P. Socioeconomic status as a coronary risk factor: The Oslo study. Acta Med Scand Suppl 1982; 660:147-151.

138. Doornbos G, Kromhout D. Educational level and mortality in a 32-year follow-up study of 18-year old men in the Netherlands. Int J Epidemiol 1990;19:374-379.

139. Fox AJ, Goldblatt PO. Longitudinal study 1971-1975: England and Wales. Office of Population Censuses and Surveys. London: Her Majesty's Stationery Office; 1982.

140. Salonen JT. Socioeconomic status and risk of cancer, cerebral stroke, and death due to coronary heart disease and any disease: a longitudinal study in eastern Finland. J Epidemiol Community Health 1982;36:294-297.

141. Hirdes JP,Forbes WF. The importance of social relationships, socioeconomic status and health practices with respect to mortality among healthy Ontario males. J Clin Epidemiol 1992;45:175-182.

142. Keil JE, Loadholt CB, Weinrich MC, Sandifer SH, Boyle E Jr. Incidence of coronary heart disease in blacks in Charleston, South Carolina. Am Heart J 1984; 108(Pt 2):779-786.

143. Rogot E, Sorlie PD, Johnson NJ, Schmitt. A mortality study of 1.3 million persons by demographic, social and economic factors: 1979-1985 Follow-up.National Institutes of Health. 1992. NIH Publication No. 92-3297:1-5.

144. Kitagawa EM, Hauser PM. Differential Mortality in the United States: A Study in Socioeconomic Epidemiology. Cambridge, Mass: Harvard University Press; 1973.

145. Schmieder RE, Ruddel H, von Eiff AW. Cardiovascular Therapy and Stress. In Messerli FH (ed): Cardiovascular Drug Therapy Philadelphia: WB Saunders, 1990:219-228.

146. Selye H: Forty years of stress research. The principal remaining problems and misconceptions. Can Med Assoc J 115:53, 1976.

147. Selye H: The stress concept. In Wheatley D (ed). Stress and the Heart. New York: Raven Press,1977:1-11.

148. Eliot RS, Buell JC, Dembroski TM. Biobehavioral perspectives on coronary artery disease, hypertension and sudden cardiac death. Acta Med Scand 1982; (Suppl)660:203.

149. Eliot RS, Buell JL. The role of CNS in cardiovascular disorders. Hosp Pract 1983; 18:189

150. Keys A, Simonsen E. Mortality and coronary heart disease among men studied for 23 years. Arch Intern Med 1971;128:201.

151. Morgan KJ, Stampley GL, Zambik ME et al. Magnesium and calcium dietary intakes of the US population. J Am Coll Nutr 1985;4:195.

152. Ruddel H, Gogolin E, Neus H. Magnesium and kardiovaskulare Reaktivitat wahrend Belastungsuntersuchungen. Magnesium Bull 1982;4:98

153. Altura BM, Altura BT. Role of magnesium ions in contractility of blood vessels and skeletal muscles. Magnesium Bull 1981;3:102.

154. Altura BM, Altura BT, Gebrewold A, et al. Magnesium deficiency and hypertension: Correlation between magnesium-deficient rats and microcirculatory changes in situ. Science 1984;223:1315.

155. Schmieder R, Ruddel H, Neus H et al. Magnesium homeostasis in hypertensives: Impact on hemodynamic pattern at rest and during challenge (abstract). J Am Coll Nutr 1985;4:378.

156. MacGregor G, Markandu N, Smith S et al. Moderate potassium supplementation in essential hypertension. Lancet 1982;2:567-570.

157. Khaw K, Thom S. Randomized double blind cross-over trial of potassium on blood pressure in normal subjects. Lancet 1982;2:1127-1129.

158. Khaw K, Barrett-Conner E. Dietary potassium and blood pressure in a population. Am J Clin Nutr 1984;39:963-968.

159. Ophir O, Peer G, Gilad J, et al. Low blood pressure in vegetarians: The possible role of potassium. Am J Clin Nutr 1983;37:755-762.

160. Facts from the Current Population Survey, March Supplement. Bureau of the Census: The Changing Situation of Americans and their Families. U.S.Department of Commerce Economics and Statistics Administration; CPS-676 (11/93)

161. Facts Sheet for the Current Population Survey. Bureau of the Census: U.S. Department of Commerce Economics and Statistics Administration; US GPO 1992-0-330-846; BC-1433(06/92)

162. Narins RG. Mild hypertension: a therapeutic dilemma. Kidney Int 1984;26:881-94.

163. Stern MP, Brown BW, Haskel WL et al. Cardiovascular risk and the use of oestrogens or estrogen-progestagen combinations. JAMA 1976;235:811.

164. Falkner B, Onesti G, Angelakos ET. Hemodynamic response to mental stress in normal adolescents with varying degree of genetic risk for essential hypertension. In Yamori Y, Lovenberg W, Freis E (eds): Prophylatic Approach to Hypertensive Diseases. New York: Raven Press, 1979:pp 149-156.

165. Neus H, Ruddel H, Schulte W. The long term effect of noise on blood pressure. J Hypertension 1985;3:31.

166. von Eiff AW. The role of the autonomic nervous system in the etiology and pathogenesis of essential hypertension. Jpn Circ J 1970;34:147.

167. von Eiff AW, Schulte W, Hensch G. Classification of homogeneous blood pressure groups and the specific hemodynamic pattern of borderline hypertension. In Yamori Y, Lovenberg W, Freis E (eds): Perspectives in Cardiovascular Research. Prophylatic Approach to Hypertensive Diseases. New York: Raven Press, 1979:pp 315-319.

168. Brod J, Fencl V, Hejl Z. Circulatory changes underlying blood pressure elevation during acute emotional stress (mental arythmetic) in normotensive and hypertensive subjects. Clin Sci 1959;18:269.

169. von Eiff AW, Gogolin E, Jacobs U et al. Heart rate reactivity under mental stress as a predictor of blood pressure development in children. J Hypertension 1985;3(Suppl 4):89.

170. von Eiff AW, DFG-Forschungsbericht Bonn-Bad Godesberg. Fluglarmwirkungen. Eine interdisziplinare Untersuchung uber die Auswirkungen des Fluglarms auf den Menschen. Der medizinische Untersuchungsteil. Bd. I. Bolt, Boppard, 1974, pp 349-424.

171. Cobb S, Rose RM. Hypertension, peptic ulcer and diabetes in air traffic controllers. JAMA 1973;244:489.

172. Schmeider RE, Messerli FH, Ruddel H. Risk for arterial hypertension. Cardiol Clin 1986;4:57.

173. Bright MB: A follow-up study of the commission on chronic illness morbidity survey in Baltimore: I. Tracing a large population sample over time. J Chronic Dis 1967;20:707-716.

174. Carpenter A. Facts About the Cities. New York, NY: HW Wilson Co; 1992.

175. Lombardi G, Gallagher EJ, Gennis P. Outcome of Out-of-Hospital Cardiac Arrest in New York City: The Pre-Hospital Arrest Survival Evaluation (PHASE) Study. JAMA 1994;271:678-683.

176. Becker LB, Ostrander MP, Barrett J, Kondos GT. Outcome of cardiopulmonary resuscitation in a large metropolitan area: where are the survivors? Ann Emerg Med 1991;20-355-361.

177. Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans: a matter of continuing concern. JAMA 1989;261:278-281.

178. Becker LB, Han BH, Meyer PM et al. Racial differences in the incidence of cardiac arrest and subsequent survival. N Engl J Med 1993;329:600-606.

179. Cowie MR, Fahrenbruch CE, Cobb LA, Hallstrom AP. Out of hospital cardiac arrest: racial differences in outcome in Seattle. Am J Public Health 1993;83:955-959.

180. Hecker MM. Report of the Secretary's Task Force on Black and White Minority Health: Volume 1, Executive Summary. Washington, DC:US Government Printing Office; 1985.

181. Lee I-M, Manson J, et al. Body weight and mortality: a 27-year follow-up of middle-aged men. JAMA 1993;270:2823-2828.

182. Whitehead M. The Black Report and The Health Divide. In: Townsend P, Davidson N eds. Inequalities in Health. London, England: Penquin; 1992.

183. Fagerberg B, Anderson O, Isaksson B, et al. Blood pressure control during weight reduction in obese hypertensive men: Separate effects of sodium and energy restriction. Br Med J 1984;288:11-14.

184. Meneely G, Battarbee H. High sodium-low potassium environment and hypertension. Am J Cardiol 1976;3:318-326.

185. Prineas R, Blackburn H. Clinical and epidemiological relationships between electrolytes and hypertension. In: Horan M, Blaustein M, Dunbar J et al., eds.NIH Workshop on Nutrition and Hypertension. New York: Biomedical Information Corp. 1985.

186. Porter G. Chronology of the sodium hypothesis in hypertension. Ann Intern Med 1983;98(5, pt 2):720-724.

187. Dahl L. Salt intake in hypertension. In: Genset J, ed. Hypertension. New York: McGraw-Hill Book Co.,548-558. 1977.

188. Glieberman L. Blood pressure and dietary salt in human populations. Ecol Food Nutr 1973;2:143-146.

189. Morgan T, Adam W, Gilles A, et al. Hypertension treated by salt restriction. Lancet 1978;1:227-230.

190. Gruchow H, Sobcinski K, Baboriak J. Alcohol, nutrient intake, and hypertension in U.S. adults. JAMA 1985;253(11):1567-1570.

191. Harlan W, Hull A, Schmouder R et al. Blood pressure and nutrition in adults. Am J Epidemiol 1985;120:17-28.

192. McCarron D, Morris C, Henry H. Blood pressure and nutrient intake in the United States. Science 1984;224:1392-1398.

193. Malarkey W. Perception of social support and blood pressure. Ohio State University General Clinical Research Center. Personal communication, Feb 24, 1994.

194. Watson R, Langford H, Abernathy J et al. Urinary electrolytes, body weight, and blood pressure: Pooled cross-sectional results among four groups of adolescent females. Hypertension 1980;2(suppl I):93-98.

195. McCarron D, Morris C, Cole C. Dietary calcium in human hypertension. Science 1982;217:267-269.

196. Barret-Conner E, Suarez L. Dairy products, calcium and blood pressure. Am J Clin Nutr 1983;38:457-461.

197. Kagan A, Yano K, Rhoads G, McGee D. Alcohol and cardiovascular disease: The Hawaiian experience. Circulation 1981;64(2):27-31, monograph 81.

198. Klatsky A, Friedman G. Alcohol and Hypertension. In: Horan M, Blaustein M, Dunbar J et al., eds. NIH Workshop on Nutrition and Hypertension. New York: Biomedical Information Corp. 1985.

199. Dyer A, Stamler J, Pauo O, et al. Alcohol, cardiovascular risk factors, and mortality: The Chicago experience. Circulation 1981;64(2):20-30, monograph 81.

200. Elmer P. Dietary methods in cardiovascular disease critique. in: Vital and Health Statistics, Dietary Methodology Workshop for the Third National Health and Nutrition Examination Survey, National Center for Health Statistics, U.S. Department of Health and Human Services.Series 4; No. 27:35. 1992.

201. Wallace R, Lynch C, Promrehn M et al. Alcohol and hypertension: Epidemiologic and experimental considerations. The Lipid Research Clinics Program. Circulation 1981;64(2):41-47, monograph 81.

202. Gordon T, Ernst N, Fisher M, Rifkind B. Alcohol and high density lipoprotein cholesterol. Circulation 1981;64(2)63-66, monograph 81.

203. Calahan D. Quantifying alcohol consumption: Patterns and problems. Circulation 1981;64(2):7-13, monograph 81.

204. Gentry E, Kalsbeek W, Hogelin G, et al. The risk factor surveys. II. Design, methods, and estimates from combined state data. Am J Prev Med 1985;1(6):9-14.

205. Shekelle RB, Shryock AM, Paul O, et al. Diet, serum cholesterol, and death from coronary heart disease: The Western Electric Company Study. N Engl J Med 1981;304:65-70.

206. Shekelle RB, Stamler J, Paul O et al. Dietary lipids and serum cholesterol level: Change in diet confounds the cross-sectional association. The Western Electric Study. Am J Epidemiol 1982;115:506-514.

207. Prineas R, Jacobs D, Crow R, et al. Coffee, tea and VPB. J Chron Dis 1980;33:67-72.

208. McCarron D, Morris C. Calcium and Hypertension. In: Horan M, Blaustein M, Dunbar J et al., eds. NIH Workshop on Nutrition and Hypertension. New York: Biomedical Information Corporation. 1985.

209. Henry H, Morris C, Parrott-Garcia M. Increasing calcium intake lowers blood pressure: The literature reviewed. J Am Dietet Assoc 1985;85:182-5.

210. Johnson NE, Smith E, Freudenheim J. Effects on blood pressure of calcium supplementation of women. Am J Clin Nutr 1985;42:12-17.

211. McCarron M, Morris C, Cole C. Blood pressure response to oral calcium in persons with mild to moderate hypertension. Ann Intern Med 1985;103:825-831.

212. Tillotson JL, Kato MA, Nichaman MZ, et al. Epidemiology of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: Methodology for comparison of diet. Am J Clin Nutr 1973;26:177- 184.

213. Kato MA, Tillotson JL, Nichaman MZ et al. Epidemiological studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California. Am J Epidemiol 1973;97:372-385.

214. Seeman I. National Mortality Followback Survey: 1986 Summary, United States. National Center for Health Statistics. Vital Health Stat 20(19);1992

215. U. S. Bureau of the Census. Current Population Reports, P23-181, Households, Families, and Children: A 30-Year Perspective. U.S. Government Printing Office, Washington, D.C., 1992.

216. Vital Statistics of the United States, 1988; vol. II. Mortality Part A. National Center for Health Statistics, PHS# 91-1101, Washington DC: U.S. Government Printing Office, 1991.

217. Vital Statistics of the United States, 1989; vol. II. Mortality Part B. National Center for Health Statistics, PHS# 92-1102, Washington DC: U.S. Government Printing Office, 1992.

218. Ries P. Educational differences in health status and health care. National Center for Health Statistics. Vital Health Stat 10(179). 1991.

219. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the United States: Projections to the year 2000. JAMA 1989;261:61-65.

220. Suarez L, Barrett-Connor E. Interaction between cigarette smoking and diabetes mellitus in the prediction of death attributed to cardiovascular disease. Am J Epidemiol 1984;120(5):670-675

221. U.S. Department of Health and Human Services: The Health Consequences of Smoking: Cardiovascular Disease. A report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health. 1983.

222. U.S. Department of Health and Human Services: Reducing the Health Consequences of Smoking--25 years of progress. A report of the Surgeon General. U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health.1989.

223. MacKenzie TD, Bartecchi CE Schrier RW. The human costs of tobacco use. N Engl J Med 1994;330:975-980.

224. Ashcroft J, chairman. Famlies First. Report of the National Comission on America's Urban Families. U.S. Government Printing Office, Washington D.C. 1993.

225. Eliot RS, Morales-Ballejo HM. The Heart, Emotional Stress, and Psychiatric Disorders. In: Schlant RC, Alexander RW, ed. Hurst's the Heart: Arteries and Veins. 8th ed., McGraw Hill, Inc. New York. 1994.

226. Eliot RS. From Stress to Strength: How toLightenYour Load and SaveYour Life. Bantam. New York. 1994.

227. Dimsdale JE, Herd JA. Variability of plasma lipids in response to emotional arousal. Psychosom Med 1982;44:413-430.

228. van Doornen LJP, Orlebeke KF. Stress, personality and serum cholesterol level. J Human Stress 1982;8:24-29.

229. Freeman LJ Nixon PGF et al. Psychological Stress and silent myocardial ischemia. Am Heart J 1987;114:477-482.

230. Lown B, DeSilva RA, et al. Psychophysiologic factors in sudden cardiac death. Am J Psychiatry 1980;137:1325-1335.

231. Verrier Rl, Lown B. Behavioral stress and cardiac arrythmias. Ann Rev Physiol 1984;46:155-176.

232. Baroldi G, Fazi G, Mariani F. Sudden coronary death: A postmortem study in 208 selected cases compared to 97 "control" subjects. Am Heart J 1979;98:20-31.

233. Tazalaar HD, Karch SB et al. Cocaine and the heart. Hum Pathol 1987;18:195-199.

234. Harburg E, Schull WJ, et al. A family set method for determining heredity and stress: I. A pilot survey of blood pressure among Negroes in high and low stress areas, Detroit, 1966-1967. J Chronic Dis 1970;23:83-92.

235. Faulkner B, Kushner H et al. Sodium sensitivity, growth, and family history of hypertension in young blacks. J Hypertens 1986;4 (suppl 5): S381-S383.

236. Syme SL. Socioenvironmental factors in heart disease. In: Beamish RE, Singal PK, Dhalla ND, (eds): Stress and Heart Disease. Boston. Martinus Nijhoff Publishing. 1985:60-70.

237. Marmot MG, Syme SL. Acculturation and coronary heart disease in Japanese Americans. Am J Epidemiol 1976;104:225-247.

238. Berkman LF, Syme SL. Social Networks, host resistance, and mortality: A nine-year follow-up study of Alameda county residents. Am J Epidemiol 1979;109:186-204.

239. Clarkson TB, Kaplan JR et al. Psychosocial influences on the pathogenesis of atherosclerosis among non-human primates. Circulation 1987;76(Suppl 1):29- 40.

240. Nerem RM, Levesque MJ, Cornhill JF. Social environment as a factor in diet-induced aortic atherosclerosis in rabbits. Science 1980;208:1475-1476.

241. Williams RB Jr, Barefoot JC, Shekelle RB. The health consequences of hostility. In: Chesney MA, Rosenman RH. (eds): Anger and Hostility in Cardiovascular and Behavioral Disorders. Washington, D.C. Hemisphere Publishing. 1985:173-185.

242. Rosenman RH, Brand RJ et al. Coronary Heart Disease in the Western Collaborative Group Study: Final follow-up experience of 81/2 years. JAMA 1975;233:872-877.

243. Julius M, Harburg E, et al. Anger-coping types, blood pressure, and all cause mortality: A follow-up in Techumseh, Michigan (1971-1983). Am J Epidemiol 1986;124:220-233.

244. Jefferson JW. Biologic treatment of depression in cardiac patients. Psychosomatics 1987;26(suppl 11):31-36.

245. Chodzko-Zajko WJ, O'Connon PJ. Plasma Cortisol, the dexamethasone supression test and depression in normal adult males. J Psychosom Res 1986;30:313-320.

246. Sims A. Neurosis and mortality: Investigating an association. J Psychosom Res 1984;28:353-362.

247. Baker S, Henry R. Parent's Guide to Nutrition. D. Estridge, ed. Addison- Wesley. Reading, Massachusetts. 1992.

248. Dossey L. Healing Words: The Power of Prayer and the Practice of Medicine. Harper: San Fransisco. 1993.

249. Byrd RC. Positive therapeutic effects of intercessory prayer in a coronary care unit population. Southern Medical Journal 1988;81(7):826-829.

250. Markovitz, JH, Matthews KA, et al. Psychological predictors of hypertension in the Framingham study: Is there tension in hypertension? Journal of the American Medical Association 1993;270:2439-2443.

251. Rosengren A, Orth-Gomer K, et al. Stressful life events, social support, and mortality in men born in 1933. British Medical Journal 1993;307:1102-1105.

252. Marceau M, Kouame N, et al. Effects of different training intensities on 24-hour blood pressure in hypertensive subjects. Circulation 1993; 88:2803-2811

253. Whitney EN, Rolfes SR. Diet and Health. in: Understanding Nutrition, 6th edition. West. Minneapolis. 1993.

254. Ullrich IH, Reid CM, Yeater RA. Increased HDL cholesterol levels with a weight lifting program. Southern Medical Journal 1987;80:328-331.

255. Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. New England Journal of Medecine 1989;320:1177-1182.

256. Krishna GG, Kapoor SC. Potassium depletion exacerbates essential hypertension. Annals of Internal Medicine 1991;115:77-82.

257. McCarron et al. Dietary calcium and blood pressure: Modifying factors in specific populations. Am J Clin Nutr (suppl) 1991;54:215-219.

258. Clark K. Calcium and Hypertension: Does a relationship exist? Nutrition Today July/Aug 1989, pp. 21-26.

259. Keleman MH and coauthors. Exercise training combined with antihypertensive drug therapy: Effects on blood lipids,blood pressure, and left ventricular mass. JAMA 1990;263:2766-2771.

260. Massie BM. To combat hypertension, increase activity. The Physician and Sportsmedicine 1992;20:89-111.

261. Caspersen CJ, Christenson GM, Pollard RA. Status of the 1990 physical fitness and exercise objectives: evidence from NHIS 1985. Public Health Rep.1986;101:587-592.

262. Millar WJ, Wigle DT. Socioeconomic disparities in risk factors for cardiovascular disease. Can Med Assoc J. 1986;134:127-132.

263. Helmert U, Herman B, et al. Social class and risk factors for coronary heart disease in the Federal Republic of Germany: results of the baseline survey of the German Cardiovascular Prevention Study (GCP). J Epidemiol Community Health 1989;43:37-42.

264. Rimm IJ, Rimm AA. Association between socioeconomic status and obesity in 59,566 women. Prev Med. 1974;3:543-572.

265. Oken B, Hartz A, Giefer E, Rimm AA. Relationship between socioeconomic status and obesity changes in 9046 women. Prev Med.1977;6:447-453.

266. Stevens J, Keil JE et al. Body mass index and body girths as predictors of mortality in black and white men. Am J Epidemiol 1992;135:1137-1146.

267. Garn SM, Ryan AS. Replicating the income-related reversal of fatness. Ecology of Food and Nutrition. 1981;10:237-239.

268. Garn SM, Hopkins PJ, Ryan AS. Differential fatness gain of low income boys and girls. Am J Clin Nutr. 1981;34:1465-1468.

269. Junshi C, Campell TC, Junyao L, Peto R. Diet, Lifestyle, and Mortality in China: A study of the Characteristics of 65 Chinese Counties. Oxford, England: Oxford University Press; Ithaca, NY:Cornell University Press; China:Peoples Medical Publishing House. volumes I, and II; 1990. (ISDN: 0-19-261843-1).

270. de Lorgeril M, Marmelle N, et al. A Mediterranean-type Diet in the Secondary Prevention of Coronary Heart Disease. Circulation 1993;88(4 part 2, supplement);abs# 3415:I-635.

271. Beasley RP, Bulger RJ et al, eds. Does a High-Fat Diet Promote Development of Diabetes? The University of Texas Houston Health Science Center Lifetime Health Letter. March 1994, 6(3):6

272. Popkin BM, Kenou G, Zhai F et al. The nutrition transition in China: a cross-sectional analysis. Eur J Clin Nutr 1993 May;47(5):333-346.

273. Kafatos A, Kouroumalis I, et al. Coronary heart disease risk-factor status of the Cretan urban population in the 1980s. Am J Clin Nutr 1991;54:591-598.

274. Kuller LH. Epidemiology of cardiovascular diseases: current perspectives. Am J Epidemiol 1976;104:425-496.

275. Keys A. Nutrition in relation to etiology and course of degenerative diseases. J Am Dietet Assn 1948;24:281-295.

276. Keys A, Anderson JT. The relationship ot the diet to the development of atherosclerosis in man. In: Symposium on Atherosclerosis. Nat Acad Sci 1954;338;181

277. Antar MA, Ohlson MA, Hodges RE. Changes in retail market food supplies in the United States in the last seventy years in relation to the incidence of coronary heart disease, with special reference to dietary carbohydrates and essential fatty acids. Am J Clin Nutr 1964;14:169-178.

278. Wells AF, Ershoff BH. Beneficial effects of pectin in prevention of hypercholesterolemia and increase in liver cholesterol in cholesterol-fed rats. J. Nutrition 1961;74:87.

279. Roe, DA. Geriatric Nutrition, Third ed. Englewood Cliffs, N.J.: Prentice Hall. 1992.

280. Klatsky AL, Armstrong MA. Alcohol and 22 Year Coronary Disease Mortality. Circulation 1993 Oct;88(4 part 2);abstract 364:I-70.

281. Sharma, H. How to control free radicals, a major cause of aging and disease. Freedom from Disease. Veda Publishing. Toronto. 1994.

282. Margetts BM, Jackson AA. Interactions between people's diet and their smoking habits: the dietary and nutritional survey of British adults. British Medical Journal 1993;307:1381-1384.

283. Thompson RL, Margetts BM et al. Cigarette smoking and food and nutrient intakes in relation to coronary heart disease. Nutrition Research Reviews 1992;5:131-152.

284. Cade J, Margetts BM. The relationship between diet and smoking: is the diet of smokers different? J Epidemiol Community Health 1991:45:270-272.

285. Wichelow MJ, Erzinclioglu SW, Cox BD. A comparison of the diets of non-smokers and smokers. Br J Addict 1991;86:71-81.

286. Bolton-Smith C, Woodward M, Brown CA, et al. Nutrient intake by duration of ex-smoking in the Scottish Heart Study. Br J Nutr 1993;69:315-332.

287. Strickland D, Graves K, Lando H. Smoking status and dietary fats. Prev Med 1992;21:228-236.

288. Gregory J, Foster K et al. The dietary and nutritional survey of British adults. London Her Majesty's Stationery Office, 1990.

289. Steinberg D, Parthasarthy S, et al. Beyond cholesterol: modifications of low density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-924.

290. Manson JE, Tosteson H, et al. The primary prevention of myocardial infarction. N Engl J Med 1992;326:1406-1416.

291. Paffenbarger RS, Hyde RT, Wing AL. Physical activity and physical fitness as determinants of health and longevity. In: Brouchard C, Shepard RJ, et al, eds.Exercise, Fitness, and Health. Champaign Ill: Human Kinetics Books; 1990.

292. Powell HE, Caspersen CJ, et al. Physical activity and chronic diseases. Am J Clin Nutr. 1989;49:999-1006.

293. Powell HE, Thompson PD et al. Physical activity and the incidence of coronary heart disease. Ann Rev Public Health 1987;8:253-287.

294. Robinson CH, Lawler MR, et al. Normal and Therapeutic Nutrition. 17th edition. New York: Macmillan; 1986.

295. The health consequences of smoking: nicotine addiction: a report of the Surgeon General. Rockville, MD.: Department of Health and Human Services, 1988:15. (DHHS publication no. (CDC) 88-8406.)

296. Strategies to control tobacco use in the United States: a blueprint for public health action in the 1990s. Smoking and tobacco control monographs no. 1. Rockville MD.: Department of Health and Human Services, 1991. (NIH publication no. 92-3316).

297. Lynch JW, Kaplan GA, et al. Childhood and adult socioeconomic status as predictors of mortality in Finland. Lancet 1994;343:524-527

298. Baker D, Illsley R, Vagero D. Today or in the past? The origins of ischemic heart disease. J Public Health Med 1993;15:243-248.

299. Rose G. Cardiovascular Disease. In: Holland WH, Detels R, Knox G, eds. Oxford textbook of public health, vol. 3. Oxford: Oxford Medical Publications, 1991:175-187.

300. Illsley R, Baker D. Contextual variations in the meaning of health inequality. Soc Sci Med 1991;32:359-365.

301. Marmot MG, Adelstein AM et al. Changing social class distribution of ischemic heart disease. British Medical Journal 1978;2:1109-1112.

302. Grossman DC, Krieger JW, et al. Health Status of Urban American Indians and Alaskan Natives. JAMA 1994;271:845-850.

303. Anderson JW. Plant fiber and blood pressure. Ann Intern Med. 1983;98:842-846.

304. Burkitt DP et al. Dietary Fiber and Disease. JAMA. 1974;229:1068-1074.

305. Trowell H. Ischemic heart disease and dietary fiber. Am J Clin Nutr. 1972;25:926-932.

306. Ascherio A, Hennekens CH, et al. Trans-Fatty Acids Intake and Risk of Myocardial Infarction. Circulation 1994;89:94-101

307. Senti FR, ed. Health Aspects of Dietary trans Fatty Acids: August 1985. Bethesda Md: Federation of American Societies for Experimental Biology; 1988.

308. Seedat YK. The prevalence, etiology, and complications of hypertension in the South African black population. in: Prophylactic Approach to Hypertensive Diseases, eds. Yamori Y, Lovenberg W, Freis ED. New York: Raven Press, 1979,p.7.

309. Seedat YK, Seedat MA. An interracial study of the prevalence of hypertension in an urban South African population. Trans Roy Soc Trop Med Hyg, 1982;76:62.

310. Seedat YK, Seedat MA, Hackland DBT. Biosocial factors and hypertension in urban and rural Zulu. S Afr Med J,1982;61:999.

311. Cassel JC. Studies of hypertension in migrants. in: Epidemiology and Control of Hypertension, Papers and Discussion from the Second International Symposium on the Epidemiology of Hypertension, 1974. Stratton Intercontinental Medical Book Co.,1975, pp. 41-61.

312. Beck M, Rosenberb D et al. The Infertility Trap. Newsweek. April 4,1994; Vol 123(14):30-31.

313. Prevention Profile, Health, United States, 1991, National Center for Health Statistics, Washington DC: U.S. Government Printing Office, 1991.

314. Adams PF, Benson V. Current estimates from the National Health Interview Survey. 1991. National Center for Health Statistics, Vital Health Stat 10(184).

315. Moriyama IM, Grover M. Statistical studies of heart diseases I. Heart diseases and allied causes of death in relation to age changes in the population. Public Health Rep 1948;63:537-545.

316. Woolsey TD, Moriyama IM. Statistical studies of heart diseases II. Important factors in heart disease mortality trends. Public Health Rep 1948;63:1247-1273.

317. Grover M, Pennell MY. Statistical studies of heart diseases VII. Mortality from eight specific forms of heart disease among white persons. Public Health Rep 1950;65:819-839.

318. Epstein FH. The epidemiology of coronary heart disease--a review. J Chronic Dis 1965;18:735-774.

319. Borhani ND, Hechter HH. Recent changes in CVR disease mortality in California. Am J Public Health 1964;79:140-160.

320. Kleinman JC, Feldman JJ, Monk MA. The effects of changes in smoking habits on coronary heart disease mortality. Am J Public Health 1979;69:795-802.

321. Stern MP. The recent decline in ischemic heart disease mortality. Ann Intern Med 1979;91:630-640.

322. Kannel WB, Thom TJ. Implications of the recent decline in cardiovascular mortality. Cardiovascular Med 1979;4:983-997.

323. Stamler J. Lifestyles, major risk factors, proof and public policy. Circulation 1978;58:3-19.

324. Cooper R, Tsong Y, et al. Is the recent decline in coronary heart disease mortality in the United States attributable to lower rates of influenza and pneumonia? Prev Med 1980;9:559-568.

325. Slater CH, Smith DP, et al. Ischemic heart disease: footprints through the data. Am J Clin Nutr 1985;42:329-341.

326. Goldman L, Cook F et al. Evidence that hospital care for acute myocardial infarction has not contributed to the decline in coronary mortality between 1973- 1974 and 1978-1979. Circulation 1982;65:936-942.

327. Marmot MG. Geography of blood pressure and hypertension. Brit Med Bull, 1984;40:380-386.

328. Cottington EM, Brock BM, et al. Psychological factors and blood pressure in the Michigan statewide blood pressure survey. Am J Epidemiol, 1985;121:515-529.

329. Roe DA. Health and Nutritional Status of Working and Non-working Mothers in Poverty Groups. USDL Contract 51-36-71-02, Final Report. Ithaca, N.Y.: Cornell University Press, 1971.

330. Ohambo HP, Okanga J, Karkar AHT. The pattern of heart disease. in: Health and Disease in Kenya. eds:Vogel LC, Muller RS, et al. Nairobi: Kenya Literature Bureau, 1974, pp. 473-478.

331. Pobee JM, Larbi EB, et al. Blood pressure distribution in rural Ghanian population. Trans Roy Soc Trop Med Hyg. 1977;71:66

332. Gortmaker SL, Must A et al. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993;329:1008-1012.

333. Steinberg D, Parthasarathy S, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.

334. Kearney JF Jr, Gaziano JM et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 1993;90:11880-4.

335. The Alpha Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and Beta Carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1029-1035.

336. Pierce JP, Lee L, Gilpin E. Smoking initiation by adolescent girls, 1944 through 1988: an association with targeted advertising. JAMA 1994;271(8):608-611.

337. Kennet L. The American Soldier in World War II. New York, New York: Charles Scribner's Sons; 1987:94.

338. Pierce JP, Gilpin E, Burns DM, et al. Does tobacco advertising target young people to start smoking: evidence from California. JAMA 1991;266:3154-3158.

339. Accessibility of cigarettes to youths aged 12-17. MMWR Morb Mortal Wkly Rep. 1992;41:485-488.

340. Klonoff EA, Landrine H, et al. The problem and sociocultural context of single cigarette sales. JAMA 1994;271:618-620.

341. Miller R. U.S. cigarette consumption, 1900 to date. In: Harr W, ed. Tobacco yearbook. Bowling Green, Ky: Cockrel Corporation; 1981.

342. U.S. Department of Agriculture. Tobacco situation and outlook report. Washington, DC: US Department of Agriculture, Commodity Economics Division, Economic Research Service, TS 224; Sept 1993.

343. Fielding JE. Preventing colon cancer: yet another reason not to smoke. J Natl Cancer Inst 1994; 86:183-191.

344. Giovannucci E, Rimm E, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994; 86:183-191.

345. Giovannucci E, Colditz GA, et al. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 1994; 86:192-199.

346. House JS, Kessler RC, et al. Social stratification, age, and health. In: Schaie KW, Blazer D, et al., eds. Aging, health behaviors, and health outcomes. Hillsdale, N.J.:Lawrence-Earlbaum Associates. 1992:1-32.

347. Davis DL, Dinse GE, Hoel DG. Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. JAMA 1994;271:431-437

348. McCormick J, Skrabanek P. Coronary heart disease is not preventable by population interventions. Lancet 1988;ii:839-841.

349. Miller AB. How do we interpret the "bad news" about cancer? JAMA 1994;271(6):468.

350. Alexander F. Emotional factors in essential hypertension. Psychosom Med 1939;1:175-179.

351. Niaura R, Goldstein MG. Psychological factors affecting physical condition. Cardiovascular disease literature review, Part II: Coronary artery disease and sudden death and hypertension. Psychosom Med 1992;2:146-155.

352. Eliot, RS. Director, Institute of Stress Medicine, International. Personal communication, April 22, 1994.

353. Sommers-Flanagan J, Greenburg RP. Psychosocial variables and hypertension: A new look at an old controversy. Journ Nerv Ment Dis 1989;1:15-24.

354. Dzau VJ. Atherosclerosis and hypertension: Mechanisms and interrelationships. J Cardiovasc Pharmacol 1990;15(suppl5):S59-S64.

355. Adelson SF, Keys A. Diet and some health characteristics of 123 business and professional men. Agricultural Research Service, ARS 62-11, Washington D.C., 1962. U.S. Department of Agriculture.

356. Antar MA, Ohlson MA. Effects of simple and complex carbohydrates on thrombus formation, stypven time, and serum lipids in young men and women. (Abstract) Fed Proc 1963;22(Part 1):327.

357. Hodges RE, Ohlson MA. Total serum lipids, cholesterol and triglycerides following ingestion of diets with two sources of carbohydrate. (Abstract) Fed Proc 1963;22(Part 1):209.

358. Wenneker MB, Epstein AM. Racial inequalities in the use of procedeures for patients with ischemic heart disease in Massachusetts. JAMA 1989;261:253- 257.

359. Ford E, Cooper R. et al. Coronary arteriography and coronary bypass survey among whites and other racial groups relative to hospital-based incidence rates for coronary artery disease: findings from NHDS. Am J Public Health 1989;79:437-446.

360. Hannan EL, Kilburn H et al. Interracial access to selected cardiac procedeures for patients hospitalized with coronary artery disease in New York State. Med Care 1991;29:430-441.

361. Wenneker MB, Weisman JS, Epstein AM. The association of payer with utilization of cardiac procedeures in Massachusetts. JAMA 1990;264:1255-1260.

362. Peniston RL, Adams-Campbell L, et al. Coronary Arteriographic findings in black patients and risk markers for coronary artery disease. Am Heart J 1994;127:552-559.

363. Pearson TA. Risk factors for arteriographically defined CAD [dissertation]. Baltimore: Johns Hopkins University, 1983:274.

364. Sue-King L, Watkins LO. Coronary arteriographic findings in black veterans [abstract]. Circulation 1984;70(Suppl II):410.

365. Maynard C, Fisher LD, et al. Blacks in the Coronary Artery Surgery Study:risk factors and coronary artery disease. Circulation 1986;74:64-71.

366. Carryon P, Matthews MM. Clinical and coronary arteriographic profile of 100 black Americans:focus on subgroup with undiagnosed suspicious chest discomfort. J Natl Med Assoc 1987;79:265-272.

367. Simmons BE, Castaner A, et al. Coronary artery disease in blacks of lower socioeconomic status: angiographic findings from the Cook County Hospital Heart Disease Registry. Am Heart J 1988;116:90-97.

368. Freedman DS, Gruchow HW, et al. Black/white differences in risk factors for arteriographically documented coronary artery disease in men. Am J Cardiol 1988;62:214-219.

369. Peniston RL, Randall OS. Coronary artery disease in black Americans 1920-1960: the shaping of medical opinion. J Natl Med Assoc 1989;81:591-600.

370. Smoking and Health: Report of the Advisory Committee to the Surgeon General of the Public Heralth Service, U.S. Department of Health, Education, and Welfare, 1964.

371. Walker WJ. Changing United States life-style and decreasing vascular mortality: cause or coincidence? N Engl J Med 1977;297:163-165

372. Mortality trends for the leading cause of death in the United States, 1950- 1969. Series 20, No. 16 (DHEW Publication No. [HRA]74-1853). Rockville Maryland, National Center for Health Statistics, 1974. p.10.

373. Strom A, Jensen RA. Mortality from circulatory diseases in Norway 1940- 1945. Lancet 1951;1:126-129.

374. Malmros H. The relation of nutrition to health: a statistical study of the effect of war-time on atherosclerosis, cardiosclerosis, tuberculosis, and diabetes. Acta Med Scan 1950;246[Suppl]:137-153.

375. United States Department of Agriculture: Agricultural Statistics 1976. Washington, D.C., Government Printing Office, 1976, pp 106,142,384,414,561.

376. Lopez-S A, Krehl W, et al. Relationship between food consumption and mortality from atherosclerotic heart disease in Europe. Am J Clin Nutr 1966;19:361-369

377. Susser M, Watson W, Hopper K. Sociology in Medicine. 3rd ed. New York, N.Y.: Oxford University Press;1985.

378. Antonovsky A. Social class and the major cardiovascular diseases. J Chronic Dis 1968;21:65-106.

379. Morgenstern H. The changing association between social status and coronary heart disease in a rural population. Soc Sci Med 1980;14A:191-201.

380. Kritz-Silverstein D, Wingard DL, Barrett-Conner E. Employment status and heart disease risk in middle-aged women: the Rancho Bernardo Study. Am J Public Health 1992;82:215-219.

381. Black D, Morris JN, Smith C. Report of the working group on inequalities in health. London: Department of Health and Social Security, 1980.

382. Townsend P, Phillmore P, Beattie A. Health and deprivation--inequality and the North. London:Routledge, 1988.

383. Kelley WF, Mahmood R, et al. Influence of social deprivation on illness in diabetic patients. Br Med J 1993;307:1115-1116.

384. Matthews KA, Kelsey SF, et al. Educational attainment and behavior and biologic risk factors for coronary heart disease in middle-aged women. Am J Epidemiol 1989;129:1132-1144.

385. Holme I, Helgeland A, et al. Physical activity at work and at leisure in relation to coronary risk factors and social class: a 4-year mortality follow-up. The Oslo Study. Acta Med Scand 1981;209:277-283.

386. Salonen JT, Slater JS, et al. Leisure time and occupational physical activity: risk of death from ischemic heart disease. Am J Epidemiol 1988;127:87-94.

387. Kaplan GA, Lazarus NB, et al. Psychosocial factors in the natural history of physical activity. Am J Prev Med 1991;7:12-17.

388. Moriyama I, Woolsey T, Stamler J. Observations on possible factors responsible for the sex and race trends in cardiovascular-renal mortality in the U.S. J. Chronic Diseases 1958;7:401-412.

389. Acheson RM. The etiology of coronary heart disease. Yale J Biol Med 1962;35:143.

390. Stamler J. Cardiovascular disease in the U.S. Am J Cardiol 1962;10:319.

391. Keys A. Diet and the development of coronary heart disease. J Chronic Diseases 1956;4:364.

392. Bierman EL, Chait A. Nutrition and diet in relation to hyperlipidemia and atherosclerosis. in: Shils ME, Young VR, eds. Modern Nutrition in Health and Disease. Philadelphia, Lea and Febiger; 1988(VII edition):1283-1297.

393. Yeracaris CA, Kim JH. Socioeconomic differentials in selected causes of death. Am J Public Health 1978;68:342-351.

394. Pamuck ER. Social class inequality in mortality from 1921 to 1972 in England and Wales. Population Studies 1985;39:17-31.

395. Marmot MG, McDowall ME. Mortality decline and widening social inequalities. Lancet 1986;2:274-276.

396. Fox AJ, Goldblatt PO, Jones DR. Social class mortality differentials: artefact, selection, or life-circumstances? J Epidemiol Community Health 1985;39:1-8.

397. Lerner M, Stutz RN. Mortality by socioeconomic status, 1959-1961 and 1969-1971. Md State Med J 1978;27:35-42.

398. Wing S, Barnett E, et al. Geographic and Socioeconomic variation in the onset of decline of coronary heart disease mortality in white women. Am J Public Health 1992;82:204-209.

399. Wing S, Casper M, et al. Socioenvironmental characteristics associated with the onset of decline of ischemic heart disease mortality in the United States. Am J Public Health 1988;78:923-926.

400. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results. I. Reduction in incidence of coronary heart disease. JAMA 1984;251:351-364.

401. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984;251:365-374.

402. St Leger AS, et al. Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1979;1:1017-1019.

403. Castelli, WP, et al. Alcohol and blood lipids. Lancet 1977;2:153-155.

404. Alexander GR et al. Am J Public Health 1993;83:1721-1725.

405. Bennett WJ. The Index of Leading Cultural Indicators. The Heritage Foundation 1993;1:1-23.

406. Senator Robert Byrd, D-W.Va, Chairman of the Senate Appropriations Committee, Associated Press Wire Release, Washington, D.C., May 14, 1994.

407. Negro Mortality. III. Course of Mortality from Specific Causes, 1920-1944. Public Health Reports 1948;63:201-213.

408. Negro Mortality. VIII. Mortality from Heart Disease among Negroes as Compared with White Persons. Public Health Reports 1951;66:57-80.

409. Heart Disease and Tuberculosis. Public Health Reports 1946;61:1425.

410. Charlewood GP, Frylinck R. Discrepancies in disease incidence between the European and South African Negro (Bantu). South African Med J. 1951;25:551-556.

411. Kesilman M. The incidence of essential hypertension in white and negro males. Medical Record 1941;154:16-19.

412. Hartnett WG, Ratcliffe HE. Study of hypertension on southern negroes. Southern Med J 1948;41:847-848.

413. Saunders GM, Bancroft H. Blood pressure studies on negro and white men and women living in the Virgin Islands of the United States. Am Heart J 1942;23:410-423.

414. Crile G. The Surgical Treatment of Hypertension. W.B. Saunders Co. Philadelphia, 1938: pp.29,37.

415. Donnison CP. Blood pressure in African natives, bearing upon etiology of hypertension and atherosclerosis. Lancet 1929;1:6.

416. Brink AJ. The coronary vessels in the Bantu. Clin Proc 1949;8:137-149.

417. Becker BJP. Cardiovascular diseases in the Bantu and coloured races of South Africa. S Af J Med Sci 1946;11:1,97.

418. White PD. Heart Disease. 2nd ed. New York: MacMillan Co. 1937.

419. Burch GE, Voorhies NW. A study of the incidence of coronary occlusion and angina pectoris in the white and negro races. Am J Med Sci 1939;198:685- 690.

420. Peery TM, Langsam SM. Study of cardiovascular disease in Charlestown, S.C. based upon necropsy statistics. Am Heart J 1940;19:424.

421. Schwab EH, Schultze VE. Heart disease in the American negro. Am HeartJ 1932;7:710.

422. Davison HM, Thoroughman J. A study of heart disease in the negro races. South Med J 1928;21:464.

423. Hunter WS. Coronary occlusion in negroes. J Amer Med Assoc 1946;131:12.

424. Allen FP. Cardiovascular impairment among 1,000 negro factory workers. J Indust Hyg 1931;13:164-168.

425 Schwab EH, Shulze VE. Incidence of heart disease and of etiological types in southern dispensary. Am Heart J 1931;7:223-224.

426. Weiss MM, Prusmack JJ. Essential hypertension in negro. Am J Med Sci 1938;195:510-516.

427. Blache JO, Handler FP. Coronary artery disease. A comparison of the rates and patterns of development of coronary atherosclerosis in the negro and white races with its relation to clinical coronary artery disease. Archives of Pathology 1950;50:189-198.

428. Gager LT, Dunn WL. Heart disease in Washington, D.C.; study of etiologic types and factors of race, age, and sex in 1,200 cases. Med Ann Dist Columbia 1933;2:112-117.

429. Hedley OF. Study of 450 fatal cases of heart disease occuring in Washington (D.C.) hospitals during 1932 with special reference to etiology, race, and sex. U.S. Public Health Reports 1935;50:1127-1153.

430. Johnston C. Racial differences in incidence of coronary schlerosis. Am Heart J 1936;12:162-167.

431. Lisa JR, Ring A. Myocardial infarction or gross fibrosis; analysis of 100 necropsies. Arch Int Med 1932;50:131-141.

432. Laws CL. Etiology of heart disease in whites and negroes in Tennessee. Am Heart J 1933;8:608-615.

433. Holoubek AB. Heart disease in the south; statistical study of 1,045 cardiac deaths. Am Heart J 1945;29:168-177.

434. Stone CT, Vanzant FR. Heart disease as seen in southern clinic; clinical and pathological survey. JAMA 1927;89:1473-1477.

435. Bruenn HG, Turner KB, Levy RL. Notes on cardiac pain and coronary disease; correlations of observations made during life with structural changes found at autopsy in 476 cases. Am Heart J 1936;11:34-40.

436. Levy RL, Bruen HG. Acute fatal coronary insufficiency. JAMA 1936;106:1080-1085.

437. Ashman R. Electrocardiographic study of caucasians and negroes. Tri State M J 1941;13:2686.

438. Yater WM, Traum AH, et al. Coronary artery disease in men 18-39 years of age, report of 866 cases, 450 with necropsy examinations. Am Heart J 1948;36:334-372, 481-526, 683-722.[Three citations].

439. Thomas J. Analysis of 317 cases of heart disease in negroes. JAMA 1946;38:202-205.

440. Federal Security Agency, United States Public Health Service, Office of Vital Statistics: Vital Statistics, in Special Report. 1948;27:295.

441. Keil PG, McVay LV. A comparative study of myocardial infarction in the white and negro races. Circulation 1956;13:712-718.

442. Walker ARP, Arvidsson UA. Fat intake, serum cholesterol concentration, and atherosclerosis in the South African Bantu. Part I. Low fat intake and the age trend of serum cholesterol concentration in the South African Bantu. J Clin Invest 1954;33:1358-1365.

443. Higginson J, Pepler WJ. Heart disease in the Bantu and white race. J Clin Invest 1954;33:1366.[

444. Brock JF, Bronte-Stewart B. Arteriosclerosis in African populations. Minnesota Med 1955;38:852-863.

445. Elliot GA. Coronary arteries and their diseases in the Bantu. The Leech 1953;23:25.

446. Elliot GA. Coronary diseases among Bantu negroes. Minerva Med 1953;1:465-470.

447. Garb S. Current status of anticoagulants in the treatment of myocardial infarction. Am J Med Sci 1955;229:534-548. (see p. 539)

448. Batson E. Different diets of Europeans, Cape Blacks, and the Bantu race. J Social Rec (Pretoria)1953;4:113.

449. Registrar-General, Decennial Supplement England and Wales, 1951, Occupational Mortality. London: H.M. Stationery Office, Part 1; page 13.

450. Holoubek JE, Holoubek AB. Heart disease in the South. Am Heart J 1947;34:715-721.

451. Higginson J, Pepler WJ. Fat intake, serum cholesterol concentration, and atherosclerosis in the South African Bantu. Part II. Atherosclerosis and coronary artery disease. J Clin Invest 1954;33:1366-1371.

452. Brull L, et al. Les etas de carence en Belgique pendant l'occupation allemande, 1940-1944. p. 286, Editions Soledi Liege, 1945.

453. Simonart E. La denutrition de guerre: Etude clinique, anatomo-pathologique et therapeutique. Acta medica belgica. p. 262, Bruxelles, 1947.

454. Gsell O. Klinik und Pathogenise von Hungerkrankheit und Hungerodem in Hottinger A, Gsell O, et al. Hungerkrankheit, Hungerodem, Hungertuberkulose, Basel, Benno Schwalbe. 1948, p. 121.

455. Schettler, G. Zum Einfluss der Ernahrung auf den Cholesteringehalt des Blutes. Klin Wchnschr 1950;28:565.

456. Peery TM, Langsam SM. Study of cardiovascular disease in Charlestown, S.C. with particular reference to hypertension. Arch Int Med 1939;64:971-987.

457. Florey C du V, Melia RJW, Darby SC. British Medical Journal 1978;1:635.

458. Crile, George. Diseases peculiar to civilized man. Archives of Surgery 1940;41:236.

459. Syme SL, Hyman MM, Enterline PE. Journal of Chronic Diseases 1964;17:277.

460. Gillanders AD. Nutritional heart disease. Brit Heart J 1951;13:177-196.

461. Goldberg L, Thorp JM, Sussman S. A survey of vitamins in African foodstuffs. S Afr J Med Sci 1946;11:121-134.

462. Levine SA, Brown CL. Medicine 1929;8:245.

463. Keys A, Mickelsen O, et al. The relationship in man between cholesterol levels in the diet and in the blood. Science 1950;112:79.

464. Keys A. The cholesterol problem. Voeding 1952;13:539.

465. Groen J, Tjiong BK, et al. The influence of nutrition, individuality and some other factors, including various forms of stress, on the serum cholesterol; an experiment of nine months duration in 60 normal human volunteers. Voeding 1952;13:556.

466. Mittleman MA, Maclure M, et al. Triggering of acute myocardial infarction by heavy physical exertion; protection against triggering by regular exertion. N Engl J Med 1993;329:1677-1683.

467. Hertog MGL, Feskens EJM, et al. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1107- 1111.

468. Esterbauer et al. Free Rad Res Commun 1989;6:67.

469. Riemersma RA, Wood DA, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991;337:1-5.

470. Stampfer MJ, Hennekens CH, et al. Vitamin E consumption and the risk of coronary artery disease in women. N Engl J Med 1993;328:1444-1449.

471. Rimm EB, Stampfer MJ, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-1456.

472. Hendler SS. The Doctors' Vitamin and Mineral Encyclopedia. Simon and Schuster: New York, N.Y.; 1990.

473. Afanasev IB et al. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochemical Pharmacology 1989;38:1763-1769.

474. Havsteen B. Flavonoids, a class of natural products of high pharmaceutical potency. Biochemical Pharmacology 1983;32:1141-1148.

475. U.S. Army Center of Military History, May 14, 1993 [personal communication].

476. Artaud-Wild S, Connor S. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not France and Finland: a paradox. Circulation 1993;88:2771-2779.

477. Cerutti PA. Prooxidant states and tumor promotion. Science 1985;277:375- 381.

478. Bierenbaum ML, Reichstein RP, et al. Effects of canola oil on serum lipids in humans. J Am Coll Nutr 1991;10:228-233.

479. Kloner RA. Introduction to the role of oxygen radicals in myocardial ischemia and infarction. Free Rad Biol Med 1988;4:5-7

480. McCord J. Free radicals and myocardial ischemia: overview and outlook. Free Rad Biol Med 1988;4:9-14.

481. Burton K. Evidence of direct toxic effects of free radicals on the myocardium. Free Rad Biol Med 1988;4:15-24.

482. Rubanyi G. Vascular effects of oxygen-derived free radicals. Free Rad Biol Med 1988;4:107-120.

483. Gower JD. A role for dietary lipids and antioxidants in the activation of carcinogens. Free Rad Biol Med 1988;5:95-111.

484. Rice-Evans C, ed. Free radicals, cell damage and disease. London: The Richelieu Press. 1988.

485. Oberley L. Free radicals and diabetes. Free Rad Biol Med 1988;5:113-124.

486. Godin D, Wohaieb S. Nutritional deficiency, starvation, and tissue antioxidant status. Free Rad Biol Med 1988;5:165-176.

487. Pryor W. Views on the wisdom of using antioxidant vitamin supplements. Free Rad Biol Med 1987;3:189-191.

488. Bieri JG. Are the recommended allowances for dietary antioxidants adequate? Free Rad Biol Med 1987;3:193-197.

489. Diplock A. Dietary supplementation with antioxidants. Is there a case for exceeding the recommended daily allowance? Free Rad Biol Med 1987;3:199- 201.

490. Draper H. Micronutrients and cancer prevention: Are the RDAs adequate? Free Rad Biol Med 1987;3:203-207.

491. Jacobson HN. Dietary standards and future developments. Free Rad Biol Med 1987;3:209-213.

492. Williams. Endocrine responses to stress and psychological stimuli. in: Endocrinology, 7th ed. 1985:662-915

493. Goldstein MG, Niaura R . Psychological factors affecting physical condition. Cardiovascular disease literature review, Part I: Coronary artery disease and sudden death. Psychosom Med 1992;2:134-145.

494. Williams RB. The role of the brain in physical disease. Folklore, normal science, or paradigm shift? JAMA 1990;263(14):1971-1972.

495. Grignani G, Soffiantino F, et al. Platelet activation by emotional stress in patients with coronary artery disease. Circulation 1991;83[suppl II]:II-128-II- 136.

496. Epstein L, Perkins K. Smoking, stress, and coronary heart disease. J Consulting and Clin Psychol 1988;56(3):342-349.

497. Feigelman W, Gorman B. Toward explaining the higher incidence of cigarette smoking among black Americans. J Psychoactive Drugs 1989;21(3):299-305.

498. Pacht ER, et al. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Journal of Clinical Investigation 1986;77:789-796.

499. Bjorneboe GA, et al. Decreased serum concentration of vitamin E in alcoholics. Annals of Nutrition and Metabolism 1988;32:56-61.

500. Bordia AK. The effect of vitamin C on blood lipids, fibrinolytic activity, and platelet adhesiveness in patients with coronary artery disease. Atherosclerosis 1980;35:181-187.

501. Cordova C, et al. Influence of ascorbic acid on platelet aggregation in vitro and in vivo. Atherosclerosis 1982;41:15-19.

502. Sarji E, et al. Decreased platelet vitamin C in diabetes mellitus: Possible role in hyperaggregation. Thrombosis Research 1979;15:639.

503. Jandak J, Steiner M, Richardson PD. Alpha tocopherol, an effective inhibitor of platelet adhesion. Blood 1989;73:141

504. Kanofsky JD, Kanofsky PD. Prevention of thromboembolic disease by vitamin E. N Engl J Med 1981;305:173. 505. Henry JP. Coronary heart disease and the arousal of the adrenal cortical axis. In: Dembrowski TM, Schmidt TH, Blumchen G (eds): Biobehavioral Basis of Coronary Heart Disease. Basel, Karger. 1983:365-381.

506. Woody WS. Incidence of heart disease in negro race. Virginia M Monthly 1924;50:784-787.

507. Wetherbee H, Tyroler H. The relation of migration to coronary heart disease risk factors. Arch Int Med 1971;128:976-981.

508. Bright MB: A follow-up study of the commission on chronic illness morbidity survey in Baltimore: II. Race and sex differences in mortality. J Chronic Dis 1967;20:717-729.

509. Bright MB: A follow-up study of the commission on chronic illness morbidity survey in Baltimore: III. Residential mobility and prospective studies. J Chronic Dis 1969;21:749-759.

510. Kaplan BH, Cassel JC, et al. Occupational mobility and heart disease. Arch Int Med 1971;128:938-942.

511. Lakka TA, Nenailanen JM, et al. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction in men. N Engl J Med 1994;330:1549-54.

512. Powell KE, Thompson PD, et al. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health 1987;8:253-287.

513. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1987;108:161-175.

514. Paffenbarger RS Jr, Hyde RT, Wing AL, et al. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605-613.

515. Paffenbarger RS Jr, Hyde RT, Wing AL, et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993;328:538-545.

516. Morris JN, Everett MG, et al. Vigorous exercise in leisure time: Protection against coronary heart disease. Lancet 1980;2:1207-1210.

517. Garcia-Palmieri MR, Costas R Jr, et al. Increased physical activity: a protective factor against heart attacks in Puerto Rico. Am J Cardiol 1982;50:749-755.

518. Yudkin J. Diet and coronary thrombosis, hypothesis and fact. Lancet 1957;2:155-162.

519. Yudkin J. Dietary fat and dietary sugar in relation to ischaemic heart disease and diabetes. Lancet 1964;2:4-5.

520. McGandy RB, Hegsted DM, Stare FJ. Dietary fats, carbohydrates, and atherosclerotic vascular disease. New Engl J Med 1967;277:417-419; 469-471.

521. Masironi R. Dietary factors and coronary heart disease. Bull World Hlth Org 1970;42:103-114.

522. Keys A, Aravanis C. et al. Epidemiological studies in relation to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand 1966[suppl]:460

523. Keys A. Sucrose in the diet and coronary heart disease. Atherosclerosis 1971; 14:193-200.

524. Keys A. Letter to the editor. Atherosclerosis 1973;18:352.

525. Shekelle RB, Shyrock AM et al. Diet, serum cholesterol and death from coronary heart disease. N Engl J Med 1981;304:65-70.

526. Keys A, with 15 collaborators. Seven Countries-A Multivariate Analysis of Death and Coronary Heart Disease. A Commonwealth Fund Book. Cambridge, Mass: Harvard University Press; 1980:1-381.

527. Keys A. (ed): Coronary heart disease in Seven Countries. Circulation 1970;41(suppl I).

528. Connor SL, Gustafson JR et al. The cholesterol/saturated fat index: an indication of the hypercholesterolaemic and atherogenic potential of food. Lancet 1986;1:1229-1232.

529. The Surgeon General's Report on Nutrition and Health. Washington, DC: US Department of Health and Human Services; DHHS Publication No. (PHS)88-50210, 1988.

530. National Research Counsel. Diet and Health, Implications for Reducing Chronic Disease Risk. Washington, DC: National Academy Press, 1989.

531. National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction. US Department of Health and Human Services, NIH publication No. 90-3046, 1990.

532. Turpeinen O. Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Circulation 1979;59:1-8.

533. Renaud S, de Lorgeril M. Dietary lipids and their relation to ischaemic heart disease: from epidemiology to prevention. J Intern Med 1989;225:1-8.

534. de Lorgeril M. Atlanta, GA. Personal communication, Nov 11, 1993.

535. Joossens JV, Brems-Heyns E, et al. The pattern of food and mortality in Belgium. Lancet 1977;1:1069-1072.

536. Statistiques des causes medicales de deces. INSERM. Tome II. Regulats par region. 1972;187:327.

537. Esterbauer H, Dieber-Rotheneder M, et al. Role of vitamin E in preventing the oxidation of low density lipoprotein. Am J Clin Nutr 1991;53:314S-321S.

538. Connor WE, Cerqueira MT, et al. The plasma lipids, lipoproteins, and diet of the Tarahumara Indians of Mexico. Am J Clin Nutr 1978;31:1131-1142.

539. Shaper AG, Jones KW. Serum cholesterol, diet and coronary heart disease in Africans and Asians in Uganda. Lancet 1959;2:534.

540. Kagan A, Harris BR, Winkelstein W Jr. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: demographic, physical, dietary, and biochemical characteristics. J Chron Dis 1974;27:345-364.

541. Worth RM, Kato H, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: mortality. Am J Epidemiol 1975;102:481-490.

542. Frankel EN, Kanner J, et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457.

543. Marmot M, Brunner E. Alcohol and cardiovascular disease: the status of the U shaped curve. Brit Med J 1991;303:565-568.

544. Moore RD, Pearson TA. Moderate alcohol consumption and coronary artery disease: a review. Medicine 1986;65:242-267.

545. Hegsted DM, Ausman LM. Diet, alcohol and coronary heart disease in men. J Nutr 1988;118:1184-1189.

546. Keys A, Menotti A, et al. The diet and 15-year death rate in the Seven Countries study. Am J Epidemiol 1986;124:903-915.

547. Becker N, Illingworth DR, et al. Effects of saturated, monounsaturated, and n-6 polyunsaturated fatty acids on plasma lipids, lipoproteins, and apoproteins in humans. Am J Clin Nutr 1983;37:355-360.

548. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res 1985;26:194-202.

549. Grundy SM. Comparison of monounsaturated fatty acids and carbohydrates for lowering plasma cholesterol. N Engl J Med 1986;314:745-748.

550. Mensink RP, Katan MB. Effect of monounsaturated fatty acids versus complex carbohydrates on high density lipoproteins in healthy men and women. Lancet 1987;1:122-125.

551. Kazawa Y, Niskizawa M, et al. Eicosapentaenoic acid of serum lipids of Japanese islanders with low incidence of cardiovascular disease. J Nutr Sci Vitaminol 1982;28:441-453.

552. Briefel RB, Sempos CT, eds. Dietary methodology workshop for the third National Health and Nutrition Examination Survey. National Center for Health Statistics. Vital Health Stat 4(27). 1992.

553. Kato H, Tillotson J, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California. Am J Epidemiol 1973;27:345-364.

554. Kushi LH, Lew RA, et al. Diet and 20-year mortality from coronary heart disease: The Ireland-Boston Diet Heart Study. N Engl J Med 1985;312:811-818.

555. Snowdon DA, Phillips RL, Fraser GE. Meat consumption and fatal ischemic heart disease. Prev Med 1984;13:490-500.

556. Kromhout D, Bosschieter EB, Coulander CD. The inverse relationship between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 1985;312:1205-1209.

557. The Medicaid Access Study Group. Access of Medicaid recipients to outpatient care. N Engl J Med 1994;330:1426-1430.

558. Snapper I. Chinese Lessons to Western Medicine. New York: Interscience Publishers, 1941:160. .

559. Voerhoef AW. Het cholesterol gehalte in het bloed bij versckillende rassen. Diss. Amsterdam. 1920.

560. Hrabak D. Media madness over trans fatty acids triggers confusion. Environmental Nutrition 1994;17(7):3.

561. Kuhnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-20.

562. Hertog MGL, Hollman PCH, et al. Estimation of daily intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer 1993;20:21-29.

563. Robak J, Gryglewski RJ. Flavonoids are scavengers of superoxide anion. Biochem Pharmacol 1988;37:83-88.

564. Husain SR, Cillard J, Cillard P. Hydroxy radical scavenging activity of flavonoids. Phytochemistry 1987;26:2489-2492.

565. De Whalley CV, Rankin SM et al. Flavonoids inhibit the oxidative modification of low density lipoproteins. Biochem Pharmacol 1990;39:1743- 1749.

566. Negre-Salvagyre A, Salvagyre R. Quercetin prevents the cytotoxicity of oxidized low-density lipoproteins by macrophages. Free Radic Biol Med 1992;12:101-106.

567. Steinberg D, Pathasarathy S, et al. Modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.

568. Laughton MJ, Evans PJ, et al. Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives: relationship to antioxidant activity and to iron-reducing ability. Biochem Pharm 1991;42:1673- 1681.

569. Hertog MGL, Hollman PCH, van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 1993;41:1242-1246.

570. Frankel EN, Kanner J, et al. Inhibition of oxidation of human low density lipoprotein by phenolic substances in red wine. Lancet 1993;341:454-457.

571. Ascherio A, Stampfer MJ, et al. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tochopherols among American men and women. J Nutr 1992;122:1792-1801.

572. Stryker WS, Kaplan LA, et al. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta carotene and alpha tocopherol levels. Am J Epidemiol 1988;127:283-296.

573. Steinberg D, Witztum JL. Lipoproteins and atherogenesis: current concepts. JAMA 1990;264:3047-3052.

574. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr 1991;53:Suppl:189S-193S.

575. Sorata Y, Takahama U, Kimura M. Protective effect of quercetin and rutin on photosensitized lysys of human erythrocytes in the presence of hematoporphyrin. Biochem Biophys Acta 1982;799:313-317.

576. Takahama U. Inhibition of lipoxygenase-dependent lipid peroxidation by quercitin: mechanism of antioxidant function. Phytochemistry 1985;24:1443- 1446.

577. Quinn MT, Parthasarathy S, Steinberg D. Endothelial cell derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein. Proc Natl Acad Sci USA 1985;82:5949-5953.

578. Quinn MT, Parthasarathy S, et al. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci USA 1987;84:2995-2998.

579. Hessler JR, Robinson AL Jr, Chisolm GM III. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213-229.

580. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987;45:Suppl:1368-1377.

581. Enstrom JE, Kanim Le, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992;3:194-202.

582. Gaziano JM, Manson JE, et al. A prospective study of beta carotene in fruits and vegetables and decreased cardiovascular mortality in the elderly. Am J Epidemiol 1992;136:985. abstract.

583. DeMaio SJ, King SB III, et al. Vitamin E supplementation, plasma lipids, and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992;11:68-73.

584. Kok FJ, de Bruiijn AM, et al. Serum selenium, vitamin antioxidants, and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987;45:462-468.

585. Salonen JT, Salonen R, et al. Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease. Am J Cardiol 1985;56:226-231.

586. Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low density lipoprotein: use of a new water-soluble probucol deravitive. J Clin Invest 1992;89:618-621.

587. Esterbauer H, Dieber-Rotheneder M, et al. Role of vitamin E in preventing the oxidation of low density lipoprotein. Am J Clin Nutr 1991;53:Suppl:314S- 321S.

588. Gaziano JM, Manson JE, et al. Beta carotene therapy for chronic stable angina. Circulation 1990;82:SupplIII:III-201. abstract.

589. Harats D, Ben-Naim M, et al. Cigarette smoking renders LDL susceptible to peroxidative modification and enhanced metabolism by macrophages. Atherosclerosis 1989;79:245-252.

590. Duthie GG, Arthur JR, James WPT. Effects of smoking and vitamin E on blood antioxidant status. Am J Clin Nutr 1991;53:Suppl:1061S-1063S.

591. Hoshino E, Shariff R, et al. Vitamin E supresses increased lipid peroxidation in cigarette smokers. J Parenter Enteral Nutr 1990;14:300-305.

592. Jialal I, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 1991;87:597-601.

593. Stocker R, Frei B. Endogenous antioxidant defenses in human blood plasma. In: Sies H, ed. Oxidative stress: oxidants and antioxidants. Orlando Fla.: Academic Press, 1991:213-243.

594. Niki E, Yamamoto Y, et al. Membrane damage due to lipid oxidation. Am J Clin Nutr 1991;53:Suppl:201S-205S.

595. Princen HMG, van Poppel G, et al. Supplementation with vitamin E but not beta carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb 1992;12:554-562.

596. Nierenberg DW, Stukel TA, et al. Determinants of plasma levels of beta carotene and retinol: Skin Cancer Prevention Study Group. Am J Epidemiol 1989;130:511-521.

597. Rimm EB, Giovannucci EL, Stampfer MJ, et al. Reproducibility and validity of an expanded self-administered semi-quantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992;135:1114- 1126.

598. Stampfer MJ, Willett WC, et al. The effect of vitamin E on lipids. Am J Clin Pathol 1983;79:714-716.

599. Kalbfleisch JH, Barboriak JJ, et al. Alpha tocopherol supplements and high density lipoprotein levels. Br J Nutr 1986;55:71-77.

600. Keys A, Aravanis C, Blackburn H. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand 1967;suppl:1-392.

601. Blot WJ, Li J-Y, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993;85:1483-1492.

602. Greenberg ER, Baron JA, et al. The Polyp Prevention Study Group. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. N Engl J Med 1994;331:141-147.

603. Williams DG. Alternatives 1994;5(13):97-99.

604. Polyunsaturated fat consumption and the incidence of melanoma. N.Z. Med J 1991;104(916):322.

605. Giovannucci E, Rimm EB, et al. A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Institute 1993;85:1571-1579.

606. Gann P, Hennekens C, Sacks F et al. Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Institute 1994;86:281-286.

607. Adlercreutz H, Markkanen H, Watanabe S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 1993;342:1209-1210.

608. Dyberg J, Bang HO. Effects on hemostasis by feeding eicosapentaenoic acid. In: Nutritional Factors: Modulating Effects on Metabolic Processes. Beers RS, Bassett EG, eds. New York: Raven Press, 1981.

609. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxological implications. Environ Health Prospect 1985;64:111-126.

610. Kimura S, Nishinaga M, et al. Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994;128:7-11.

611. Pittilo BM. Cigarette smoking and endothelial injury: a review. In: Diana JN, ed. Tobacco smoking and atherosclerosis. New York: Plenum Press, 1990:61-78.

612. Murchison LE, Fyfe T, et al. Effects of cigarette smoking on serum lipids, blood glucose, and platelet adhesiveness. Lancet 1966;2:182-184.

613. Cryer PE, Haymond MW, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic effects. N Engl J Med 1976;295:573-577.

614. Myers MJ, Benowitz NL, et al. Cardiovascular effects of smoking in patients with ischemic heart disease. Chest 1988;93:14-19.

615. Hawkins RI. Smoking, platelets, and thrombosis. Nature 1972;236:450-452.

616. Nowak J, Murray JJ, et al. Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes. Circulation 1987;76:6-14.

617. Allen RA, Kuft C, et al. Effect of chronic smoking on fibrinolysis. Arteriosclerosis 1985;5:443-450.

618. Haire WD, Goldsmith JC, et al. Abnormal fibrinolysis in healthy male cigarette smokers: Role of plasminogen activator inhibitors. Am J Hematol 1989;31:36-40.

619. O'Brien. Some effects of adrenaline and anti-adrenaline compounds on platelet in vitro and in vivo. Nature 1963;200:763-764.

620. Jern C, Eriksson E, et al. Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemostas 1989;62:767-771.

620. Kugiyama K, Kerns SA, et al. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160-162.

621. Regnstrom J, Nilsson J, et al. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 1992;339:1183-1186.

622. Stampfer MJ, Malinow MR, et al. A prospective study of plasma homocyst(e)ine and risk of infarction in U.S. physicians. JAMA 1992;268(7):877- 881.

623. Zhao BL, et al. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophysics 1989;14(2):175-185.

624. Jialal I, Grundy SM. Effect on combined supplementation with alpha tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation. Circulation 1993;88:2780-2786.

625. Robbins AS, Manson JE, et al. Cigarette smoking in a cohort of U.S. male physicians. Ann Intern Med 1994;120:458-462.

626. Kannel WR, Belanger A, et al. Physical activity and physical demand on the job and risk of cardiovascular disease and death: The Framingham Study. Am Heart J 1986;112:820-825.

627. Ginzberg E. Improving health care for the poor. lessons from the 1980s. JAMA 1994;271(6):464-467.

628. Fielding JE, Cumberland WG, Pettitt L. Immunization status of children of employees in a large corporation. JAMA 1994;271:525-530.

629. Carstairs V, Morris R. Deprivation: explaining differences in mortality between Scotland, England, and Wales. Br Med J 1989;299:886-889.

630. Wood DA, Riemersma RA, et al. Linoleic and Eicosapentaenoic Acids in adipose tissue and platelets and risk of coronary heart disease. Lancet 1987;i:177-180.

631. Post CA, The importance of being in control. Cardisense 1994;4(3):1-3.

632. House JS, Landis KR, Umberson D. Social relationships and health. Science 1988;241:540-545.

633. Orth-Gomer R, Johnson J. Social network interaction and mortality. A six- year follow-up study of a random sample of the Swedish population. J Chronic Dis 1987;40:949-957

634. House JS, Robbins C, Metzner HL. The association of social relationships and activities with mortality: prospective evidence from the Techumseh community health study. Am J Epidemiol 1982;116:123-140.

635. Welin L, Tibblin G, et al. Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet 1985;i:915-918.

636. Helsing K, Szklo M. Mortality after bereavement. Am J Epidemiol 1981;114:41-52.

637. Cassel J. The contribution of the social environment to host resistance. Am J Epidemiol 1976;104:107-123.

638. Cobb S. Social support as a moderator of life stress. Psychosom Med 1976;38:300-314.

639. Schectman G, Byrd JC, Gruchow HW. The influence of smoking on vitamin C status in adults. Am J Publ Health 1989;79:158-162.

640. Kallner AB, Hartman D, Hornig DH. On the requirements of ascorbic acid in man: steady state turnover and body pool in smokers. Am J Clin Nutr 1981;34:1347-1355.

641. Fulton M, Thomson M, et al. Cigarette smoking, social class, and nutrient intake: relevance to coronary heart disease. Eur J Clin Nutr 1988;42:797-803.

642. Stryker WS, Kaplan LA, et al. The relation of diet, cigarette smoking, and alcohol consumption to plasma beta carotene and alpha tocopherol levels. Am J Epidemiol 1988;127:283-296.

643. Riemersma RA, Oliver M, et al. Plasma antioxidants and coronary heart disease: vitamins C and E, and selenium. Eur J Clin Nutr 1990;44:143-150.

644. Thomson M, Fulton M, et al. A comparison of the nutrient intake of some Scottish men with dietary recommendations. Human Nutr Appl Nutr 1985;39a:443-455.

645. Ginter E. Decline of coronary mortality in the United States and vitamin C. Am J Clin Nutr 1979;32:511-512.

646. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States Population. Epidemiol 1992;3:194-202.

647. Concoby R. Vitamin C and life extension. in: Nicol D, ed. A report from the American Commission on Anti-Aging. New York: Hanford Press,1993.

648. Smith WCS, Turnstall-Pedoe H, et al. Concomitants of excess coronary deaths--major risk factor and lifestyle findings from 10,359 men and women in the Scottish heart Health Study. Scot Med J 1989;34:550-555.

649. Barker JD, Osmond C. Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales. Lancet 1986;1:1077-1081.

650. Knox EG. Ischaemic heart disease mortality and dietary intake of calcium. Lancet 1973;i:1465-1467.

651. Werbach M. Nutritional Influences on Illness. Connecticut:Keats Publishing, 1987.

652. Guarnieri C, Ferrari R, et al. Effect of tocopherol on hypoxic perfused and re-oxygenated heart muscle. J Mol Cell Cardiol 1978;10:893-906.

653. Bernier M, Hearse DJ, Manning AS. Reperfusion-induced arrythmias and oxygen-derived free radicals. Circ Res 1986;58:331-340.

654. Bell D, Jackson M, et al. Inflammatory response, neutrophil activation, and free radical production after acute myocardial infarction: effect of thrombolytic treatment. Br Heart J 1990;63:82-87.

655. Lapenna D, de Gioia S, et al. Heightened free radical activity in angina pectoris. Am J Cardiol 1993;72:830-831.

656. Grech ED, Dodd NJF, et al. Free radical generation during angioplasty reperfusion for acute myocardial infarction. Lancet 1993;341:990-991.

657. Grech ED, Jack CI, et al. Differential free radical activity after successful and unsuccessful thrombolytic reperfusion in acute myocardial infarction. Coronary Art Dis 1993;4:769-774.

658. Esterbauer H, Jurgens G, et al. Autooxidation of human low density lipoprotein: loss of polyunsaturated acids and vitamin E and generation of aldehydes. J Lipid Res 1987;28:495-509.

659. Ramirez J, Flowers NC. Leucocyte ascorbic acid and its relationship to coronary heart disease in man. Am J Clin Nutr 1980;33:2079-2087.

660. W.P.G. Livestock and Poultry Farming. In: Encylcopaedia Britannica; vol.10; Chicago: William Benton, 1979:1279.

661. M.Ke. Alcohol Consumption. In: Encylcopaedia Britannica; vol.1; Chicago: William Benton, 1979:444.

662. Pryor WA. The free-radical theory of aging revisited: a critique and suggested disease-specific theory. In: Butler RN, Spritt RL, et al, eds. Modern Biological Theories of Aging. New York: Raven Press;1987:89-112.

663. Gey KF. On the antioxidant hypothesis with regard to atherosclerosis. Biblthea Nutr Dieta 1986;37:53-91.

664. Smith J, Turner J. A perspective on the history and use of the Recommended Daily Allowances. Currents, Journal of Food, Nutrition and Health 1986;2:4.

665. Committee on Dietary Allowances, Food and Nutrition Board. Recommended Daily Allowances. 9th ed. Washington, D.C.: U. S. A. National Academy of Sciences, National Research Council, 1980.

666. Niwa Y, Hanssen M. Protection for life: How to Boost your Body's Defenses Against Free Radicals and the Aging Effects of Pollution and Modern Lifestyles. Wellingborough:Thorsons Publishers Ltd, 1989:9.

667. Palgi A. Association between dietary changes and mortality rates: Israel 1949-1970; a trend-free regression model. Amer J Clin Nutr 1981;34:1569-1583.

668. Herbert V, Kasdan T. Misleading nutrition claims and their gurus. Nutrition Today 1994;29(3):28-35.

669. Nomura A, Stemmermann G, et al. Serum vitamin levels and the risk of cancer specific sites in men of Japanese ancestry in Hawaii. Cancer Res 1985;45:2369-2372.

670. Menkes M, Comstock G, et al. Serum beta carotene, vitamins A and E, selenium and the risk of lung cancer. N Engl J Med 1986;315:1250-1254.

671. Willett W, Polk B, et al. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 1985;310:430-434.

672. Committee on Diet, Nutrition, and Cancer. Diet, nutrition and cancer. Washington, D.C.: National Academy of Sciences;1982.

673. Pauling L. How to live longer and feel better. New York: W.H. Freeman, 1987.

674. Pauling L. Vitamin C and the common cold. New York: W.H. Freeman, 1970.

675. Cameron E, Pauling L. Supplemental ascorbate in the supportive treatment of cancer. Prolongation of survival times in terminal human cancer. Proc Natl Acad Sci U.S.A. 1976;73:3685-3689.

676. Anderson R. The immunostimulatory, anti-inflammatory, and anti-allergic properties of ascorbate. Adv Nutr Res 1984;6:19-45.

677. Williams R, Sorlie P, et al. Cancer incidence by levels of cholesterol. J Am Med Assoc 1981;245:247-252.

678. Mettlin C. Epidemiologic studies on vitamin A and cancer. Adv Nutr Res 1984;6:47-65.

679. Wald N, Boreham J, et al. Plasma retinol, beta carotene and vitamin E levels in relation to the future risk of breast cancer. Br J Cancer 1984;49:321- 324.

680. Dhanakoti S, Draper H. Response of urinary malondialdehyde to factors which stimulate lipid peroxidation in vivo. Unpublished results, in: Reference 22: Draper HH, Bird RP. Micronutrients and cancer prevention: are the RDAs adequate? Free Rad Biol Med 1987;3:203-207.

681. Cavarocchi N, England M, et al. Superoxide generation during cardiopulmonary bypass: is there a role for vitamin E? J Surgical Res 1986;40:519-527.

682. Brown E, Bieri J, et al. Plasma response in normal men to various carotenoid sources. Fed Proc 1987;46:1189.

683. Willet W. Vitamin A and selenium intake in relation to human cancer risk. In: Hayashi Y, Nagao M, et al., eds., Proc 16th International Symposium on Diet, Nutrition, and Cancer, Japanese Sci Soc Press, The Netherlands: Utrecht;1986:237-245.

684. Burton G, Ingold K. Beta Carotene: an unusual type of lipid antioxidant. Science 1984;224:569-573.

685. Horwitt M. The promotion of vitamin E. J Nutr 1986;116:1371-1377.

686. Salonen J, Salonen R, et al. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: matched case-control analysis of prospective data. Br Med J 1985;290:417-420.

687. Stahelin H, Rosel F, et al. Cancer, vitamins, and plasma lipids: prospective Basel study. J Natl Cancer Inst 1984;73(6):1463-1468.

688. Russek H, Zohman B. Reactive significance of heredity, diet and occupational stress in coronary heart disease of young adults. Am J Clin Sci 1958;235:266-277.

689. Pearson H, Joseph J. Stress and occlusive coronary artery disease. Lancet 1963;1:415-418.

690. Wolf S. Psychosocial forces in myocardial infarction and sudden death. Circulation 1969;40(suppl IV):IV-74-IV-83.

691. Haft J, Fani K. Stress and the induction of intravascular platelet aggregation in the heart. Circulation 1973;48:164-169.

692. Rozanski A, Bairey C, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005-1012.

693. LaVeau P, Rozanski A, et al. Transient left ventricular dysfunction during provocative mental stress in patients with coronary artery disease. Am Heart J 1989;118:1-8.

694. Haft J, Arkel Y. Effect of emotional stress on platelet aggregation in humans. Chest 1976;70:501-505.

695. Levine S, Towell B, et al. Platelet activation and secretion associated with emotional stress. Circulation 1985;71:1129-1134.

696. Jern C, Hadenvik H, et al. Haematological changes during acute mental stress. Br J Haematol 1989;71:153-156.

697. Larsson P, Hjemdahl P, et al. Altered platelet function during mental stress and adrenaline infusion in humans: evidence for an increased aggregability in vivo as measured by filtragometry. Clin Sci 1989;76:369-376.

698. Matthews K, Haynes S. Type A behavior pattern and coronary disease risk: update and critical evaluation. Am J Epidemiol 1986;123:923-960.

699. Dimsdale J, Ziegler M. What do plasma and urinary measures of catecholamines tell us about human stressors? Circulation 1991;83[suppl II]:II- 36-II-42.

700. Coumel P, Leenhardt A. Mental activity, adrenergic modulation, and cardiac arrythmias in patients with heart disease. Circulation 1991;83[suppl II]:II-58-II-70.701. Schnall P, Pieper C, et al. The relationship between "job strain," workplace diastolic pressure, and left ventricular mass index. Results of a case control study. JAMA 1990;263:1929-1935.

702. Pickering T, Harshfield G, et al. Comparison of blood pressure during normal daily activities, sleep, and exercise in normal and hypertensive subjects. JAMA 1982;247:992-996.

703. Devereux R, Pickering T, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983;68:470-476.

704. Karasek R. Job demands, job decision latitude, and mental strain: implications for job redesign. Admin Sci Q 1979;24:285-307.

705. Karasek R, Baker D, et al. Job decision latitude, job demands and cardiovascular disease: a prospective study of Swedish men. Am J Publ Health 1981;71:694-705.

706. Karasek R, Theorell T, et al. Job characteristics in relation to the prevalence of myocardial infarction in the U.S. Health Examination Survey (HES) and Health and Nutrition Examination Survey (HANES). Am J Public Health 1988;78:910-919.

707. Alfredson L, Karasek R, Theorell T. Myocardial infarction risk and psychosocial environment: an analysis of the male Swedish working force. Soc Sci Med 1982;3:463-467.

708. Schwartz J, Pieper C, Karasek R. A procedeure for linking psychosocial job characteristics data to health surveys. Am J Public Health 1988;78:904-909.

709. Pieper C, LaCroix AZ, Karasek RA. The relationship of psychosocial dementions of work with coronary heart disease risk factors: a meta-analysis of five United States data bases. Am J Epidemiol 1989;129:484-494.

710. Mathews K, Cottington EM, et al. Stressful work conditions and diastolic blood pressure among blue collar factory workers. Am J Epidemiol 1987;126:280-291.

711. Gelernt M, Hochman J. Acute myocardial infarction triggered by emotional stress. Am J Cardiol 1992;69:1512-1513.

712. Muller J, Toffler G, et al. Circadian variations and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-743.

713. Muller J, Toffler G, et al. Probable triggers of onset of acute myocardial infarction. Clin Cardiol 1989;12:473-475.

714. Rozanski A, Krantz D, Bairey C. Ventricular responses to mental stress testing in patients with coronary artery disease: pathophysiological implications. Circulation 1991;83(suppl II):II-137-II-144.

715. Myers A, Dewar H. Circumstances attending 100 sudden deaths from coronary artery disease with coroner's necropsies. Br Heart J 1975;37:1133- 1143.

716. Guibbini R, Galli M, et al. Effects of mental stress on myocardial perfusion in patients with ischemic heart disease. Circulation 1991;83[suppl II]II-100-II- 107.

717. Young DZ, Dimsdale JE, et al. Left ventricular performance during psychological stress. Eur J Nucl Med 1989;15:118.

718. Deanfield JE, Shea M, et al. Silent myocardial ischemia due to mental stress. Lancet 1984;2:1001.

719. Rosengren A, Wilhelmsen L, et al. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. Br Med J 1990;300:634-638.

720. Wilhelmsen L, Svardsudd K, et al. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984;311:501-505.

721. Meade TW, Mellows S, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park heart study. Lancet 1986;ii:533- 537.

722. Stone MC, Thorp JM. Plasma fibrinogen--a major coronary risk factor. J R Coll Gen Pract 1985;35:565-569.

723. Kannel WB, Wolf PA, et al. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA 1987;258:1183-1186.

724. Markowe HLJ, Marmot MG, et al. Fibrinogen: a possible link between social class and coronary heart disease. Br Med J 1985;291:1312-1314.

725. Rosengren A, Wedel H, et al. Coronary heart disease and mortality among men from different occupational classes in Sweden. Br Med J 1988;297:1497- 1500.

726. Marmot MG, Shipley MJ, Rose G. Inequalities in death--specific explanations of a general pattern? Lancet 1984;i:1003-1006.

727. Holme I, Helgeland A, et al. Four-year mortality by some socioeconomic indicators: the Oslo Study. J Edidemiol Community Health 1980;34:48-52.

728. Reed D, McGee D, et al. Social networks and coronary heart disease among Japanese men in Hawaii. Am J Epidemiol 1983;117:384-396.

729. Fuller JH, Keen H, et al. Haemostatic variables associated with diabetes and its complications. Br Med J 1979;ii:964-966.

730. Korsan-Bengtsen K, Wilhelmsen L, et al. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to "risk factors" for myocardial infarction. Thrombosis et Diathesis Haemorrhagica 1972;28:99-108.

731. Meade TW, Imeson J, Stirling Y. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 1987;ii:986-988.

732. Kannel WB; D'Agostino RB, Belanger AJ. Fibrinogen, cigarette smoking and risk of cardiovascular disease: insights from the Framingham study. Am Heart J 1987;113:1006-1010.

733. Meade TW,Chakrabarti R, et al. Characteristics involving fibrinolytic activity and plasma fibrinogen concentrations. Br Med J 1979;i:153-156.

734.Astrand N-E, Hanson BS, Isacsson S-O. Job Demands, job decision latitude, job support, and social network factors as predictors of mortality in a Swedish pulp and paper company. Brit J Industrial Med 1988;1:334-340.

735. Specchia G, Falcone C, et al. Mental stress as a provocative test in patients with various clinical syndromes of coronary heart disease. Circulation 1991;83[supplII]:II-108-II-114.

736. Allman BJC, Zimbler A. Determination of the relationships between psychological stress levels and blood pressure,pulse and respiratory rates, weight and cigarette consumption. S Afr Med J 1988;73:113-116.

737. L'Abbate A, Simonetti I, et al. Coronary dynamics and mental arithmetic stress in humans. Circulation 1991;83[suppl II];II-94-II-99.

738. Weiner H. Stressful experience and cardiorespiratory disorders. Circulation 1991;83[supplI]:II-2-II-8.

739. Siegrist J, Matschinger H, et al. Atherogenic risk in men suffering from occupational stress. Atherosclerosis 1988;69:211-218.

740. Krantz D, Raisen S. Environmental stress, reactivity and ischaemic heart disease. Br J Med Psychol 1988;61:3-16.

741. Verrier R, Dickerson L. Autonomic nervous system and coronary blood flow changes related to emotional activation and sleep. Circulation 1991;83[supplI]:II-81-II89.

742. Brown V, Eisenberg S, Ginsburg H. [in:] Diet, Lifestyle, and Coronary Risk. Lipids and Atherogenesis. New York:Cahners Publishing Co., 1991:11-12.

743. Friedman M, Rosenman RH, Carroll V. Changes in the serum cholesterol and blood clotting time in men subjected to cyclic variations of occupational stress. Circulation 1958;17:852.

744. Thomas CB, Murphy EA. Further studies on cholesterol levels in the Johns Hopkins medical students: The effect of stress at examination. J Chron Dis 1958;8:661.

745. Wolf S, McCabe W, et al. Change in serum lipids in relation to emotional stress during rigid control of diet and exercise. Circulation 1962;26:379.

746. Kasl SV, Cobb S, Brooks GW. Changes in serum urine acids and cholesterol levels in men undergoing job loss. JAMA 1968;206:1500.

747. Jenkins CD, Hames CG, Zyzanski SJ. Psychological traits and serum lipids. Psychosom Med 1969;31:116.

748. Rahe RH, Rubin RT, et al. Psychological correlates of serum cholesterol in men: a longitudinal study. Psychosom Med 1971;33:399.

749. Taggart P, Carruthers M. Endogenous hyperlipidemia induced by emotional stress of racing drivers. Lancet 1971;i:363.

750. Goldstein JL, Kitta T, Brown MS. Defective lipoprotein receptors and atherosclerosis. N Engl J Med 1983;309:288.

751. Johnson JV. The impact of workplace and social support, job demands and work control upon cardiovascular disease in Sweden. (Report No.1), Stockholm:Department of Psychology, University of Stockholm, Division of Environmental and Organisational Psychology, 1986.

752. Alfreddson L, Karasek R, Theorell T. Myocardial infarction risk and psychosocial work environment: an analysis of the male Swedish working force. Soc Sci med 1982;16:463-467.

753. Theorell T, Floderus-Myrhed B. "Workload" and risk of myocardial infarction--a prospective psychosocial analysis. Int J Epidemiol 1977;6:17-21.

754. Alfredsson L, Spetz C-L, Theorell T. Type of occupation and near-future hospitilization for myocardial infarction and some other diagnoses. Int J Epidemiol 1985;14:378-388.

755. Mausner B, Platt ES. Smoking: A behavioral analysis. New York:Pergamon Press, 1971.

756. McArthur C, Waldron E, Dickenson J. The psychology of smoking. J Abnorm Psychol 1958;56:267-275.

757. Devereux RB, Pickering TG, et al. Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation 1983;68:470-476.

758. Theorell T, Knox S, et al. Blood pressure variations during a working day at age 28: effects of different types of work and blood pressure level at age 18. J Human Stress 1985;11:36-41.

759. Frankenhaeuser M. Coping with stress at work. Int J Health Serv 1981;11:491-510.

760. Suarez EC, Williams RB. Situational determinants of cardiovascular and emotional reactivity in high and low hostile men. Psychosom Med 1989;51:404- 418.

761. Hamburg DA. Frontiers of research in neurobiology. Science 1983;222:969.

762. French-Belgian Cooperative Group: Ischemic heart disease and psychological patterns: prevalence and incidence studies in Belgium and France. Adv Cardiol 1982;29:25-31.

763. Haynes SG, Feinleib M. Women, work, and coronary heart disease: prospective findings from the Framingham Heart Study. Am J Public Health 1980;70:133-141.

764. Farrow SC. Unemployment and health: A review of methodology, in: Cullen J, Siegrist J (eds): Breakdown in Human Adaption to Stress. Boston: Martinus Nijhoff; vol 1, 1984:149-158.

765. Ruberman W, Weinblatt E, et al. Psychosocial influences on mortality after myocardial infarction. N Engl J Med 1984;311:552-559.

766. Orth-Gomer K, Unden AL. Type A behavior, social support and coronary risk. Interaction and significance for mortality in cardiac patients. Psychosom Med 1990;52:59-72.

767. Johnson JV, Hall EM. Job strain, work place social support, and cardiovascular disease: a cross-sectional study of a random sample of the Swedish working population. Am J Public Health 1988;78:1336-1342.

768. Medalie J, Goldbourt V. Angina pectoris among 10,000 men:II. Psychosocial and other risk factors as evidenced by a multivariate analysis of a five-year incidence study. Am J Med 1976;60:910-921.

769. Blumenthal JA, Burg MM, et al. Social support, type-A behavior, and coronary artery disease. Psychosom Med 1987;49:331-340.

770. Deanfield JE, Kensett N, et al. Silent myocardial ischemia due to mental stress. Lancet 1984;2:1001-1004.

771. Selwyn AP, Ganz P. Myocardial ischemia in coronary disease. N Engl J Med 1988;318:1058-1060.

772. Rozanski A, Bairey CN, et al. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med 1988;318:1005-1012.

773. Krantz DS, Helmers KF, et al. Cardiovascular reactivity and mental stress- induced myocardial ischemia in patients with coronary artery disease. Psychosom Med 1991;53:1-12.

774. Va Veau PJ, Rozanski A, et al. Transient left ventricular dysfunction during provocative mental stress in patients with coronary artery disease. Am Heart J 1989;118:1-8.

775. Reich P, DeSilva RA, et al. Acute psychological disturbance preceeding life-threatening ventricular arrythmias. JAMA 1981;246:233-235.

776. Tavazzi L, Zotti AM, Rondanelli R. The role of psychological stress in the genesis of lethal arrythmias in patients with coronary artery disease. Eur Heart J 1986; (suppl A):99-106.

777. Schwartz PJ. Stress and sudden cardiac death: the role of the autonomic nervous system. Journal of Clinical Psychiatry Monograph Series 1984;2:7-13.

778. Follick MJ, Gorkin L, et al. Psychological stress as a predictor of ventricular arrythmias in a post-myocardial infarct population. Am Heart J 1988;116:32-36.

779. Lown B, DeSilva RA. Roles of psychological stress and autonomic nervous system changes in provocation of ventricular premature complexes. Am J Cardiol 1978;41:979-985.

780. Kamarck T, Jennings JR. Biobehavioral factors in sudden cardiac death. Psychol Bull 1991;109:42-75.

781. Shapiro AP. Psychological factors in hypertension: an overview. Am Heart J 1988;116:632-637.

782. Light KC. Psychosocial precursors of hypetension:experimental evidence. Circulation 1987;76(suppl I);I-67-I-76.

783. Houston BK. Psychological variables and cardiovascular and neuroendocrine reactivity.In: Handbook of Stress, Reactivity, and Cardiovascular Disease. Matthews KA, Weiss SM, et al, (Eds.), New York: John Wiley; 1986:207-229.

784. Dimsdale, JE. Research links between psychiatry and cardiology: hypertension, type A behavior, sudden death, and the psychology of emotional arousal. Gen Hosp Psychiatry 1988;10:328-338.

785. James SA. Psychosocial precursors of hypertension: a review of the epidemiologic evidence. Circulation 1987;76(suppl I):I-60-I-66.

786. Epstein LH, Jennings JR. Smoking, stress, cardiovascular reactivity and coronary heart disease. In: Handbook of Stress, Reactivity, and Cardiovascular Disease; Matthews KA, Weiss SM, et al. (Eds.), New York:John Wiley; 1988:291-310.

787. Dembroski TM, MacDougall JM, et al. Selective cardiovascular effects of stress and cigarette smoking in young women. Health Psychology 1985;4:153- 167.

788. Cryer PE, Haymond MW, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-577.

789. Gilbert DG. Paradoxical tranquilizing and emotion-reducing effects of nicotine. Psych Bull 1979;86:643-661.

790. Krantz DS, Contrada RJ, et al. Environmental stress and biobehavioral antecedents of coronary heart disease. J Consulting and Clin Psychol 1988;56:331-341.

791. Conway TL, Vickers RR, et al. Occupational stress and variation in cigarette, coffee, and alcohol consumption. J Health and Soc Behavior 1981;22:155-165.

792. Maisel A, Wright M, et al. Norepinephrine kinetics in hypertrophic cardiomyopathy. In: Hypertrophic Cardiomyopathy. Marion B, Toshimo H, eds. Tokyo:University of Tokyo Press, 1989:129-139.

793. Thomas J, Marks B. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978;41:233-243.

794. Creager M, Faxon D, et al. Determinants of clinical responses and survival in patients with congestive heart failure treated with captopril. Am Heart J 1982;104:1147-1154.

795. Nadeau R, DeChamplain J. Plasma Catecholamines in acute myocardial infarction. Am Heart J 1979;98:548-554.

796. Karlsberg R, Cryer P, Roberts R. Serum plasma catecholamine response early in the course of acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 1981;102:24-29.

797. Ziegler M, Lake C, Kopin I. The sympathetic nervous system defect in primary orthostatic hypotension. N Engl J med 1977;296:293-297.

798. Goldstein D. Plasma catecholamines in essential hypertension: an analytic review. Hypertension 1983;5:86-99.

799. Cleland J, Dargie H. Arrythmias, catecholamines, and electrolytes. Am J Cardiol 1988;62:55A-59A.

800. Frankenhaeuser M. The sympathetic-adrenal and pituitary-adrenal response to challenge: comparison between the sexes. In: Dembroski T, Schmidt T, Blumchen G, (eds.), Biobehavioral Bases of Coronary heart Disease. Basel:Karger; 1983.

801. Collins A, Frankenhaeuser M. Stress responses in male and female engineering students. J Human Stress 1978;4:43-48.

802. James G, Jenner D, et al. Differences in catecholamine excretion rates, blood pressure, and lifestyle among young Western Samoan men. Hum Biol 1985;57:635-647.

803. Davidson L, Baum A. Chronic stress and posttraumatic stress disorders. J Consult Clin Psychol 1986;54:303-308.

804. Machlin LJ, Sauberlich HE. New Views on the function and health effects of vitamins. Nutrition Today 1994;29(1):25-29.

805. Manson JE, Stampfer MJ, et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 1991;84(Suppl II):2168.

806. Choi ESK, McGandy RB, et al. The prevalence of cardiovascular risk factors among elderly Chinese Americans. Arch Intern Med 1990;150:413-418.

807. Moran JP, Cohen L, et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 1993;57:213-217.

808. Gaziano JM, Manson JE, et al. Dietary beta carotene and decreased cardiovascular mortality in an elderly cohort. J Am Coll Cardiol 1992;19(3 Suppl A):377A.

809. Rector R. Reducing the crushing tax burden on American families. The Heritage Foundation Backgrounder; March 7, 1994.

810. Herman T. Tax Report, The Wall Street Journal; May 11, 1994: p.A-1.

811. Nye L. Blood pressure in the aboriginal with a consideration of possible aetiological factors in hyperpiesia and its relation to civilization. Med J Austrtailia 1937(Dec 4);2:1000.

812. Gilbert C, Gillman J. Diet and disease in the Bantu. Science 1944;99:398- 399.

813. Beyers CF. Journ Med Assn South Africa 1927;1:606.

814. Gillman J. Am Journ Phys Anthropology 1936;21:313.

815. Eagle PC, Gillman J. South Afr Journ Med Sci 1938;3:1

816. Schulze VE, Schwab EH. Nervous factors in the development of hypertension. Am Heart J 1936;11:66.

817. Thomas J. Low incidence of coronary heart disease among 317 cases of heart disease at an all-negro hospital. JAMA 1946;38:202.

818. Federal Security Agency. Death rates per one hundred thousand from disease of the coronary arteries among white and negro populations. United States Public Health Service, Office of Vital Statistics: Vital Statistics, in Special Report, 1948;27:295.

819. Hjermann I, Velve Byre K, et al. Effect of diet and smoking on the incidence of coronary heart disease: report from the Oslo Study Group of a randomized trial in healthy men. Lancet 1981;2:1303-1310.

820. Beaglehole R, La Rosa JC, et al. Serum cholesterol, diet, and the decline in coronary heart disease mortality. Prev Med 1979;8:538-547.

821. Iacono JM. Dietary intervention studies to reduce risk factors related to cardiovascular diseases and cancer. Prev Med 1987;16:516-524.

822. Stamler J. Primary prevention of coronary heart disease: the last 20 years. Am J Cardiol 1981;47:722-735.

823. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation 1994;89:969-974.

824. Halliwell B. Current status review: free radicals, reactive oxygen species, and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Pathol 1989;70:737-757.

825. McCord JM. Is iron sufficiency a risk factor in ischemic heart disease? Circulation 1991;83:1112-1114.

826. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-1188.

827. Salonen JT, Nyyssonen K, et al. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992;86:803-811.

828. Ihanainen M, Salonen R, et al. Nutritional data collection in the Kuopio ischaemic heart disease risk factor study: nutrient intake of middle-aged Eastern Finnish men. Nut Res 1989;9:597-604.

829. Snowdon DA, Phillips RL, Fraser GA. Meat consumption and fatal ischemic heart disease. Prev Med 1984;13:490-500.

830. Princen HMG, Poppek GV, et al. Supplementation with vitamin E but not beta carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: effect of cigarette smoking. Arterioscler Thromb 1992;12:554-562.

831. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 1992;33:899-906.

832. Dieber-Rothender M, Puhl M, et al. Effect of oral supplementation with d- alpha-tocopherol on the vitamin E content of human LDL and resistance to oxidation. J Lipid Res 1991;32:1325-1332.

833. Esterbauer H, Dieber-Rotheneder M, et al. Role of vitamin E in preventing the oxidation of low density lipoproteins. Am J Clin Nutr 1991;53:314S-321S.

834. Chisolm GM, Kimberly CI, Penn MS. Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes. Diabetes 1992;(suppl 2):61-66.

835. Hunt JV, Dean RT, Wolf SP. Hydroxyl radical production and autooxidative glycosilation. Biochem J 1988;256:205-212.

836. Sakurai T, Sugioka K, Nakano M. O2-generation and lipid peroxidation during the oxidation of a glycated polypeptide, glycated polylisine, in the presence of iron-ADP. Biochem Biophys Acta 1990;1043:27-33.

837. Frei B, Forte TM, et al. Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Biochem J 1991;277:133-138.

838. Biemond P, Swaak AG, et al. Superoxide-dependent and -independent mechanisms of iron mobilization from ferritin xanthine oxidase. Biochem J 1986;239:169-173.

839. Koster JF, Slee RG. Ferritin, a physiological donor for microsomal lipid peroxidation. FEBS Lett. 1986;199-85-88.

840. Stampfer MJ, Grodstein F, et al. A prospective study of plasma ferritin and risk of myocardial infarction in U.S. physicians. Circulation 1993;87:10 [Abstract].

841. Cook JD. Adaption in iron metabolism. Am J Clin Nutr 1990;51:301-308.

842. Miller M, Hutchins GM. Is iron overload a risk factor for coronary artery disease? Circulation 1993;88(No 4, Part II):I-636 [abstract 3422].

843. Balla G, Jacob HS, et al. Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 1991;11:1700-1711.

844. Dunne LJ. Nutrition Almanac. New York: McGraw-Hill Publishing; 1990.

845. Garrison RH, Somer E. The Nutrition Desk Reference. New Canaan, Connecticut: Keats Publishing;1990.

846. Balch JF, Balch PA. Prescription for Nutritional Healing. Garden City Park, N.Y.: Avery Publishing Group; 1990.

847. Haenszel W, Kurihara M. Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 1968;40:43-68.

848. Staszewski W, Haenszel W. Cancer mortality among the Polish-born in the United States. J Natl Cancer Inst 1965;35:291-297.

849. Roberts TL, Wood DA, et al. Adipose linoleic acid and risk of coronary heart disease in women. Circulation 1993;88(No.4, Pt. 2):I-221 [Abstract 1179].

850. de Lorgeril M, Renaud S, et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994;343:1454-1459.

851. Fraser GE, Sabate J, et al. A possible protective effect of nut consumption on risk of coronary heart disease. The Adventist Health Study. Arch Intern Med 1992;152(7):1416-1424.

852. Wilder LB, Miller KW, et al. Intake of high fat foods among urban blacks and whites. Circulation 1993;88(No.4, Pt. 2):I-517 [Abstract 2785].

853. Stephen AM, Wald NJ. Trends in individual consumption of dietary fat in the Unites States, 1920-1984. Am J Clin Nutr 1990;52:457-469.

854. Hargreaves MK, Banquet C, Gamshadzahi A. Diet, nutritional status, and cancer risk in American blacks. Nutr Cancer 1989;12:1-28.

855. Campbell TC, Junshi C. Diet and chronic degenerative diseases: perspectives from China. Am J Clin Nutr 1994;59(suppl):1153S-1161S.

856. Levine PH, Fisher M, et al. Dietary supplementation with omega-3 fatty acids prolongs platelet survival in hyperlipidemic patients with atherosclerosis. Arch Intern Med 1989;149:1113-1116.

857. Mustard JF, Murphy EA. Effect of different dietary fats on blood coagulation, platelet economy, and blood lipids. Br Med J 1962;1:1651-1655.

858. Renaud S. Dietary fats and thrombosis. Bibl Nutr Dieta 1977;25:92-101.

859. Renaud S, Godsey F, et al. Influence of long term diet modification on platelet function and composition in Moselle farmers. Am J Clin Nutr 1986;43:136-150.

860. Miller GJ, Martin JC, et al. Association between dietary fat intake and plasma factor VII coagulant activity: a predictor of cardiovascular mortality. Atherosclerosis 1986;60:269-277.

861. Gordon T, Kagan A, et al. Diet and its relation to coronary heart disease in three populations. Circulation 1981;63:500-515.

862. Morris JN, Marr JW, Clayton DG. Diet and heart: a postscript. Br Med J 1977;2:1307-1314.

863. Shekelle RB, Missell L, et al. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:820.

864. Vollset SE, Heuch I, Bjelke E. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:821.

865. Curb JD, Reed DM. Fish consumption and mortality from coronary heart disease. N Engl J Med 1985;313:821-822.

866. Norell SE, Ahlbom A, et al. Fish consumption and mortality from coronary heart disease. Br Med J 1986;293:426.

867. Lapidus L, Andersson H, et al. Dietary habits in relation to incidence of cardiovascular disease and death in women: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Clin Nutr 1986;44:444-448.

868. Hunter DJ, Kazda I, et al. Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. Am J Prev Med 1988;4:5-10.

869. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721-724.

870. Byers T. Vitamin E supplements and coronary heart disease. Nutr Rev 1993;51:333-345.

871. Gutteridge JMC. Free radicals in disease processes: a compilation of cause and consequence. Free Radic Res Commun 1993;19:141-158.

872. de Lorgeril M, Renaud S. Anomalies de l'hemostase et risque coronaire. Revue de Praticien 1992;42(17):2136-2140.

873. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992;339(8808):1523-1526.

874. Young V, Pellett P. Plant proteins in relation to human protein and amino acid nutrition. Am J Clin Nutr 1994;59(suppl):1203S-1212S.

875. Anderson JW, Smith BM, Gustafson NJ. Health benefits and practical aspects of high-fiber diets. Am J Clin Nutr 1994;59(suppl):1242S-1247S.

876. Burkitt TP, Trowell HC. Refined carbohydrate foods and disease. Some implications of dietary fibre. London: Academic Press, 1975.

877. Anderson JW, Gustafson NJ. Hypercholesterolemic effects of oat and bean products. Am J Clin Nutr 1988;48:749-753.

878. Anderson JW, Deakins DA, et al. Dietary fiber and coronary heart disease. Crit Rev Food Sci Nutr 1990;29:95-147.

879. Anderson JW. Plant fiber and blood pressure. Ann Intern Med 1983;98:843-846.

880. Anderson JW, Bryant CA. Dietary fiber: diabetes and obesity. Am J Gastroenterol 1986;81:898-906.

881. Kromhout D, Bosschieter EB, de Lezenne Coulander C. Dietary fiber and 10-year mortality from coronary heart disease, cancer, and all causes: the Zutphen study. Lancet 1982;2:512-522.

882. Madar Z, Odes HS. Dietary fiber research. Basel, Switzerland: Karger, 1990.

883. Anderson JW, Akanji AO. Dietary fiber--an overview. Diabetes Care 1991;14:1126-1131.

884. Robertson WBL. Atherosclerosis and ischaemic heart disease. Observations in Jamaica. Lancet 1959;1:444.

885. Herbert V. The antioxidant supplement myth. Am J Clin Nutr 1994;60:157- 158.

886. Herbert V, Shaw S, et al. Most free radical injury is iron-related: it is promoted by iron, hemin, holoferritin, and vitamin C, and inhibited by Desferoxamine and apoferritin. Stem Cells 1994;12:289-303.

887. Bovard J. Suburban Guerrilla. The American Spectator 1994;27(9):26-32.

888. Richard M Nixon. The Memoirs of Richard M. Nixon. New York: Simon and Schuster;1990:353-353.

889. Lecomte E, Herbeth B, et al. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994;60:255-261.

890. Johnston PK. Prefact to the Symposium on Vegetarian Nutrition. Am J Clin Nutr 1994;59(suppl):vii

891. Fraser G. Diet and coronary heart disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J Clin Nutr 1994;59(suppl):1117S-1123S.

892. Anderson JT, Jacobs DR, Foster N, Keys A, et al. Scoring system for evaluating dietary pattern effect on serum cholesterol. Prev Med 1979;8:525- 537.

893. Hegsted DM, McGandy RB, et al. Quantitative effects of dietary fat on serum cholesterol in men. Am J Clin Nutr 1965;17:281-295.

894. Hennekens CH, Gaziano JM. Antioxidants and heart disease: epidemiologic and clinical evidence. Clin Cardiol 1993;16(suppl):I10-I15.

895. Barradas MA, Christofides JA, et al. The effect of olive oil supplementation on human platelet function, serum cholesterol-related variables and plasma fibrinogen concentrations: a pilot study. Nutr Res 1990;10:403-411.

896. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 1992;85:1927-1938.

897. Beswick AD, Fehily AM, et al. Long-term diet modification and platelet activity. J Intern Med 1991;229:511-515.

898. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from arginine. Nature 1988;333:664-666.

899. Brown KA, Morrice PC, Duthie GG. Vitamin E supplementation suppresses indexes of lipid peroxidation and platelet counts in blood of smokers and nonsmokers but plasma lipoprotein concentrations remain unchanged. Am J Clin Nutr 1994;60:383-387.

900. Cassidy A, Bingham S, Setchell K. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994;60:333-340.

901. Ahmed S, Leo MA, Lieber CS. Interactions between alcohol and beta carotene in patients with alcoholic liver disease. Am J Clin Nutr 1994;60:430- 436.

902. Smith GD, Song S, Sheldon TA. Cholesterol lowering and mortality: the importance of considering the initial level of risk. Br Med J 1993;306:1367- 1373.

903. Hulley SB, Newman TB, et al. Should we be measuring blood cholesterol levels in young adults? JAMA 1993;269:1416-1419.

904. Schwartz DF, Grisso JA, et al. A longitudinal study of injury morbidity in an African-American population. JAMA 1994;271:755-760.

905. Bassler TJ. "Regression" of atheroma. West J Med 1980;132:474-475.

906. Bassler TJ, Bassler TJ Jr. Long term mortality after primary prevention for cardiovascular disease. JAMA 1992;267:2183.

907. Mensink RP, Katan MB. Effect of dietary trans fatty acids on high density and low density lipoprotein cholesterol levels in healthy subjects. N Engl J Med 1990;323:439-445.

908. Report from the committee of principal investigators. A coororative trial in the primary prevention of ischemic heart disease using clofibrate. Br Heart J 1978;40:1069-1118.

909. Ornish D, Brown SE, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990;336:129-133.

910. Mantzioris E, James M, et al. Dietary substitution with alpha-linolenic acid- rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr 1994;59:1304-1309.

911. Harris T, Feldman JJ, et al. The low cholesterol-mortality association in a national cohort. J Clin Epidemiol 1992;45:595-601.

912. Smith GD, Shipley MJ, et al. Plasma cholesterol concentration and mortality: The Whitehall Study. JAMA 1992;267:70-76.

913. Anonymous. The effects of non-pharmacologic interventions on blood pressure of persons with high normal levels. Results of the trials of Hypertension Prevention, Phase I. JAMA 1992;267:1213-1220.

914. Goto Y, Moriguchi EH. Diet and ischemic heart disease in Japan. Atherosclerosis Rev 1990;21:21-33.

915. Parodi PW. Distribution of isomeric octadecenoic fatty acids in milk fat. J Dairy Sci 1976;50:1870-1873.

916. Zock PL, Katan MB. Hydrogenation alternatives: effects of trans fatty acids and stearic acid versus linoleic acid on serum lipids and lipoproteins in humans. J Lipid Res 1992;33:399-410.

917. Willett WC, Stampfer MJ, et al. trans-Fatty acid intake in relation to the risk of coronary heart disease among women. Lancet 1993;341:581-585.

918. van Oye E, Charles P. Contribution a l'etude de la fonction hepatique chez le noir Africain. vi. La cholesterolemie. Ann soc belge de med trop 1952;32:297.

919. Lindenbaum J, Rosenberg IH, et al. Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 1994;60:2-11.

920. Brattstrom LE, Israelsson B, et al. Folic acid--an innocuous means to reduce plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-221.

921. Ferroli CE, Trumbo PR. Bioavailability of vitamin B-6 in young and older men. Am J Clin Nutr 1994;60:68-71.

922. Mori TA, Vandongen R, et al. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 1994;59:1060-1068.

923. Clarke R, Daly L, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.

924. Coull BM, Malinow MR, et al. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Stroke 1990;21:572-576.

925. Pancharuniti N, Lewis CA, et al. Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 1994;59:940-948.

926. Boers GHJ, Smals AGH, et al. Heterozygosity for homocysteinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313:709-715.

927. Malinow MR, Kang SS, et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180- 1188.

928. Genest JJ, McNamara DN, et al. Plasma homocyst(e)ine levels in men with premature coronary artery disease. J Am Coll Cardiol 1990;16:1114-1119.

929. Parkinson AJ, Cruz AL, et al. Elevated concentrations of omega-3 polyunsaturated fatty acids among Alaskan Eskimos. Am J Clin Nutr 1994;59:384-388.

930. Davidson M, Bulkow LR, Gellin BG. Cardiac mortality in Alaska's indigenous and non-native residents. Int J Epidemiol 1993;22:62-67.

931. Melby CL, Toohey ML, Cebrick J. Blood pressure and blood lipids among vegetarian, semivegitarian, and non-vegetarian African-Americans. Am J Clin Nutr 1994;59:103-109.

932. Clark LT, Karve MM, et al. Obesity, distribution of body fat and coronary artery disease in black women. Am J Cardiol 1994;73:895-896.

933. Kumanyita S. Obesity in black women. Epidemiol Rev 1987;9:31-50.

934. Dawson D. Ethnic differences in female overweight: data from the 1985 National Health Interview Survey. Am J Public Health 1988;78:1326-1329.

935. Gillum R. Overweight and obesity in black women: a review of published data from the National Center for Health Statistics. J Natl Med Assn 1987;79:865-871.

936. Gillum RF. The association of body fat distribution with hypertension, hypertensive heart disease, coronary heart disease, diabetes, and cardiovascular risk factors in men and women aged 18-79 years. J Chron Dis 1987;40:421-428.

937. Folsom AR, Burke GL, et al. Implications of obesity for cardiovascular disease in blacks: the CAD-DIA and ARIC studies. Am J Clin Nutr 1991;53:1604S-1611S.

938. Adams-Campbell LL, Nwankwo M, et al. Body fat distribution patterns and blood pressure in black and white women. J Natl Med Assn 1990;82:573-576.

939. Svec F, Rivera M, Huth M. Correlation of waist to hips ratio to the prevalence of diabetes and hypertension in black females. J Natl Med Assn 1990;82:257-261.

940. Reading R, Raybould S, Jarvis S. Deprivation, low birth weight, and childrens' height: a comparison between rural and urban areas. Br Med J 1993;307:1458-1462.

941. Dahl LK. Salt intake and salt need. N Engl J Med 1958;258:1152.

942. American Heart Association. Cardiovascular disease and stroke in African-Americans and other racial minorities in the United States: a statement for health professionals. Circulation 1991;83:1462-1480.

943. Bengtsson C, Bjorkelund C, et al. Associations of serum lipid concentrations and obesity with mortality in women: 20 year follow up of participants in prospective population study in Gothenburg, Sweden. Br Med J 1993;307:1385-1388.

944. Lapidus L, Bengtsson C, et al. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J 1984;289:1257- 1261.

945. Hartz A, Grubb B, et al. The association of waist hip ratio and angiographically determined coronary artery disease. Int J Obes 1990;14:657- 665.

946. Thompson CJ, Ryu JE, et al. Central adipose distribution is related to coronary atherosclerosis. Arterioscler Thromb 1991;11:327-333.

947. Cassel J, Heyden S, et al. Occupation and physical activity and coronary heart disease. Arch Int Med 1971;128:920-928.

948. Simpson ME. Social mobility, normlessness, and powerlessness in two cultural contexts. Amer Sociol Rev 1970;35:1002-1013.

949. Stuckert RP. Occupational mobility and family relationships. Social Forces 1963;41:301-307.

950. Seeman M. On the meaning of alienation. Amer Sociol Rev 1959;24:783- 791.

951. Warner W, Abegglen JC. Big Business Leaders in America. New York: Harper Brothers, 1955.

952. Meier D, Bell W. Anomia and differential access to the achievement of life goals. Amer Sociol Rev 1959;24:189-207.

953. McDonough JR, Hames CG, et al. Coronary heart disease among negroes and whites in Evans County, Georgia. J Chronic Dis 1968;18:443-468.

954. Miall WE, Del Campo E, et al. A longitudinal study of heart disease in a Jaimacan rural population. Bull World Health Organization, 1971.

955. Pepler WJ, Meyer BJ. Interarterial coronary anastomoses and coronary arterial pattern: A comparison of South African Bantu and European hearts. Circulation 1960;22:14-24.

956. Walker ARP, Walker BF. The bearing of race, sex, age, and nutritional state on the precordial electrocardiograms of young South African Bantu and Caucasian subjects. Am Heart J 1969;77:441-459.

957. Kuller L. Sudden death in arteriosclerotic heart disease. Am J Cardiol 1969;24:617-628.

958. Chapman JM, Coulson AH, Clark V. Negro-white differences in risk factors and disease incidence in an epidemiologic study of ischemic heart disease. Circulation 1970;42(suppl III):143.

959. Lilienfield AM. Variation in mortality from heart disease:Race, sex, and socioeconomic status. Publ Health Rep 1956;71:545-552.

960. McVay LF, Keil PG. Myocardial infarction with special reference to the Negro. Arch Intern Med 1955;96:762-767.

961. Thomas WA, Blanche JO, Lee KI. Race and the incidence of acute myocardial infarction. Arch Intern Med 1957;100:423-429.

962. Roberts DW, Meck PG, Grueger DE. Prevalence of heart disease in a population of Baltimore. Circulation 1956;14:988-989.

963. Moriyama IM, Woolsey TD. Statistical studies of heart disease: IX. Race and diabetes. Publ Health Rep 1951;66:355-368.

964. Pennel MY, Lehman JL. Statistical studies of heart disease: VIII. Mortality from heart disease among Negroes as compared to white persons. Publ Health Rep 1951;66:57-80.

965. Bartel A, Heyden S, et al. Electrocardiographic predictors of coronary heart disease. Arch Intern Med 1971;128:929-937.

966. Hagstrom RM, Federspiel CF, Ho YC. Incidence of myocardial infarction and sudden death in Nashville, Tennessee. Circulation 1971;44:884-890.

967. Oalmann MC, McGill HC Jr, Strong JP. Cardiovascular mortality in a community: results of a survey in new orleans. Am J Epidemiol 1971;94:546- 555.

968. Keil JE, Saunders DE Jr, et al. Acute myocardial infarction: period prevalence, case fatality, and comparison of black and white cases in urban and rural areas of South Carolina. Am Heart J 1985;109:776-784.

969. Bowering J, Lowenberg RL, Morrison MA. Nutritional studies of pregnant women in East harlem. Am J Clin Nutr 1980;33:1987-1996.

970. Salen P, de Lorgeril M, et al. Effects of a French Mediterranean diet on heart transplant recipients with hypercholesterolemia. Am J Cardiol 1994;73:825-827.

971. Whitaker, J. A breakthrough therapy for diabetes and high blood pressure. Health and Healing. 4;12:1-3 1994.

972. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Summary of the second report of the National Cholesterol Education Program (Adult Treatment Panel II). JAMA 1993;269:3015-3023.

973. Krolewski A.S., et al. Glycosated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J. Med 1995;332:1251-5

974. Krolewski A.S., et al. Magnitude and determinants of coronary artery disease in juvenile onset insulin-dependent diabetes mellitus.Am J Cardiol 1987;59:750-5.

975. Langsjoen, P, et al. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease. Drugs Exptl Clin Res 1985;XI(8);577-579.

976. Biomedical anc clinical aspects of coenzyme Q10, volume 5, Proceedings of the Fifth International Symposium on the Biomedical and Clinical Aspects of Coenzyme Q-10, Tokyo, Japan, 24-26 October,1985. K Folkers, Y Yamamura, eds. Elsevier Science Publishers, New York, 1986.

977. Greenberg S, Frishman WH. Coenzyme Q10: A new drug for cardiovascular disease. J Clin Pharmacol 1990 Jul;30(7):596-608.

978. "Cardiovascular Drugs for the Medically Indigent," Heart Disease and Stroke, American Heart Association Publication, May/June 1992.

979. 1992 Directory of Perscription Drug Indigent Programs, Aug, 1992. Pharmaceutical Manufacturers Association Publication.

980. Report of the Task Force on the Availability of Cardiovascular Drugs to the Medically Indigent. Circulation 1992 (Feb);85(2)#71-0012.

981. Shizukuishi, et al. "Clinical Effect of Coenzyme Q-10 on periodontal disease." Osaka University Faculty of Dentistry, and Osaka Medical School, Suita, Osaka, 565Biomedical and Clinical Aspects of Coenzyme Q-10, Vol 5, (1986), Elsvier/North-Holland Biomedical Press. Amsterdam, p.359.

982. Littarru GP, Nakamura R, Ho L, Folkers K, Kuzell WC. Proc Natl Acad Sci USA 1971;68:2232-2235.

983. Nakamura R, Littarru GP, Folkers K, et al. Proc Natl Acad Sci USA 1974;71:1456-1460.

984. Hanse I, Iwamoto Y, Kishi T, Folkers, K. Res Commun Chem Pathol Pharm 1976;14:729-742.

985. Wilkinson EG, Arnold RM, Folkers K, et al. Res Commun Chem Pathol Pharm 1975;12:111-124.

986. Iwamoto Y, Watanabe T, Okamoto H, Ohta N, Folkers K. Biomedical and Clinical Aspects of Coenzyme Q-10, Vol 3, (1981), Elsvier/North-Holland Biomedical Press. Amsterdam, pp. 109-119.

987. Kantrowitz et al. Progress in Cardiovascular Diseases. Vol XXVII, No. 3, "Cardiotoxicity of Antitumor Agents,"Grune and Stratton Inc, Nov/Dec 1984.

988. Chiba. "A protective action of coenzyme Q10 on Chlorpromazine-induced myocardial cell damage." Japanese Heart Journal 1984(Jan);vol 25, no. 1.

989. Solani G, Ronca G, Bertelli A. Drugs Under Experimental and Clinical Research. Vol XI(8), "Inhibitory effects of several anthracyclines on myocardial respiration and coenzyme Q10 protection." Bioscience ediprint, 1985.

990. Cortes E, Gupta M, Chou C, Amin VC, Folkers K. Cancer Treatment Reports. Vol. 62, No. 6, "Adriamycin Cardiotoxicity: Early detection by systolic time interval and possible prevention by coenzyme Q10." Long Island Jewish-Hillside Medical Center, Hyde Park, N.Y., 1978.

991. Aubel-Sadron G, Londros-Gagliardi D. Biochimie, vol. 66, no. 5, "Daunorubicin and doxorubicin anthracycline antibiotics, a physiochemical and biological review." Masson publishing, New York, 1984.

992. Choe JY, Combs AB, Folkers K. Research Communications in Chemical Pathology and Pharmacology, Vol XIII, No.1. "Prevention by coenzyme Q10 of electrocardiographic changes induced by andriamycin in rats."

993. Sanma H, Nakamura T. Biochemistry International. Vol 5, No. 5, "Effects of Adriamycin and coenzyme Q10 on leukotriene C-like substance formation in the guinea pig heart." Academic Press. Austrailia, 1982 (November).

994. Karlsson J, Folkers, K, Astrom H, et al. "Effect of Adriamycin on heart and skeletal muscle coenzyme Q10 in man. Biomedical and Clinical Aspects of Coenzyme Q-10, Vol 5, (1986), Elsvier/North-Holland Biomedical Press. Amsterdam, p. 241-246.

995. Okuma K, Ota K. "The effect of coenzyme Q10 on ECG changes induced by Doxorubicin." Biomedical and Clinical Aspects of Coenzyme Q-10, Vol 5, (1986), Elsvier/North-Holland Biomedical Press. Amsterdam, p. 247-256.

996. Kishi T, Takahashi T, et al. "Protective effect of coenzyme Q10 on adriamycin toxicity in beating heart cells." Biomedical and Clinical Aspects of Coenzyme Q-10, Vol 4, (1984), Elsvier/North-Holland Biomedical Press. Amsterdam, p. 181-194.

997. Drzewoski J, Polakowski P, et al. "Effect of coenzyme Q10 and doxorubicin on hemodynamic parameters in rabbits." Biomedical and Clinical Aspects of Coenzyme Q-10, Vol 4, (1984), Elsvier/North-Holland Biomedical Press. Amsterdam, p.195-200.

998. Fuchs CS, Stampfer MJ, Colditz MB, et al. Alcohol consumption and mortality among women. New Engl J Med 1995;332:1245-50.

999. Blackwelder WC, Yank K, et al. Alcohol and mortality: The Honolulu Heart Study. Am J Med 1980;68:164-9.

1000. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology 1990, ,1:342-8.1001. Cullen K.J., et al. Alcohol and mortality in Busselton, Western Austrailia. Am J Epidemiol 1993;137:242-8. 1002. De Labry LO, et al. Alcohol consumption and mortality in an American male population:recovering the U-shaped curve--findings from the normative aging study. J Stud Alcohol 1992;53:25-32.1003. Doll R, et al. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. Br Med J 1994;309:911-18.1004. Dyer AR, et al. Alcohol consumption, cardiovascular risk factors, and mortality in two Chicago epidemiologic studies. Circulation 1977;56:1067-74.1005. Gordon T, et al. Drinking and mortality: The Albany study. Am J Epidemiol 1987;125:263-70. 1006. Gronbak M, et al. Influence of sex, age, body mass index and smoking on alcohol intake and mortality. BMJ 1994;308:302-6.1007. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in framingham. Am J Epidemiol 1986;124:481-9.1008. Kittner SJ, et al. Alcohol and coronary heart disease in Puerto Rico. Am J Epidemiol 1983;117:538-50. 1009. Klatsky AL et al. Alcohol and Mortality. Ann Intern Med 1992;117:646-54. 1010. Kono S, et al. Alcohol and mortality: A cohort study of Japanese male physicians. Int J Epidemiol 1986;15:527-32. 1011. Kozaraevic D, et al. Frequency of alcohol consumption and morbidity and mortality: The Yugoslavia cardiovascular disease study. Lancet 1980:1:613-6.1012. Marmot MG, et al. Alcohol and mortality: A U-shaped curve. Lancet 1981:1:580-3. 1013. Longnecker MP. Alcoholic beverage consumption in relation to risk of breast cancer: meta-analysis and review. Cancer Causes Control 1994;5:73-821014. Willett WC, Stampfer MJ, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 1987;316:1174-80.1015. Selhub J, et al. Association between plasma homocysteine concentration and extracranial carotid-artery stenosis. New Engl J Med 1995,332(5);286-291.1016. Pearson D, Shaw S, Life Extension. Warner Books. New York, New York. 1983. 1017. Golding J, et al. Childhood cancer, intramuscular vitamin K, and pethidine given during labour. Br Med J 1992;305:341-6.1018. Schatzkin A, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med 1987;316:1169-73.1019. Jacobs MM. Vitamins and Minerals in the Prevention and Treatment of Cancer. American Institute for Cancer Research, Washington, DC; CRC Press Inc. 1991.1020. Nixon DW. Chemoprevention of Cancer. Hollings Cancer Center, Medical University of South Carolina, Charleston; CRC Press Inc. 1995.1021. Forse RA, Blackburn GL, Kabbash LG, eds. Diet Nutrition and Immunity. Harvard University Medical School, and Cancer Research Institute, New England Deaconess Hospital, Boston. CRC Press, 1994.1022. Anderson JJ, Garner SC. Calcium and Phosphorous in Health and Disease. Department of Nutrition, Schools of Medicine and Public Health, University of North Carolina. Modern Nutrition Series. CRC Press, 1995.1023. Kirby DF, Dudrick SJ., eds. Nutritional Immunology. in: Practical Handbook of Nutrition in Clinical Practice. Modern Nutrition Series. CRC Press, 1994.1024. Seelig M. Prenatal and Genetic Magnesium Deficiency in Cardiomyopathy. in: Lifshitz F, ed. Childhood Nutrition. Modern Nutrition Series. CRC Press, 1995.1025. Bucci LR. Nutrition Applied to Injury Rehabilitation and Sports Medicine. CRC Press, 1995. 1026. Stampfer MJ, et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 1988;319:267-73.1027. Gaziano JM, et al. Moderate alcohol intake, increased levels of high density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993;329:1829-34.1028. Rimm EB, Giovannucci EL, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991;338:464-8.1029. Klatsky AL, Armstrong MA, et al. Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers, and non-drinkers. Am J Cardiol 1990;66:1237-42.1030. Alcohol and cancer. Lancet 1990;335:634-5. 1031. McGinnis JM, Foege WH. Actual Causes of death in the United States. JAMA 1993;270:2207-12. 1032. Kaski JC et al. J Am Coll Cardiol 1995;25:807-814. 1033. Syndrome X Angina. Am J Obstet Gynecol 1992;167:467-472. 1034. Report of the committee on the operation of abortion law. Ottawa, 1977:321. 1035. Gronbaek M. Alcohol consumption and mortality. Br Med J, May 6, 1995. 1036. Sobel BJ. Hypertension, a clinicians guide to diagnosis and treatment. Hanley and Belfus, Philadelphia, 1995. 1037. Colditz GA, et al. The use of estrogens and progestins and the risk of breast cancer in post menopausal women. N Engl J med 1995;332:1589-93.1038. Lilienfield AM. The relationship of cancer of the female breast to artificial menopause and marital status. Cancer 1956;9:927-34.1039. Fienlieb M. Breast cancer and artificial menopause: a cohort study. J Natl Cancer Institute 1968;41:315-29. 1040. Cauley JA, et al. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 1989;129:1120-31.1041. Tretli S. Height and weight in relationship to breast cancer morbidity and mortality: a prospective study of 570,000 women in Norway. Int J Cancer 1989;44:23-30.1042. Lew EA, Garfinkel L. Variations among mortality by weight among 750,000 men and women. J Chron Dis 1979;32:563-76.1043. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med 1994;330:1062-71. 1044. Amsterdam, EA, (ed); Cardiology Drug Facts. Facts and Comparison Division. J.B. Lippincott Co., St Louis, Missouri: 1989.1045. Petrosino S. {Dissertation} The Welfare State and the Paradoxical Shift of Coronary Artery Disease Risk Associated with Socioeconomic Status. LaSalle University, September 1994.1046. Gillman MW, Cupples LA, et al. Margarine intake and subsequent coronary heart disease. Circulation 1995;91:925[abstract].1047. Michels KB, Sacks F. Transfatty acids in margarine. N Engl J Med 1995;333:130-2. 1048. Haas, R. Eat Smart, Think Smart. Harper Collins, New York, NY: 1993. 1049. Christensen K, Schmidt M, et al. Absence of an environmental effect on the recurrence of facial-cleft defects. N Engl J Med 1995;333:161-4.1050. Haynes SG, Levine S, et al. The relationship of psychosocial factors to coronary heart disease in the Framingham study. I: methods and risk factors. Am J Epidemiol 1978;107:362-383.1051. Rose RM, Jenkins CD, Hurst MW. The Air Traffic Controller Health Change Study: A Prospective Investigation of Physical, Psychological, and Work-Related Changes. Boston, Mass: Boston University School of Medecine, A report to the Federal Aviation Administration.1978.1052. Salonen JT, Salonen R, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability, and prevalent ischaemic heart disease in eastern Finnish men. Atherosclerosis 1988;70:155-60.1053. Anderson JW, Johnstone, BM, et al. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995;333:276-82.1054. Giovannucci E, et al. The association of body mass and exercise with the incidence of colon cancer. Annals of Internal Medecine 1995;122:327-334.1055. Ornish DL. Reversing Heart Disease. Ballantine Books: New York, NY: 1990. 1056. Wannamethee G, et al. Low serum cholesterol concentrations and mortality in middle-aged British men. British Medical Journal 1995;311:409-13.1057. Chapuy MC et al. Regression of osteoporosis of the femur by calcium and vitamin D supplementation among a cohort of elderly women. N Engl J Med 1992;327:1637-42.1058. Byrne PM, et al. Vitamin D supplementation and osteoporosis. Calcif Tissue Int 1995;56;518-520. 1059. Burger Scott R. Barnes Hospital Laboratory Reference Values. in: Ewald GA and McKenzie CR, eds. The Washington Manual of Medical Therapeutics. 28th edition. 1995. Little, Brown, and Co, Boston MA:551-557.1060. Schaiff RA and Watson LA. Drug Interactions of Commonly Prescribed Medicines. in: Ewald GA and McKenzie CR, eds. The Washington Manual of Medical Therapeutics. 28th edition. 1995. Little, Brown, and Co, Boston MA:558-561.1061. Falchuk KH. Disturbances in Trace Element Metabolism. in: Isselbacher KJ, Braunwald E, et al, eds. Harrison's Principles of Interenal Medicine. McGraw Hill, Inc. New York, New York. Thirteenth Edition, 1994.1062. Dawson-Hughes B, et al. Vitamin D and bone loss in post-menopausal women. Am J Clin Nutr 1995;61:1140-1145. 1063. Kritz H, Schmid P, and Sinzinger H. Passive smoking and cardiovascular risk. Arch Int Med 1995;155:1942-48. 1064. Schwartz CA, Valente AJ, Sprague EA. Am J Cardiol 1993;71:9B-14B. 1065. Davidson MH. Am J Cardiol 1993;71:32B-36B 1066. Harris WS. Clin Cardiology 1992;15:636-640. 1067. Knekt P, et al. Am J Epidemiol 1994;139(12):1180-1189. 1068. Rifici VA, Khachadurian AK. Am Coll Nutr 1993;12(6):631-637. 1069. Buettner, GR. Arch Biochem Biophys. 1993:300(2):535-543. 1070. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. In: Sauberlich HE, Machlin LJ, eds. Beyond Deficiency. Ann NY Acad Sci 1992;669:7-20.1071. Jialal I, Scaccini C. Current Opinion in Lipidology. 1992;3:324-328. 1072. Block G. Am J Clin Nutr 1991;53:270S-282S. 1073. Goldenberg RL, et al. The effect of zinc supplementation on pregnancy outcome. JAMA 1995; Aug 9;274:463-468. 1074. Strauss WE, Fortin T, et al. A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with medical therapy. Circulation 1995;92:1710-1719.1075. Hoes AW et al. Diuretics, beta blockers, and the risk for sudden cardiac death in hypertensive patients. Ann Intern Med 1995 Oct 1;123:481-487.1076. Oliver MF. Doubts about preventing coronary heart disease. Multiple interventions in middle aged men may do more harm than good. British Medical Journal 1992;304:393-394.1077. Davey Smith G, Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? British Medical Journal 1992;304:431-434.1078. Muldoon MF, Manuck SB, Matthews KA. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. British Medical Journal 1990;301:309-314.1079. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990;323:1112-19.1080. The Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-89.1081. Coghlan A. Vitamin E could reduce heart disease. New Scientist,1991;(May 25):24. 1082. Shepherd J, Cobbe S, et al. The West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995;333;1301-7.1083. Donegan P. Stopping cancer in its tracks. The Harvard Health Letter 1995;21(2):1-3. 1084. Williams, MH. The use of nutritional ergogenic aids in sports: Is it an ethical issue? International Journal of Sports Nutrition 1994;4:120-131.1085. Mindell E. Vitamin Bible, Warner Books, New York, N.Y. 1991 1086. Nitrosamines and Nitroso-compounds. Journal of Agricultural and Food Chemistry, January 1994. 1087. Arky R, ed. The Physicians' Desk Reference, volume 49, Medical Economics Data, Montvale N.J., 1995 1088. Kowalski TE et al. Am J Med 1994;97:523-28. 1089. Silverman H.M., Romano J.A., Elmer G. The Vitamin Book, Bantam, 1985 1090. Quillin P. Healing Nutrients, Contemporary Books, 1987 1091. Young G. Elemental boron and osteoporosis. Vaxa Heartbeat, Vaxa International, 1993 1092. Thomas, C (ed), Taber's Cyclopedic Medical Dictionary, 15th ed, Philadelphia: F.A. Davis Co., 1986. 1093. Strachan DP. Vegitarian diet and risk of tuberculosis among south London immigrants. Thorax 1995; 502(2):175-180. 1094. Batmanghelidj, F. Your Body's Many Cries for Water. Global Health Solutions Press. Falls Church, VA. 1992. 1095. Homeopathic medicines in symptomatic disease. British Medical Journal, Feb 9, 1991 1096. The Lancet, December 10, 1994. 1097. Pediatrics, May 1994. 1098. Null G. The Complete Guide to Health and Nutrition. Dell: New York, 1984. 1099. Williams DG. Copper's connection to violence and other problems. Alternatives 1995;5(24):185-186. 1100. Webb D, ed. Borage seed oil and evening primrose oil may relieve arthritis pain and swelling. Environmental Nutrition 1994; 17(3):6.1101. Fish oil supplements and rheumatoid arthritis. Lancet. Oct 12, 1991; pp. 899-902. 1102. Fish oil supplements and rheumatoid arthritis. Medical World News 27;13:9, 1986. 1103. Margen S., ed. University of California at Berkeley Wellness Letter. 11(10); 1995:1-2. 1104. Williams DG, ed. "Fishing for the right oil." Alternatives 1994; 5(9):68-70. 1105. Jacobs, M. Vitamins and Minerals in the Prevention and Treatment of Cancer. Am Instit for Cancer Research, Washington, D.C.:1991.1106. Beta carotene and risk of cancer. Am J Epidemiology, Dec 1991. 1107. Elemental chlorine and bowel cancer. American Journal of Public Health, January, 1992. 1108. Shimon. Thiamine Suppliments Improve Left Ventricular Function in Patients with Chronic Heart Failure, Am Coll Cardiol 42nd Ann Scientific Session, Abstract #54221, March 1993.1109. Benowicz, R.J.; Vitamins and You, Berkley; 1981 1110. University of Texas Lifetime Health Letter, Houston Health Science Center, 1994; vol 6 (2):1-8 1111. M. Shaevitz. Side effects of common supplements. Bottom Line Personal; Vol 14; No. 15, 1993: p.12 1112. Physiologic effects of Melatonin. Psychopharmacology 1990;100(2):222-6 1113. Walsh D, et al. Subjective response to lysine in the therapy of herpes simplex. J Antimicrobial Chemotherapy 1983;12:489.1114. Williams, D. Simple deficiencies causing major problems. Alternatives 1995, (5)No.20:153-157. 1115. Shorposner G, et al. Journal of Allergy and Clinical Immunology April 1995;95(4):886-892. 1116. USA Today, Sept 27, 1993 1117. Melatonin and sleep disorders. Biol Psychiatry 1991;30(4):371-6. 1118. The effect of melatonin on sleep patterns. Brit Med J 1989;298(6675):705-7. 1119. Davis, W, Ziady U, Pretroia, South Africa. Second International Symposium on Magnesium. Montreal: 1976. 1120. Vitamin B12 and sleep patterns. Sleep 1990:13(1):15-23 1121. Berger, S.M., How to be Your Own Nutritionist, Morrow & Co., 1987. 1122. Penland J. Effects of trace element nutrition on sleep patterns in adult women. Fed Am Soc Exp Biol J w:A434, 1988.1123. New England Journal of Medicine, March 1993 1124. Margen S. DHEA-The promise of youth and health. Univ of Berkeley Wellness Ltr 1996 (12)4:1-2. 1125. Wood, A.J. N Engl J Med 1995;332:581-588. 1126. Eur J Clin Nutr 1993;47:251-254. 1127. Van Der Spoel JI, et al. Dangers of dietary germanium supplements. Lancet vol.336:117. 1128. Anon. Germanium dangers. Lancet 1989;2:755. 1129. Nagata N, et al. Accumulation of germanium in the tissues of a long term user of germanium preparation who died of acute renal failure. J Toxicol Sci 1985;10:333-341.1130. Omata M, et al. Drug-induced nephropathy: Our recent clinical experience. in: Tanabe T, et al, eds. Nephrotoxicity of antibiotics and immunosuppressants. Amsterdam. Elsevier, 1986:15-20.1131. Okuda S, et al. Persistent renal dysfunction induced by chronic intake of germanium-containing compounds. Curr Ther Res 1987;41:265-75.1132. Matsusaka T, et al. Germanium-induced nephropathy: report of two cases and a review of the literature. Clin Nephrol 1988;30:341-45.1133. Okada K, et al. Renal failure caused by long-term use of a germanium preparation as an elixir. Clin Nephrol 1989;31:219-24.1134. Marcus R, Coulston AM. The vitamins: Introduction. In: Gillman A, et al, eds. Goodman and Gillman's Pharmacological Basis of Therapeutics.7th ed, New York: MacMillan, 1985:1544-51.1135. Anon. Warning issued by the department of health of the United Kingdom. Pharm J 1989;242:475. 1136. Lesser, M. Nutrition And Vitamin Therapy. Bantam, New York. 1981. 1137. Platt O.S. Easing the suffering caused by sickle cell disease. N Engl J Med 1994;330(11):783-784. 1138. Justice, Blair, Ph.D., Who Gets Sick, Los Angeles: Jeremy Tarcher, 1988 1139. Holmes, T.H., "The Social Readjustment Rating Scale," Journal of Psychosomatic Research, 1967;11:213-218. 1140. Kark JD. Journal of the American Medical Association, April 1995. 1141. Gillman MW. Protective effects of fruits and vegetables in the development of stroke in men. Journal of the American Medical Assn, April 12, 1995,273:1113-7.1142. Shinton R, Sagar G. Lifelong exercise and stroke. Br Med J 1993;307:231-234. 1143. Wannamethee G, Shaper AG. Physical activity and stroke in middle aged British men. Br Med J 1992;304;597-601.1144. Paffenbarger RS, Wing AL. Characteristics in youth predisposing to fatal stroke in later years. Lancet 1967;i:753-754.1145. Leon AS, Connett J et al. Leisure time physical activity levels and risk of coronary heart disease and death: the multiple risk factor intervention trial. JAMA 1987;258:2388-2395.1146. University of California at Berkeley Wellness Letter, Aug 1993. 1147. Vitamin E. American Institute of Health and Nutrition, 1993. 1148. McKenney JM, Proctor JD, et al. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in Hypercholesterolemic patients. JAMA 1994;271:672-677.1149. Christensen AN, Anchor RWP et al. Nicotinic Acid treatment of hypercholesterolemia. JAMA 1961;177:546-550. 1150. Berge KG, Anchor RWP et al. Hypercholesterolemia and nicotinic acid. Am J Med 1961;31:24-35. 1151. Knopp RH, Ginsbert J, et al. Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemia subjects: Clues to the mechanism of action of niacin. Metabolism 1985;34:642-650.1152. Alderman JD, Pasternak RC, et al. Effect of a modified, well tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol 1989;64:725-729.1153. Superko HR, Krauss RM. Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis 1992;95:69-76.1154. Carlson LS, Hamsten A, Asplund A. Pronounced lowering of serun lipoprotein Lp(a) in hyperlipidemic subjects treated with nicotinic acid. J Intern Med 1989;226:271-276.1155. Hertog. Arch Int Med 1995;155:381-386. 1156. Ann Nutr Metab 1993;37:75-84. 1157. Arduini A. Carnitine and its acyl esters as secondary antioxidants? Am Heart J 1992;123(6):1726-1727. 1158. Paulson DJ et al. Metabolic and physiologic difference between zero-low and low-flow myocardial ischemia: effects of acetyl-L-carnitine. Basic Res Cardiol 1984;79:551-561.1159. Liedtke AJ et al. Effects of propionyl-L-carnitine on mechanical recovery during reflow in intact hearts. Am J Physiol 1988;255:169-176.1160. Rizzon P et al. High doses of L-carnitine in acute myocardial infarction:metabolic and anti-arrythmic effects. Eur Heart J 1989;10:502-508.1161. Schinetti M et al. Protective action of acetyl-L-carnitine on NADPH-induced lipid peroxidation of cardiac microsomes. Drugs Exp Clin Res 1987;13:509-515.1162. Geremia E et al. Antioxidant action of acetyl-L-carnitine: In vitro study. Med Sci Res 1988;699-700. 1163. Archives of Biochemistry and Biophysics 1992;292:47. 1164. Clinical Investigator 1993;71:Suppl 134. 1165. Journal of Cardiac Failure 1995;1:101. 1166. Fish oil in the treatment of Crohn's Disease. Eur J Clin Nutr 1993;47:255-259. 1167. Katan MB. Fish and Heart Disease. New Engl J Med 1995;332:1024-1025 1168. Burr ML. Effects of changes in fish, fat, and fiber intakes on death and myocardial reinfarction. Lancet 1989;2:757-761.1169. Burr ML. Diet and Reinfarction. Eur Heart J 1994;15:1152-3. 1170. Kromhout D. Inverse relation between fish consumption and 20 year mortality from Coronary heart disease. N Engl J Med 1985;312:1205-9.1171. Shekelle RB. Fish consumption and mortality from heart disease. N Engl J Med 1985;313:820. 1172. Doleck. PUFA and mortality in MRFIT. World Rev Nutr Diet 1991;66:205-16. 1173. Ascherio A. Dietary intake of marine fatty acids and the risk of CAD. New Engl J Med 1995;332:1004-1014. 1174. Cerda, J. Drug Nutr Interact 1985;3:109-113. 1175. Cerda J. Clin Cardiol 1988;11:595-600. 1176. Sharma H, et al. Inhibition of human low-density lipoprotein oxidation in vitro by Marharishi Amrit Kalash herbal mixtures. Pharmacol Biochem and Behavior, 1992;43:1175-82.1177. Calcium supplementation and osteoporosis. N Engl J Med, Feb 18, 1993. 1178. Bagchi. Federation of American Societies for Experimental Biology. April 10, 1995 (oral presentation). 1179. Manson JE et al. Antioxidant Vitamins and Secondary Prevention of Cardiovascular Disease in High Risk Women. Circulation 1993;88(4)2:I-70 (abs#362).1180. Rothman KJ, Mooore LL, et al. Teratogenicity of high vitamin A intake. N Engl J med 1995;333:1369-73. 1181. Oakley G, Erickson J. Vitamin A and birth defects. N Engl J Med 1995;333:1414-1415. 1182. Teratology Society. Recommendations for vitamin A use during pregnancy. Teratology 1987;35:269-75. 1183. Use of supplements containing high-dose vitamin A. New York State, 1983-1994. MMWR Morb Mortal Wkly Rep 1987;36:80-2.1184. Vitamin A policy. Council for responsible nutrition news. March 1987:1-2. 1185. Bendich A, Langseth L. Safety of vitamin A. Am J Clin Nutr 1989;49:358-71. 1186. Hathcock J, Hattan D et al. Evaluation of vitamin A toxicity. Am J Clin Nutr 1990;52:183-202. 1187. Cohlan SQ. Congenital abnormalities in the rat produced by excessive intake of vitamin A during pregnancy. Pediatrics 1954;13:556-67.1188. Geelen JA. Hypervitaminosis A induced teratogenesis. Crit Rev Toxicol 1979;6:351-75. 1189. Pinnock CB, Alderman CP. The potential for teratogenicity of vitamin A and its cogeners. Med J Aust 1992;157:804-809.1190. Carper J. The Food Pharmacy, New York: Bantam, 1989. 1191. Wagner E. How to Stay out of the Doctor's Office. New York: Instant Improvement, 1992. 1192. Shills M. Modern Nutrition in Health and Disease, 7th edition, Philadelphia: Lea and Febiger, 1988. 1193. Somer E. Health Media of America, ed. Prescription Drugs and Nutrition, San Diego, CA: Garrison, 1986. 1194. Cleary A. Nutrition Letter, Eating Well, IV(4), 1994. 1195. Evans GW. The effect of chromium picolinate on insulin controlled parameters in humans. Int J Biosoc Med Res 1989;11(2):163-180.1196. Page TG, Ward TL, Southern LL. J Animal Sci 1991;69; Suppl 1: Abstract 403. 1197. Felig P. Clin Physiol 1984;4:267-273. 1198. Kimball SR, Jefferson LS. Diabetes Metab Rev 1988;4:773. 1199. Fukugawa NK, Minaher KL, Rowe JW et al. J Clin Invest 1985;76:2306. 1200. Fehlmann M, Freychet P. Biol Chem 1981;256:7449. 1201. Pittman CS, Suda AK, Chambers JB, Jr., Ray GY. Metabolism 1979;28:333. 1202. Danforth E, Jr. Am J Clin Nutr 1985; 41:1132. 1203. McCarty MF. Med Hypoth 1986;20:183. 1204. Bielinski R, Schutz Y, Jequier E. Am J Clin Nutr 1985;42 1205. Young JC, Treadway JL, Balon TW et al. Metabolism 1986;35:1048. 1206. Alastair JJ. Paclitaxel (Taxol). New Engl J Med 1995;332:1004-1014. 1207. Ketterer, M.W. American Psychosomatic Society, (oral presentation) March, 1 1995. 1208. Imai K. Cross sectional study on the effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995;310:693-6.1209. AIBR Scientific Reviews. Botanical Medical Series. No.7, 1987. 1210. Alderman MH, et al. The association of different levels of sodium intake with morbidity and mortality in men with hypertension. Hypertension, June 1995.1211. Free Radical Res 1994;21(5):267-276. 1212. Woosley J. Am Med Assn. March 24, 1993. 1213. Guengerich. Carcinogenesis, 1990, pp2275-2279. 1214. Bailey et al. The Lancet, 1991. 1215. Edgar et al. Eur J. Clin Pharm, 1992. 1216. Soons et al. Clin Pharmacol Ther, 1991. 1217. Journal of the National Cancer Institute 1994;86:1403. 1218. Journal of the National Cancer Institute 1993;85:819. 1219. Czeisler, CA. Supression of Melatonin secretion in some blind patients by exposure to bright light. N Engl J Med 1995;332:6-11. 1220. Clark N, ed. Environmental Nutrition 1995;18(12):7. 1221. Lowe C. The Complete Vitamin Book. New York. Berkley Books, 1994. 1222. Whitaker, J, ed. The three minerals that control your blood pressure. Health and Healing. 4(3), March 1994:3-4. 1223. Spraycar M. ed. The PDR Medical Dictionary. Williams and Wilkins: Baltimore, MD. 1995. 1224. Peto R, Doll R, et al. Can dietary beta carotene materially reduce human cancer rates? Nature 1981;290:201-208. 1225. National Research Council. Diet, Nutrition, and Cancer. Washington, DC: National Academy Press, 1982. 1226. Shekelle RB, Lepper M, Liu S, et al. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 1981;2:1185-90.1227. Harayama T. Diet and cancer. Nutr Cancer, 1979;1(3):67-81. 1228. Ziegler, RG. A review of epidemiologic evidence that carotenoids reduce the risk of cancer. J Nutr 1989;119:116-122.1229. Byers T, Perry G. Dietary carotenes, vitamin C and vitamin E as protective antioxidants in human cancers. Annu Rev Nutr 1992;12:139-159.1230. Bjelke E. Dietary vitamin A and human lung cancer. Int J Cancer 1975;15:561-565. 1231. Kvale G, Bjelke E, Gart JJ. Dietary habits and lung cancer risk. Int J Cancer 1983;31:397-405. 1232. Comstock GW, Bush TL, Hezlsouer K. Serum retinol, beta carotene, vitamin E and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 1992;135:115-121.1233. Longnecker MP, Martin-Moreno JM, et al. Serum alpha tocopherol concentration in relation to subsequent colorectal cancer: pooled data from five cohorts. J Natl Cancer Inst 1992;84:430-435.1234. Bostik R, Potter J, et al. Reduced risk of colon cancer with high intake of vitamin E: the Iowa Women's Health Study. Cancer Res 1993;53:4230-7.1235. Oral vitamin B12 and supression of asthmatic reaction in children. J Allergy Clin Immunol 1992;90:103-109. 1236. Hydroxycitric acid, a derivative of garcinia cambogia reduces food intake and body weight gain. Nutrition Research 1988; 8:209-212.1237. Stoecker BJ. Chromium. in Present Knowledge in Nutrition. Brown ML, ed. International Life Sciences Institute. Nutrition Foundation, Washington, D.C., 1990.1238. Anderson RA, Kozlosvsky AS. Chromium intake, absorption and excretion of subjects consuming self selected diets. Am J Clin Nutr 1985;41:1177-1183.1239. Anderson RA, Polansky MM, et al. Effect of exercise (running) on serum glucose, insulin, glucagon, and chromium excretion. Diabetes 1982;31:212.1240. Anderson RA, Bryden NA, et al. Exercise effects on chromium excretion of trained and untrained men consuming a constant diet. J Appl Physiol 1988;64:249.1241. Levander OA, Burk RF. Selenium. in Present Knowledge in Nutrition. Brown ML, ed. International Life Sciences Institute. Nutrition Foundation, Washington, D.C., 1990.1242. Welland M. Caffeine controversy. in: Environmental Nutrition 1996:19(1):1-6. 1243. Castelli, W. in: McCarthy L. What the experts eat. Cooking Light 1996;10(1):84. 1244. Webb D. Environmental nutrition 1996 nutrition guide. Environmental Nutrition 1996:19(1):4. 1245. American Heart Association. American Heart Association mission statement. Dallas, Texas, 1996. 1246. Schutz Y. Macronutrients and energy balance in obesity. Metabolism 1995;44(9); suppl 3:7-11. 1247. Vitamin D deficiencies in the elderly. Journal of the American Medical Association, 1995;274:1683. 1248. Manson JE, Willett WC, et al. Body weight and mortality among women. New Engl J Medicine 1995:333;677-685. 1249. Serum cholesterol levels and risk of death from coronary heart disease in the elderly. Journal of the American Medical Association 1995;274:539-544.1250. Fischer JA. The Chromium Program. Harper and Row publishers. New York, 1990. 1251. Hypovitaminosis in mental diseases. Acta Med Scand 1965;177:689-699. 1252. Zucker DK, et al. B12 deficiency and Psychiatric disorders: case report and literature review. Biol Psychiatry 1981;16:197-205.1253. Reading CM. Latent pernicious anemia: a preliminary report. Med J Aust 1975;1:91-94. 1254. Bell I, et al. Vitamin B12 and folate status in acute geropsychiatric inpatients: affective and cognitive characteristics of a vitamin nondeficient population. Biol Psychiatry 1990;27(2):125-37.1255. van Praag HM, et al. Therapeutic indications for serotonin-potentiating compounds: an hypothesis. Biol Psychiatry 1987;22(2):205-12.1256. Brain trace elements in Alzheimer's disease. Terry RD, Katzman R, Bick KL, editors. Alzheimer Disease. Raven Press. New York, 1991.1257. Crook et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology 1991;41:644-649. 1258. Hikino et al. Antihepatotoxic actions of silymarin. Planta Medica 1984;50:248-50. 1259. McCarty. Toward a bioenergy supplement, Lipoic Acid. Med Hyp 1981;7:515-538. 1260. Sprince et al. Protective action of ascorbic acid and sulfur compounds (cysteine) against acetylaldehyde toxicity. Implications in alcoholism and smoking. Agents and Actions 1975;5:164-173.1261. Bryson Y, Pang S, et al. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-8.1262. Barshi S, Tetali S, et al. Repeatedly positive human immunodeficiency virus type 1 DNA polymerase chain reaction in human immunodeficiency virus-exposed seroconverting infants. Pediatr Infect Dis J 1995;14:658-62.1263. Roques PA, Gras G, et al. Clearance of HIV infection in 12 perinatally infected children: clinical, virological, and immunological data. AIDS 1995;9(12):F19-F26.1264. Dusenberg, Peter (Ph.D.). Inventing the AIDS Virus. 1996. 1265. Takihara K. Azuma J. et al. Beneficial effects of Taurine in rabbits with chronic congestive heart failure. Am Heart J 1986;112(6):1278-84.1266. Poole-Wilson P.A. Current therapeutic priinciples in the acute management of severe congestive heart failure. Am J Cardiol 1988;62(5):4C-8C.1267. Wallach J. Ma Lan. Rare Earths. Double Happiness Publishers: Bonita California. 1995. 1268. Ridker PM, Baldwin J. Heart Disease. Harvard Health Letter 1996;21(9)1-3. 1269. University Group Diabetes Program Study. Diabetes 1970;19; Suppl.2: 747-830. 1270. American Diabetes Association. Position Statement: implications of the Diabetes Control and Complication Trial. Diabetes 1993;42:1555-1558.1271. Brown G, Albers JJ, et al. Regression of coronary artery disease as a result of intensive lipid lowering therapy in men with high levels of apolipoprotein B. Familial Atherosclerosis Treatment Study (FATS). N Engl J Med 1990;323:1289-1298.1272. Palor M, Guralnik J, et al. Do calcium channel blockers increase the risk of cancer? Am J Hypertens 1996;9:695-699.1273. Whitfield JF. Calcium signals and cancer. Crit Rev Oncogen 1992;3:55-90. 1274. Carlson DA, Ribeiro JM. Apoptosis and disease. Lancet 1993;341:1251-1254. 1275. Martin SJ; Green DR. Apoptosis and cancer: the failure of controls on cell death and survival. Crit Rev Oncol Hematol 1995;18:137-153.1276. Trump BF, Berezesky IK. Calcium mediated cell injury and cell death. FASEB J 1995;9:219-228. 1277. Furberg CD, Pahlor M, Psaty BM. The unnecesary controversy. Eur Heart J 1996. 1278. Barta S, Popper LD. Effect of calcium and calcium antagonists on calcium influx and cellular growth of human prostatic tumor cells. Prostate 1991;19:299-311.1279. Tenniswood MP, Guenette MS, et al. Active cell death in hormone-replacement tissues. Cancer Metast Rev 1992;11:197-220.1280. Mountz JD, Wu J, et al. Autoimmune disease. A problem of defective apoptosis. Arthritis Rheum 1994;37:1415-1420. 1281. Beilharz EJ, Williams CE, et al. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res 1995;29:1-14.1282. Gottlieb RA, Burleson KO, et al. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J clin Invest 1994;94:1621-1628.1283. Isner JM, Kearney M, et al. Apoptosis in human atherosclerosis and restenosis. Circulation 1995; 91:2703-2711. 1284. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary arteriosclerotic plaques. J Clin Invest 1995;95:2266-2274.1285. Wright SC, Zhong J, et al. Nicotine inhibition of apoptosis suggests a role in tumor promotion. FASEB J 1993;7:1045-1051.1286. Maneckjee R, Minna JD. Opoids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 1994;5:1033-1040.1287. Garland C, Shekelle RB, Barrett-Connor E, et al. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;i:307-309.1288. Orrenius S, McClonkey DJ, et al. Role of calcium in toxic cell killing. Trends Pharmacol Sci 1989;10:281-285. 1289. Food interactions with warfarin. New Engl J Med 1983;308;20:1229. 1290. Smith DL. Understanding Presciption Drugs. Pocket Books. New York, 1987. 1291. American Journal of Obstetrics and Gynecology 1985 (July 15);152 (6):668-670. 1292. Ceriello A, Guigliano D, et al. Vitamin E and reduction of protein glycosylation in diabetes. Diabetes Care 1991;14:68-72.1293. Davie S, Gould B, Yudkin J. Effect of vitamin C on glycosylation of proteins. Diabetes 1992;41:167-73. 1294. Cunningham J, Mearkle P, Brown RG. Vitamin C: An aldose reductase inhibitor that normalizes erythrocyte sorbitol in insulin-dependent diabetes mellitus. J Am Coll Nutr 1994;13(4):344-350.1295. Jain S, McVie R, et al. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989;38:1539-43.1296. Paolisso G, Maro G, et al. Pharmacologic doses of vitamin E and insulin action in elderly subjects. Am J Clin Nutr 1994;59:1291-1296.1297. Giovanucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willet WC. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993;269(7):873-877.1298. Morrison H, Savitz D, et al. Farming and prostate cancer mortality. Am J Epidemiol 1993; 137(3):270-280. 1299. Lu-Lao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in the USA. Lancet 1994;343(8892):251-254.1300. Kurtzberg J, Laughlin M, et al. Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J med 1996;335:157-166.1301. Hypertension 1995;25:305. 1302. Belluzzi A, Brignola C, et al. Effect of an enteric-coated fish oil preparation on relapses in Crohn's disease. N Engl J Med 1996;334:1557-60.1303. Herbert J. The age of dehydroepiandosterone. The Lancet 1995; 345:1193-1194. 1304. Passwater RA, Kandaswami C. Pycnogenol, the Super Protector Nutrient. New Canaan, CT: Keats Publishing, Inc., 1994. 1305. Anderson TN, et al. Letter: Ischemic heart disease, water hardness, and myocardial magnesium. Can Med Assoc J 1975;113:119-203.1306. Coren S. The Left-Hander Syndrome. University of British Columbia, Vancouver. Vintage Books, 1996. 1307. Flynn M. Vitamin E: Evidence is finally catching up with hype. in: Environmental Nutrition 1996;19(8):1-4. 1308. Casdorph HR, Walker M. Toxic Metal Syndrome. Avery Publishing: New York. 1995. 1309. Leslie D, Gheorghiade M. Is there a role for thiamine supplementation in the management of heart failure? Am Heart J 1996;131(6):1248-50.1310. Fitzgerald GA, Reilly M, et al. A measure of oxidant stress and the protective effects of antioxidant vitamins in smokers. Circulation 1996;93 (July 1). 1311. Rector T, Bank A, et al. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93:2135-2141.1312. Kalimi M, Regelson W. (eds) The biologic role of dehydroepiandosterone. New York: DeGruyter, 1990. 1313. Holden C. Interest grows in anti-aging drug. Science 1995;269:33. 1314. Barrett-Connor E, et al. A prospective study of dehydroepiandosterone sulfate, mortality, and heart disease. New Engl J Med 1986;315:1519-1524.1315. Bilger B. Forever young. Sciences 1995;(September/October):26-31. 1316. Regelson W, et al. Dehydroepiandosterone (DHEA), "the mother steroid". Ann NY Acad Sci, 1994;719:553-563. 1317. Cleary MP. Minireview. The antiobesity effect of DHEA in rats. Proc Soc Exp Biol Med 1991;196:8-16. 1318. Cleary MP et al. Effects of short term DHEA treatment on serum and pancreatic insulin in Zucker rats. J Nutr 1988;118:382-387.1319. Berdanier CD. DHEA: useful or useless as an antiobesity agent. Nutrition Today 1993; November/December:34-38. 1320. Usiskin KS et al. Lack of effect of DHEA in obese men. Int J Obesity 1990;14:457-463. 1321. Barrett-Connor E, Edelstein SL. A prospective study of DHEA-S and cognitive function in an older population. The Rancho Bernardo Study. J Am Geriat Soc 1994;42:420-423.1322. Carlstrom KS, et al. Dehydroepiandosterone sulfate and dehydroepiandosterone in serum. Differences related to age and sex. Maturitas 1988;10:297-306.1323. Rosenberg S et al. Serum levels of DHEA-S in the perimenopause. Ann NY Acad Sci 1990;592:469-471. 1324. Bologna L, et al. DHEA and its sulfated derivative reduce neuronal death and enhance astrocytic differentiation in brain cell cultures. J Neurosci Res 1987;17:225-234.1325. Rudman D, et al. Plasma DHEA-S in nursing home men. J Am Geriat Soc 1990;38:421-427. 1326. Crespo D, et al. Interactions between melatonin and estradiol on morphological and morphometric features of MCF-7 human breast cancer cells. J Pineal Res 1994;16:215-222.1327. Ebeling P, Koivisto V. Physiological importance of DHEA. Lancet 1994;343:1479-1481. 1328. Holden C. Interest grows in anti-aging drug. Science 1995;269:33. 1329. Mortola Y, Yen S. The effects of oral dehydroepiandosterone on endocrine parameters in postmenopausal women. Endocrinol Metab 1990;71:690-704.1330. Barett-Connor E, Khaw K. Absence of an inverse relation of DHEA-S with cardiovascular mortality in postmenopausal women. N Engl J Med 1987;317:711.1331. Bush T, et al. Cardiovascular mortality and non-contraceptive use of estrogen in women: Results from the Lipid Research Clinics program follow-up study. Circulation 1987;75:1102-1109.1332. Rotter J, et al. A genetic component to the variation of DHEA. Metabolism 1985;34:731-736. 1333. Williams D, et al. Relationship of body fat percentage and fat distrobution with DHEA in premenopausal females. J Clin Endocrin Metab 1993;77:80-85.1334. Nestler J, et al. DHEA reduces serum low density lipoprotein levels and bodyfat but doesnt alter insulin sensitivity in normal man. J Clin Endocrinol Metab 1988;66:57-61.1335. Mortola J, Yen S. Effects of DHEA on endocrine metabolic parameters in postmenopausal women. J Endocrinol Metab 1990;71:696-704.1336. Porter JR et al. The effect of discontinuing DHEA supplementation on Zucker rat food intake and hypothalamic neurotransmitters. Int J Obesity 1995;19:480-488.1337. Bremmer W, et al. Loss of circadian rythmicity in blood testosterone levels with aging in normal men. J Clin Endocrin Metab 1983;56;1278-1281.1338. Morales A et al. Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endocrin Metab 1994;78:1360-1367.1339. Haffner S, et al. Decreased testosterone and DHEA-S concentrations are associated with increased insulin and glucose concentrations in men. Metabolism 1994;43:599-603. 1340. Coleman D, et al. Therapeutic effects of DHEA in diabetic mice. Diabetes 1982;31:830-833. 1341. Coleman D, et al. Effects of genetic background on the therapeutic effects of DHEA in diabetes-obesity mutants and in aged normal mice. Diabetes 1984;33:26-32.1342. Casson P, et al. Replacement of DHEA enhances T-lymphocyte insulin binding in postmenopausal women. Fertil Steril 1995;63:1027-1031.1343. Fried S, et al. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J Clin Invest 1993;92:2191-2198. 1344. Zurnoff B. Acta Med Scand 1988;723:153-160. 1345. Motzer R, Bander N, Nanus D. Renal cell carcinoma. New Engl J Med 1996;335(12):865-875. 1346. Douban S, Brodsky M, et al. Significance of magnesium in congestive heart failure. Am Heart J 1996;132(3):664-671.1347. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996;64:190-6.1348. Kushi LH, Folsom AR, et al. Dietary antioxidant vitamins and death from coronary heart disease in post menopausal women. N Engl J Med 1996;334:1156-62.1349. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.1350. Omenn GS, Gordon GE, et al. Effects of a combination of beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1996;334:1150-5.1351. Zhou YF, Leon MB, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.1352. Manson JE, Faich GA. Pharmacotherapy for obesity--Do the risks outweigh the benefits? N Engl J Med 1996;335(9):659-60.1353. Siscovick D et al. Fish consumption and the incidence of cardiac arrest in a metropolitan population. JAMA 1995;274:13631354. National Research Council, Committee on Diet and Health. Diet and health: implications for reducing chronic disease risk. Washington, D.C. National Academy Press, 1989.1355. Singer A, Werther K, Nestle M. The Nutritional Value of University Hospital Diets. N Engl J Med 1996;335:1466-7. 1356. Payton M, Hu H, et al. Low level lead exposure and renal function in the normal aging study. Am J Epidemiol 1994;140;821-9.1357. Whitaker, J. Special Update. Health and Healing; Supplement; 6(7);1-2 July,1996. 1358. Ornish D, et al. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol 1992;69(10):845-853.1359. Gabriel SE, O'Fallon W, et al. Risk of connective tissue diseases and other disorders after breast implantation. N Engl J Med 1994;330:1697-1702.1360. Sanchez-Guerrero J, Colditz G, et al. Silicone breast implants and the risk of connective tissue diseases ans symptoms. N Engl J Med 1995;332:1666-1670.1361. Goldberg E. Evaluating the health risks of breast implants. N Engl J Med 1996;335:1154 1362. Garland C, Shekelle RB, Barrett-Connor E, et al. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 1985;i:307-309.1363. Pahor M, Guralnik J, et al. Calcium channel blockade and the incidence of cancer in aged populations. Lancet 1996;348:493-497.1364. Chapuy MC et al. Regression of osteoporosis of the femur by calcium and vitamin D supplementation among a cohort of elderly women. New England Journal of Medicine, 1992:327;1637-42.1365. Smith CJ. Non-hormonal control of vasomotor flushing in menopausal patients. Chicago Medicine, 1964 (March 7). 1366. Robbins RC. On bioflavonoids: new findings about a remarkable plant defense against disease and its dietary transfer to man. Executive Health 1980;17(12), (September, 1980).1367. Daling JR, Malone Ke, et al. Risk of breast cancer among young women: relationship to induced abortion. J Natl Cancer Inst 1994;86:1584-92.1368. Newcomb PA, Storer BE, et al. Pregnancy termination in relation to risk of breast cancer. JAMA 1996;275:283-7. 1369. Ewertz M, Duffy SW. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 1988;58:99-104.1370. Howe HL, Senie RT, et al. Early abortion and breast cancer risk among women under age 40. Int J Epidemiol 1989;18:300-4.1371. Pike MC, Henderson BE, et al. Oral contraceptive use and early abortion as risk factors for breast cancer: a case-control study in Greece. Int J Cancer 1995;61:181-4.1372. Brind J, Chichilli VM, et al. Induced abortion as an independent risk factor for breast cancer: a comprehensive review and meta-analysis. J Epidemiol Community Health 1996;50:481-96.1373. Melbye M, Wohlfahrt J, et al. Induced abortion and the risk of breast cancer. N Engl J Med 1997;336:81-5. 1374. Takekoshi N, Murakami E, Ohkubo S. Effects of some radical scavengers on reperfusion-induced arrhythmias in the canine heart. Cardiovas Drugs Ther (United States), March 1991;(5);suppl 2:289-95.1375. Davini A, Cellerini F, Topi PL. Coenzyme Q10: contractile dysfunction of the myocardial cell and metabolic therapy. Minerva Cardioangiol (Italy); Nov 1992;40(11):449-53.1376. Janson M. The Vitamin Revolution in Health Care. Arcadia Press, Greenville, NH; 1996. 1377. Freye E, Hartung E. The potential use of thiamine in patients with cardiac insufficiency. Acta Vitaminol Enzymol 1982;4(4):285-90.1378. Shimon I, Almog S, et al. Improved left ventricular function after thiamine supplementation in patients with congestive heart failure receiving long-term furosemide therapy. Am J Med 1995;98:485-90.1379. Seligmann H, Halkin H, et al. Thiamine deficiency in patients with congestive heart failure receiving long term furosemide therapy: a pilot study. Am J Med 1991;91:151-5.1380. Hogue VW, Keeys CA. Multidisciplinary monitoring of adverse drug reactions. Federal Practitioner 1997;14(1):27-36.1381. McCarron DA, Oparil S, et al. Nutritional management of cardiovascular risk factors. Arch Intern Med 1997;157:169-177.1382. Slattery ML, Jacobs DR Jr, Nichaman MZ. Leisure time physical activity and coronary heart disease death: the US Railroad Study. Circulation 1989;79:304-11.1383. Champault G, Patel JC, Bonnard AM. A double blind trial of an extract of the plant Serona Repens in Benign Prostatic Hyperplasia. British J Clin Pharmacol 1984;18:461-2.1384. Buccafoschi C, Annoscia S. Comparison of Serona Repens Extract with placebo by controlled clinical trial in patients with prostatic adenomatosis. Urologica 1983;50:1257-1268.1385. Duvia R, Radice GP, Galdini R. Advances in the phytotherapy of prostatic hypertrophy. Med Praxis 1983;4:143-8. 1386. Burton Goldberg Group, eds. Alternative Medicine, the Definitive Guide. Future Medicine Publishing. Fife, WA. 1995.1387. Irwin M, et al. Partial sleep deprivation reduces natural killer cell activity in humans. Psychosomatic Medicine, November 1994.1388. Trentham DE, et al. Oral collagen in the treatment of rheumatoid arthritis. Science 1993:261:1727-1730. 1389. Barinaga M. Type II oral collagen in the treatment of severe rheumatoid arthritis. Science 1993;261:1669-1670. 1390. Adriazola, Semino, et al. Symptomatic treatment of benign hypertrophy of the prostate. Comparative study of prazosin and Serona repens. Archivos Espanoles de Urologica 1992;45(3):211-3.1391. Barlet A, et al. Efficacy of Phygeum africanum extract in the treatment of micturitional disorders due to benign prostatic hyperplasia. Evaluation of objective and subjective parameters. A multicenter, randomized, double-blind trial. Wiener Klinische Wochenschrift 1990;102(22):667-673 (November 23, 1990).1392. Bassi P, et al. Standardized phygeum africanum extract in the treatment of benign prostatic hypertrophy: a controlled clinical trial versus placebo. Minerva Urologica e Nephrologica 1987;39:45-50.1393. Carani C, et al. Urological and sexual evaluation of treatment of benign prostatic disease using phygeum africanum at high doses. Archivia Italiano di Urologica, Nephrologia, Andrologia 1991;63(3):341-5.1394. Di Siliverio F et al. Evidence that serona repens extract displays an antiestrogenic activity in prostatic tissue of benign prostatic hypertrophy patients. European Urology 1992;21(4):309-14.1395. Fahim MS, et al. Effect of panax ginseng on testosterone level and prostate in male rats. Archives of Andrology 1982;8(4):261-3.1396. Feinblatt HM, Grant JC. Palliative treatment of benign prostatic hypertrophy; value of glycine, alanine, glutamic acid combination. Journal of the Maine Medical Association, 1958.1397. Leake A, Chrisholm G et al. The effect of zinc on 5-alpha reduction of testosterone by the hyperplastic human prostate gland. Journal of Steroid Biochemistry 1984;20(2):651-665.1398. Fahim MS, Sutcu MF, et al. Zinc arginine, a 5-alpha reductase inhibitor, reduces rat ventral prostate weight and DNA without effecting testicular function. Andrologia 1993;25(6):369-75 (Nov-Dec 1993).1399. Doombrowicz E, Zadernowski R, Swiatck L. Phenolic acids in the leaves of arctostaphylos uva ursi. Pharmazie 1991;46(9):680-1.1400. Matsudia H, Kubo M. Pharmacological studies on leaf of arctostaphylos uva ursi. Journal of the Pharmaceutical Society of Japan 1992;112(9):673-77.1401. Thieblot L, Berthelay S, Berthelay J. Preventive and curative action of a bark extract from an African plant, phygeum africanum, on experimental prostatic adenoma. Therapie 1971;26(3):575-580.1402. Evans G, Johnson E. Effect of iron, vitamin B6 and picolinic acid on zinc absorption in the rat. Journal of Nutrition 1981;111:68-75.1403. Sulton C, et al. Inhibition of adrogen metabolism and binding by a liposterolic extract of serona repens B in human foreskin fibroblasts. Journal of Steroid Biochemistry 1984;20(1):515-519 (January, 1984).1404. Abyholm T, Kofstad. Seminal plasma fructose, zinc, magnesium and acid phosphatase in cases of male infertility. International Journal of Andrology 1981;4:75-81.1405. Deger O, Akkus I. Semen magnesium levels in fertile and infertile subjects. Magnesium 1988;7: 6-8. 1406. Whelan P, Walker BE, Kelleher J. Zinc, vitamin A and prostatic cancer. British Journal of Urology 1983;55(5):525-8.1407. Rugendorff EW, Buck AC. Results of treatment with pollen extract (Cernilition N) in chronic prostatitis and prostatodynia. British Journal of Urology 1993;71(4):433-438.1408. Stanko, RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a 4.25 MJ/d low energy diet supplemented with pyruvate. American Journal of Clinical Nutrition 1992;56:630-5.1409. Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization and nitrogen metabolism with severely restricted diet supplemented with dihydroxyacetone and pyruvate. American Journal of Clinical Nutrition 1992;55:771-5.1410. Elghamry MI, Hansel, R. Experientia 1969;25:828-9. 1411. Harnischfeger G, Stolze H. Zeitschrift fur Phytotherapie 1989;10:71. 1412. Bundesanzeiger, January 5, 1989 and February 1, 1990. 1413. Lowe FC, et al. Phytotherapy in the treatment of benign prostatic hyperplasia. Urology 1996;48(1):12-20 (July, 1996).1414. Schauss AG. Colloidal Minerals: Clinical Implications of clay suspension products sold as dietary supplements. American Journal of Natural Medicine 1997;4(1):5-10.1415. Anderson RA. In: Essential and Toxic Trace Elements in Human Health and Disease: An Update. Wiley-Liss, Inc. 1993: 221-234.1416. Anderson RA, Klotsky AS. Am J Clin Nutr 1985;41:1177-1183. 1417. Anderson RA. Stress and Chromium Depletion. Clin Physiol Biochem 1986;4:31-41. 1418. Kaats GR, Blum K, Fisher JA, Adelman JA. Curr Ther Res 1996;57:747-756. 1419. Bulbulian R, Pringle DD, Liddy MS. J Am Coll Sports Med 1996;28(suppl 5):S111. 1420. Pak CY, Fuller C, et al. Long term treatment of calcium nephrolithiasis with potassium cirtrate. J Urol 1985;134:11-19.1421. Preminger GM, Pak CY. The practical evaluation and selective medical management of nephrolithiasis. Seminars in Urology 1985;3:170-184.1422. Nygard O, Nordrehaug J, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.1423. Moreland LW, Baumgartner SW, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor antagonist fusion protein. N Engl J Med 1997;337:141-7.1424. Chu CQ, Field M, et al. Localization of tumor necrosis factor alpha in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.1425. Saxne T, Palladino MA, et al. Detection of tumor necrosis factor alpha but not tumor necrosis factor beta in rheumatoid arthritis synovial fluid and serum. Arthritis Rheum 1988;31:1041-5.1426. Beckman JC, Caldwell DS, et al. Disease severity in rheumatoid arthritis: relationships of tumor necrosis factor alpha, soluble interlukin-2 receptor, soluble CD4/CD8 ratio, neopterin, and fibrin d-dimer to traditional severity and functional measures. J Clin Immunol 1992;12:353-61.1427. Digel W, Porzsolt F, et al. High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest 1992;89:1690-3.1428. Elsasser-Beile U, Gallati H, et al. Increased plasma concentrations for type I and type II tumor necrosis factor receptors and IL-2 receptors in cancer patients. Tumor Biol 1994;15:17-24.1429. Tsukada N, Matsuda M, et al. Increased levels of intracellular adhesion molecule-1 and tumor necrosis factor receptor in the cerebrospinal fluid of patients with multiple sclerosis. Neurology 1993;43:2679-82.1430. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.1431. Liuzzo G, Biasucci LM, et al. The prognostic value of C-reactive protein and serum amyloid-A protein in severe unstable angina. N Engl J Med 1994;331:417-24.1432. Graham IM, et al. Plasma homocysteine as a risk factor for vascular disease. JAMA 1997;277(22):1775-1786. 1433. McCully KS. Vascular pathology of homocysteinemia--implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111.1434. McCully KS. The Homocysteine Revolution. Keats Publishing, Inc. New Canaan, CT, 1997. 1435. Holvey DN, Talbott JH, eds. The Merck Manual of Diagnosis and Therapy. Merck and Co., Rahway, NJ. 1972. 1436. Harvard Men's Health Watch. Harvard College. September 1997; Volume 2(2). 1437. Gupta, S. Apoptosis and programmed cell death. A historical perspective. Advances in Experimental Medicine and Biology. 406:1, 1996.1438. Langsjoen PH, Vadhanavikit S, Folkers K. Respose of patients in classes III and IV of cardiomyopathy to therapy in a blind and crossover trial with coenzyme Q-10. Proc Natl Acad Sci USA 1985;82:4240.1439. Langsjoen PH, Langsjoen PH, Folkers K. Long term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 1990;65:521-3. 1440. Kamikawa T, Kobayashi A, et al. Effects of Coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol 1985;56:247-51.1441. Mayer R, Schnipper L. Winning the war on cancer. New Engl J Med 1997;337:935 1442. Bailar J, Gornick H. Cancer undefeated. N Engl J Med 1997;336:1569-74. 1443. Greenhaff, PL. Creatine and its application as an ergogenic aid. International Journal of Sport Nutrition 1995;5:S100-S110.1444. Greenhaff PL, Casey A, Shrot, AH, et al. Influence of oral creatine supplementation on muscle torque during repeated bouts of maximal voluntary exercise in man. Clinical Science 1993;84:565-571.1445. Walker JB. Creatine: Biosynthesis, regulation and function. Advances in Enzymology and Related Areas of Molecular Biology. 1979;50:177-242.1446. Webster's Encyclopedic Unabridged Dictionary of the English Language. Gramercy Books. New York. 1989. 1447. Trans fatty acids and coronary heart disease risk: report of the Expert Panel on Trans Fatty Acids and Coronary Heart Disease. Am J Clin Nutr 1995;62:Suppl:655s-708s.1448. Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997;337:1491-9.1449. Ascherio A, Rimm EB, Giovanucci, Spiegelman D, Stampfer M, Willett WC. Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ 1996;313:84-90.1450. Pietinen P, Ascherio A, Korhonen, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta Carotene Cancer Prevention Study. Am J Epidemiol 1997;145:876-87.1451. Gillman MW, Cupples LA, et al. Margarine intake and subsequent coronary heart disease in men. Epidemiology 1997;8:144-9.1452. Kohlmeier L, Simonsen N, et al. Adipose tissue trans fatty acids and breast cancer in the European Community Multicenter study on Antioxidants, Myocardial Infarction, and Breast Cancer. Cancer Epidemiol Biomarkers Prev 1997;6:705-10.1453. Pang PKT, Lewanchuk RZ, et al. The discovery of a new hormone from the parathyroid gland. Perspectives in Comparative Endocrinology 1994:186-190.1454. Pang PKT, Shan J, et al. Parathyroid hypertensive factor and intracellular calcium regulation. Hypertension 1996;14:1053-1060.1455. Thomson B. Health Brief: Colloidal Minerals. Natural Health, May/June 1997:130. 1456. O'Sullivan JB, Mahan CM. Criteria for the oral glucose tolerance test in pregnancy. Diabetes 1964;13:278-85. 1457. Greene. Screening for Gestational Diabetes Mellitus. N Engl J Med 1997;337(22):1625-6. 1458. Naylor CD, Sermer M, Chen E, et al. Selective screening for gestational Diabetes Mellitus. N Engl J Med 1997;337(22):1591-6.1459. Martin W. Reducing deaths from heart attacks and cancer. Townsend Letter for Doctors and Patients;1988;174:72-76 1460. Fitzpatrick AL et al. Use of calcium channel blockers and breast carcinoma in postmenopausal women. Cancer; October 15,19971461. Gibbon AG. Ischemic necrosis of the heart. Lancet 1925;i;1270-9. 1462. Findlayson, R. Ischemic heart disease, aortic aneurysms and atherosclerosis in the city of London 1868-1982. Medical History Supplement 5, 1995;151-169. 1463. Mackinnon A. The origin of the modern epidemic of coronary heart disease in England. Journal of the Royal College of General Practitioners 1987 (April);174-176.1464. Maughan RJ. Creatine supplementation and exercise performance. International journal of Sports Nutrition 1995;5:94-101.1465. Thun MJ, Peto R, Lopez AD, et al. Alcohol consumption and mortality among middle aged and elderly U.S. adults. N Engl J Med 1997;337:1705-141466. Farrell PM, et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 1997;337:963-9. 1467. Oliver MF. It is more important to increase the intake of unsaturated fats than to decrease the intake of saturated fats: evidence from the clinical trials relating to ischemic heart disease. Am J Clin Nutr 1997;66(suppl):980S-9866S.1468. Fleming, DT. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997;337:1105-1111. 1469. Weinberg, RA. How Cancer Arises. Scientific American, September, 1996. 1470. Thune I, et al. Physical activity and the risk of breast cancer. N Engl J Med 1997;336(18):1269-1275. 1471. Whelton PH, He J, Cutler JA, et al. Effects of oral potassium on blood pressure: meta-analysis of randomized, controlled clinical trials. JAMA 1997;1624-1632.1472. Cappuccio FP, Elliott P, Allender PS, et al. Epidemiologic association between dietary calcium intake and blood pressure: a meta-analysis of published data. Am J Epidemiol 1995;142:935-945.1473. Allender PS, Cutler JA, Follmann D, et al. Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med 1996:124:825-31.1474. Toft I, Bonna KH, Ingebretsen OC, et al. Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension: a randomized, controlled trial. Ann Intern Med 1995;123:911-918.1475. Stamler J, Caggiuala AW, Grandits GA. Chapter 12. Relation of body mass and alcohol, nutrient, fiber, and caffeine intakes to blood pressure in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr 1997;65(suppl):338S-365S.1476. Obarzanek E, Velletri PA, Cutler JA. Dietary protein and blood pressure. JAMA 1996;275:1598-1603. 1477. Stamler J, Elliottt P, Kesteloot H, et al. Inverse relationship of dietary protein markers with blood pressure: findings for 10,020 men and women in the INTERSALT study. Circulation 1996;94:1629-1634.1478. The Maylay Mail. Friday, November 17, 1995. p. 76. 1479. Pincus et al. Alpha tocopherol and Alzheimer's disease. New Engl J Med 1997:337(8):572. 1480. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid wall thickness. The ARIC study. Circulation 1995;92:2142-2150.1481. Haigney MC, Silver B, Tanglao E, et al. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 1995;92:2190-2197.1482. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any other death in Eastern Finnish men. Circulation 1995;91:645-655.1483. Salonen JT, Seppanen K, Nyyssonen K, et al. Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any other death in Eastern Finnish men. Correspondence. Circulation 1995;92(8):2355-23561484. Sporn M. Chemoprevention of cancer. Lancet 1993;342:1211-1213. 1485. Lippman SM, Benner SE, Hong WK. Cancer Chemoprevention. J Clin Oncology 1994;12:851-873. 1486. Sorensen HT, Mellemkjaer L, et al. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 1998;338:1169-73.1487. Epstein S, Steinman D. The Breast Cancer Prevention Program. Macmillan, October, 1997. 1488. Lee JS, Lippman SM, et al. Randomized placebo-controlled trial of isotrentinoin in chemoprevention of bronchial squamous metaplasia. J Clinical Oncology 1994;12:937-945.1489. Lippman SM, Kessler JF, et al. Retinoids as preventive and therapeutic anticancer agents (part 1). Cancer Treatment Reports 1987;71:391-405.1490. Lotan R, Lippman SM, Hong WK. Retinoid modulation of squamous cell differentiation and carcinogenesis. Cancer Bulletin 1991;43:490-498.1491. Boyd AS. An overview of the retinoids. Am J Med 1989;86:569-574. 1492. Lippman SM, Batsakis JG, et al. Comparison of low-dose isotrentinoin with beta carotene to prevent oral carcinogenesis. N Engl J Med 1993; 328:15-20.1493. Paginini-Hill A. Aspirin and the prevention of colorectal cancer: A review of the evidence. Seminars in Surgical Oncology 1994;10:158-164.1494. Turner D, Berkel H. Nonsteroidal anti-inflammatory drugs for the prevention of colon cancer. Canadian Medical Association Journal 1993;149:595-602.1495. Renaud S, et al. Epidemiology 1998;9:184. 1496. Smith-Warner S, et al. Journal of the American Medical Association 1998;279:535 1497. Alpha tocopherol and Alzheimer's disease. N England J Med 1997;336:1216. 1498. Ginkgo Biloba and Alzheimer's disease. J Amer Med Association 1997;278:1327. 1499. Schwartz PJ, Stramba-Badiale, M, et al. Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 1998;338:1709-14.1500. Boden WE, O'Rourke RA, et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998;338:1785-92.1501. Link MS, Wang PJ, et al. An experimental model of sudden death due to low energy chest wall impact. N Engl J Med 1998;338:1805-11.1502. Stephen Frankel et al. British Medical Journal 1998;316:499-503. 1503. Nancy Potischman et al. Journal of the National Cancer Institute 1998;90:226-233 1504. Journal of the American Medical Association 1998;279:440-444 1505. Everett W. Newcomb III, Revised Heat Casualty/Overhydration Casualty Prevention Strategies, United States Army Infantry Center Publications, 19981506. Gennari, G. Hypokalemia. N Engl J Med 1998;339:451-8 1507. Gremillion RB, van Vollenhoven RF. Rheumatoid Arthritis: Designing and implementing a treatment plan. Postgraduate Medicine 1998;103(2):103-1231508. Tanner SB, Callahan LF, Panush R, et al. Dietary and allergic associations with rheumatoid arthritis: self report of 704 patients. Arthritis Care Res 1990;3:189.1509. Kremer JM, Bigauoette J, Michalek AV, et al. Effects of manipulation of dietary fatty acids on clinical manifestations of rheumatoid arthritis. Lancet 1985;1(8422):184-7.1510. Kremer JM, Jubiz W, Michalek A, et al. Fish-oil fatty acid supplementation in active rheumatoid arthritis: a double-blinded, controlled, cross-over study. Ann Intern Med 1987;106(4):497-503.1511. Kremer JM, Lawrence DA, Petrillo GF, et al. Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs: clinical and immune correlates. Arthritis Rheum 1995;38(8):1107-14.1512. Monastersky, Richard, Breast implants and autoimmune disease., Vol. 142, Science News, 12-12-1992, pp. 414. 1513. Bough WA, Landes DR. Recovery and nutritional evaluation of proteinaceous solids separated from whey by coagulation with chitosan. J Dairy Sci 1976 Nov;59(11):1874-80



References

Nutrition Advisor
1-800-833-3220
8815 Tayport Drive
Dublin, OH 43017


 

 

©2003 Nutritionadvisor, Inc
DISCLAIMER: We make no medical claims regarding our supplements. Our nutritional supplements are not intended to treat or cure any disease. Please contact your physician before embarking on any weight loss or exercise program.


This site was modified to present format on August 5, 2004.
This website was originally Established on November, 7 1997.